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Abstract 
 
The development of systems for the long term in vitro culture of functional 
liver tissue is a major research goal. The central limitation of experimental 
systems to date has been the early de-differentiation of primary hepatocytes in 
cultures. Several factors including cell-cell interaction, cell-matrix interaction, 
soluble factors and 3D structures have been identified as the keys to overcome 
this limitation. The first aim of this project is to compare the established 3D 
model, co-culture of hepatocytes and hepatic stellate cells (HSCs) on PDLLA 
coated surfaces, to other best available systems using collagen and Matrigel. 
The hypothesis is that hepatocytes functionalities, established by cell-cell 
interaction, 3D structures and soluble factors, can be further enhanced by 
introduction of cell-matrix interaction. 
 
In order to test the hypothesis, rat hepatocytes were cultured in five different 
systems, including monoculture of hepatocytes on collagen gel, in collagen-
Matrigel sandwich, co-culture of hepatocytes and HSCs on collagen gel, in 
collagen-Matrigel sandwich and on PDLLA coated surface. Hepatocyte specific 
function assays, namely albumin secretion, urea secretion, testosterone 
metabolism by HPLC and CYP activities by LC-MS-MS, were used to analyze 
cell functionalities.  
 
Homo-spheroids were only formed in monoculture on collagen gel, but hetero-
spheroids were developed in all the co-culture systems. The results of function 
II 
 
assays showed hepatocytes in collagen-Matrigel sandwich configuration had 
the best secretion of albumin and urea and best CYP activities during the 
culture period. These data demonstrated the hypothesis that hepatocyte 
functions of the established model can be further improved by introduction of 
cell-matrix interaction.  
 
In addition to establishment of rat hepatocyte culture systems, hetero-spheroids 
of primary human hepatocytes and primary human HSCs on PDLLA coated 
plates were developed successfully, due to the great improvements of isolation 
and culture of primary human HSCs. However, hepatocyte function assays 
have not been applied yet. 
 
Hepatic cell lines have several advantages that are not applicable to primary 
cultured human hepatocytes, namely unlimited lifespan and stable phenotype. 
The immortalized Fa2N-4 cell lines have recently been assessed as 
replacements of primary human hepatocytes in CYP induction studies. The 
second aim of this study was to simultaneously characterize CYP1A2, 
CYP2C9, CYP3A4 and CYP2B6 induction in Fa2N-4 cells through assessment 
of mRNA, protein and activity endpoints for a range of prototypical 
compounds (previously assessed in human hepatocytes) with known positive 
and negative induction potential. LC-MS-MS and RT-PCR were used for 
assessment of activity and mRNA endpoints respectively. As a result, it is 
considered that Fa2N-4 cells offer a substitute for primary human hepatocytes 
for CYP1A2 and CYP3A4 induction but not for CYP2B6 due to lack of 
cytosolic CAR expression.  
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1 Introduction 
1.1 The liver 
1.1.1 Liver anatomy and microscopic structure 
The liver is the largest gland of the body, weighing approximately 1200-1500 g 
and making up to one-fiftieth of the total adult body weight. It is situated in the 
upper right portion of the abdominal cavity. The organ enveloped in a thin 
capsule (Glisson's capsule), is divided by fissures into four lobes, namely the 
right (the largest lobe), left, quadrate and caudate lobes. (Sherlock and Dooley, 
2005) 
 
The entire liver consists of thousands of functional units, usually visualised as 
a six-side structure, known as the ‘classical lobule’. In addition, portal lobule 
and liver acini are two other common ways to consider parenchyma of liver 
structure, and simply use different aspects of liver vasculature to demarcate the 
functional unit. The structure of the classical lobule is shown in Figure 1.1. 
Each corner is made up of portal triads, which contain branches of the bile duct, 
the portal vein, and the hepatic artery. Along the central axis of each lobule 
runs the central vein, and cords radiate from the central vein towards the portal 
triad. These cords occupy the bulk of the lobule and are separated by sinusoids. 
(Rodés et al., 2007)  
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Figure 1.1: A schematic diagram of three classical liver lobules. Portal triad 
consists of bile duct, hepatic artery and portal vein. Central vein is located at 
the center of lobule and cords are separated by sinusoids. 
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A cord is composed of thousands of hepatocytes and each hepatocyte attaches 
to its neighbor. The tissue space between hepatocytes and sinusoidal 
endothelium is named the space of Disse and the sinusoids are vascular spaces 
lined by fenestrated endothelium. (Figure 1.2) The space of Disse contains a 
network of reticular fibers, for example collagen type III, which bring 
hepatocytes together. More importantly, since the endothelium has no 
underlying basement membrane, the blood plasma passages freely into the 
space of Disse. As, further, there is no epithelial basement membrane, the 
hepatocyte is the only epithelial cell in the body not separated from the 
vasculature by two continuous basement membranes. This facilitates rapid 
bidirectional macromolecular exchange between plasma and hepatocytes. 
(Sherlock and Dooley, 2005) 
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Figure 1.2: A schematic diagram of hepatic cords, sinusoid and fenestrated 
endothelium. Hepatocytes are arranged as cords and the apical surfaces of 
adjacent hepatocytes form bile canaliculi. Sinusoids are the space between 
fenestrated endothelium. 
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Unlike other organs, the liver is supplied with blood by two sources. One-third 
of the blood and 50% of the oxygen is delivered through the hepatic artery; the 
remaining two-thirds and 50% of the blood supply is provided by the hepatic 
portal vein. The latter source of the blood travels from the digestive tract where 
it collects the nutrients, which are delivered to liver for future storage. After the 
blood enters the liver by these two sources, it flows through the sinusoids and 
drains through three major hepatic veins into the vena cava (Rodés et al., 2007). 
 
1.1.2 Cells of the liver  
The predominant cell type, which performs the majority of liver functions, is 
the hepatocyte. These cells are present at a density of about 10
8
 cells/g liver 
tissue in humans (Stacey et al., 2001). In addition to hepatocytes, at least 15 
different cell types can be observed in the liver, including hepatic stellate cells 
(HSCs), Kupffer cells (KCs), sinusoidal endothelial cells (SECs), bile duct 
cells, liver-associated lymphocytes and nerve cells (Rodés et al., 2007). Of 
these, HSCs, KCs and SECs are the major non-parenchymal cell types and line 
the walls of the hepatic sinusoid (Rodés et al., 2007). The schematic in    
Figure 1.3 illustrates the position of these cells in relation to each other. 
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Figure 1.3: A schematic of the liver sinusoid and relation of parenchymal 
(hepatocytes) and non-parenchymal cell types (sinusoidal endothelial cells, 
Kupffer cells and hepatic stellate cells) 
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1.1.2.1 Hepatocytes 
Highly differentiated hepatocytes make up approximately 80% by mass of the 
cell population of the liver (Rodés et al., 2007). The majority of hepatocytes 
possess single nuclei, although approximately 15% to 25% of the population is 
bi- or multi-nucleate. It has been reported that polyploidy affects the secretion 
of plasma protein and proliferation of hepatocytes (LeGuilly et al., 1973). 
 
In vivo, human hepatocytes contain three membranes. They are highly 
polarized cells (Musat et al., 1993), which depend on the maintenance of two 
main membrane domains, namely apical (bile canalicular) and basal (sinusoidal) 
surfaces. The edges of the apical surface are attached by junctional complexes 
to those of adjacent hepatocytes, forming the bile canaliculi; the basal surfaces 
of the cells face the sinusoid and the space of Disse. (Figure 1.4) These two 
membranes show different hepatocellular functions (Dunn et al., 1989). Bile 
acids are excreted into the bile duct by traversing the bile canaliculi (apical 
surface), whereas proteins associated with the transport of metabolites are 
secreted into the circulation through the basal surface. (Figure 1.4) 
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Figure 1.4: A schematic of three faces of a hepatocyte. Basal surface faces the 
sinusoid and space of Disse, apical surface faces bile canaliculous and lateral 
surface faces neighboring hepatocytes. 
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Hepatocytes are the “functional units’ of the liver. They perform many 
functions including uptake, transport, synthesis, biotransformation and 
degradation of proteins, lipids, hormones, xenobiotics, etc. They contain 
numerous mitochondria, where numbers of energy-providing processes take 
place, particularly oxidative phosphorylation. These mitochondria contain 
enzymes involved in citric acid cycle and ȕ-oxidation of fatty acids. Ion 
balance and water metabolism are relevant to the mitochondria as well. In 
addition, hepatocytes have extensive endoplasmic reticulum, including both 
smooth (SER) and rough endoplasmic reticulum (RER). RER, where 
ribosomes are located, is responsible for synthesis of specific proteins, 
particularly albumin and Glucose-6-phosphatase. It may also participate in 
glycogenesis; SER, which contains microsomes, is the site of bilirubin 
conjugation and the detoxification of many drugs and other foreign compounds, 
particularly cytochrome P450-dependent monooxygenase system. Steroids are 
also synthesized on SER, including cholesterol and the primary bile acids. 
Moreover, peroxisomes, which are distributed near the SER and glycogen 
granules, have complex catabolic and biosynthetic roles. They contain the 
enzymes involved in the ȕ-oxidation cycles, the glyoxalate cycle, ether lipid 
synthesis, and cholesterol and dolichol biosynthesis. Also, hepatocytes contain 
lysosomes, which have numerous hydrolytic enzymes and play a role in the 
degradation of extracellular and intracellular macromolecules. Furthermore, 
Golgi apparatus is found in hepatocyte cytoplasm, which is regarded as a 
'packaging' site before excretion into the bile and is involved in the synthesis of 
glycoproteins. Finally, the cytoskeleton, consisting of microtubules, micro-
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filaments and intermediate filaments, is fundamental for the stability and 
spatial organization of the hepatocyte. (Figure 1.5) (Sherlock and Dooley, 2005) 
 
 
 
 
 
Figure 1.5: The organelles of the hepatocyte 
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1.1.2.2 Non-parenchymal cells 
A functional and histological unit is formed by sinusoidal cells, including SECs, 
KCs and HSCs, in combination with the sinusoidal aspect of hepatocytes 
(Sherlock and Dooley, 2005). SECs line the sinusoids and KCs are associated 
with endothelium. HSCs lie in the space of Disse between the hepatocytes and 
endothelial cells. (Figure 1.3) 
 
1.1.2.2.1 Endothelial cells 
Endothelial cells form a continuous lining to the sinusoid. They differ from 
endothelial cells elsewhere as they do not possess a regular basal lamina but 
have numerous fenestrae.  Fenestrae act as a biofilter between sinusoidal blood 
and the plasma within the space of Disse, and permit the exchange of 
macromolecules of different size with nearby hepatocytes. Particles > 0.2 µm 
do not pass, but smaller triglyceride-depleted, cholesterol-rich and retinol-rich 
residues can enter the space of Disse (Sherlock and Dooley, 2005). Therefore, 
the fenestrae might play a vital role in chylomicron and lipoprotein metabolism. 
Endothelial cells have a high capacity for receptor-mediated endocytosis and 
are active in clearing both macromolecules and small particles from the 
circulation (Sherlock and Dooley, 2005). In addition, they are known to secrete 
IL-1, IL-6, interferon and hepatocyte growth factor (HGF) and proteins that 
effect extracellular matrix (ECM) (Noji et al., 1998), together with a variety of 
mediators, such as tumour necrosis factor, prostaglandin E2, prostacyclin, and 
angiotensin-converting enzyme, which could regulate hepatocyte function 
(Hashimoto et al., 1992). 
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1.1.2.2.2 Kupffer cells 
KCs, derived from circulating monocytes, are attached to the endothelial lining 
of the sinusoid. These highly mobile macrophages are responsible for 
removing old and damaged blood cells or cellular debris, also bacteria, viruses, 
parasites and tumour cells by several different mechanisms (Sherlock and 
Dooley, 2005). 
 
KCs are activated by a number of agents, including endotoxin, sepsis, shock, 
interferon-Ȗ, arachidonic acid and tumour necrosis factor (TNF). Interestingly, 
activated KCs can release an array of inflammatory mediators, growth factors, 
and reactive oxygen species, including cytokines, hydrogen peroxide, nitric 
oxide, TNF, interleukin (IL) 1, IL6, interferon-Į and ȕ, and transforming 
growth factor (TGF- ȕ). (Sherlock and Dooley, 2005) 
 
The role of KCs in liver biology has not been fully understood, but can be 
described into two categories: KCs as the primary target of toxic signals and 
KCs as a second target responsive to the toxic signals received by the 
hepatocytes. For the first category, these cells might be the primary site of an 
initially protective response that develops to cause damage with further 
stimulation (Ito et al., 2003). They could act as not only a protector (He et al., 
2005; Kresse et al., 2005) but also as a mediator of damage (Prins et al., 2004). 
For the second category, the KCs play a more supportive role in the overall 
response to the toxicant. However, the detailed mechanism of KC-hepatocyte 
interaction is still uncertain. 
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1.1.2.2.3 Hepatic stellate cells 
HSCs were firstly identified by Von Kupffer in 1876 as "sternzellen"; however, 
these cells were not identified as unique vitamin A-storing lipocytes with an 
important role in hepatic fibrosis until 1952 by Ito and Nemeto. In 1985, 
Friedman and colleagues found out that hepatic "lipocytes" were the main cells 
responsible for collagen production in rat. After that, with the development of 
techniques of isolation and culture of HSCs, research has established HSCs as 
key elements in liver fibrosis at many levels.  
 
HSCs reside in the space of Disse, between endothelial cells of sinusoids and 
hepatocytes. They comprise approximately 1.4% of total liver volume and 15% 
of the total number of cells, respectively (Geerts, 2001; Friedman, 2004). They 
are present at a ratio of about 3.6 to 6 cells per 100 hepatocytes (Moreira, 
2007). HSCs exhibit mainly two phenotypes. In quiescent state, HSCs are 
characterised by large perinuclear lipid droplets and long cytoplasmic 
processes with fine branching (Sato et al., 2003). They are essential in the 
regulation of retinoic acid homeostasis (Li and Friedman, 1999; Geerts, 2001). 
The storage of vitamin A is not homogeneous, and particular lobules and sub-
lobules appear to be the major site of storage for retinoid (Ballardini et al., 
1994). Also, they play a vital role in the maintenance of basement membrane 
matrix, mainly type IV, VI collagen and glycoproteins, essential for the 
maintenance of the normal hepatic perisinusoidal environment (Pinzani et al., 
1992). In addition, quiescent HSCs are responsible for the regulation of hepatic 
blood flow (Tanikawa, 1995) and portal venous pressure (Rockey and Weisiger, 
1996). Furthermore, quiescent HSCs express the hepatocyte mitogen, 
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hepatocyte growth factor, which may play a role in control of regeneration in 
the normal liver. 
 
Besides the quiescent state, HSCs can undergo activation or transdifferentiation 
to a myofibroblast-like cell, which is regulated by paracrine and autocrine 
loops of growth factors in association with fibrosis in pathological conditions 
such as liver injury and cirrhosis (Friedman, 2000; Lieber, 2005).  The 
activated HSCs are with several new phenotypic characteristics, including 
enhanced cell adhesion and migration, expression of Į-SMA, increased 
proliferation, production of chemotactic substances capable of recruiting 
inflammatory cells, contractibility, loss of normal retinoid-storing capacity, 
increased rough endoplasmic reticulum, changes in cytockeletal organization 
and cellular morphology and acquisition of fibrogenic capacity. Conceptually, 
activation occurs in two phases, namely initiation and perpetuation (Friedman, 
2000). Initiation refers to the early events which make cells responsive to a 
great number of proliferative and fibrogenic cytokines, including TGF-ȕ 
(Gressner et al.,1993), TNF-Į, matrix metalloproteinase (MMP)-9 (Winwood 
et al., 1995) and reactive oxygen species (ROS) (Nieto et al., 2002) from KCs; 
interferon (IFN)-Ȗ and IL from lymphocytes (Wynn, 2004 and Sugimoto et al., 
2005); Toll-like receptor 4 (TLR4) from both HSCs themselves and KCs. Also, 
initiation is associated with the events resulting from early changes in ECM 
caused by the transcriptional activation of many profibrogenic genes including 
Į1 (I) collagen, TGF-ȕ1, type I and II TGF-ȕ (Li et al., 2008).  
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Perpetuation is the result of a continuously dynamic process of release of 
cytokines to the cells, which can be subdivided into at least seven distinct 
events occurring simultaneously. These events include proliferation, 
chemotaxis, contractility, fibrogenesis, release of cytokines, degradation of the 
liver's normal matrix and loss of vitamin A droplets. (Friedman, 2006) 
 
The molecular mechanism of the above phenotypic responses of activated 
HSCs is related to a numerous number of cytokines and mediators. Platelet-
derived growth factor (PGDF) is identified as the main mediator for 
proliferation (Borkham-Kamphorst, 2004) and endothelin-1 (ET-1) and other 
contraction-stimulating cytokines secreted by HSCs are the key contractile 
stimuli (Shi-Wen et al., 2004). A variety of mediators, however, have been 
demonstrated to promote HSCs fibrogenesis, for example, TGF-ȕ is the most 
potent fibrogenic factor for HSCs (Olaso and Friedman, 1998) and leptin has 
been regarded as a profibrogenic hormone in the liver (Bethanis and 
Theocharis, 2006; Niu et al., 2007). In addition, HSCs express virtually all the 
key components required for matrix degradation, mainly matrix 
metalloproteinase (MMP)-2 and MMP-3. A rapid decrease of expressions of 
tissue inhibitor of metalloproteinase (TIMP)-1 and -2 is caused by increased 
activity of MMP-2 (Arthur, 2000). Moreover, several chemo-attractants, 
including PDGF, insulin-like growth factor (IGF)-1, ET and monocyte 
chemotactic protein (MCP)-1, have a role in HSCs chemotaxis. 
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1.1.3 Liver extracellular matrix  
The liver ECM relates to the array of various macromolecules which consist of 
the scaffolding of the liver. In addition to a physical scaffold, it is a modulator 
of biologic processes including cell attachment, migration, differentiation, 
repair and development. In normal liver, apart from Glisson's capsule, ECM is 
restricted to portal triads, sinusoid walls and central veins. (Bedossa and 
Paradis, 2003) 
 
Collagens, elastin, structural glycoprotein and proteoglycans are the four major 
components of ECM in normal liver. Of these, collagens are the most 
frequently found proteins and serve as scaffolding that supports the 
parenchyma and maintains hepatic integrity. Small bundles of type I and 
fibrillar collagen type III are confined to the space of Disse (Clement et al., 
1985). However, type V collagen is more abundant near portal triads and 
central veins (Schuppan et al., 1986). Type IV collagen takes part in the 
formation of basement membrane of nerves, bile ducts, arterial and venous 
vessels (Martinez-Hernandez, 1984), together with laminin, entactin and 
perlecan. Glycoproteins, including fibronectin, laminin, tenascin and entactin, 
are major ECM constituents with a role in cell adhesion (Schuppan, 1990). 
They share epidermal growth factor-like domains, polymer-forming capacities 
and specific amino acid sequences interacting with cell receptor integrins 
(Ilynes, 1987; Alhelda and Buck, 1990). In addition to collagens and 
glycoproteins, proteoglycans including heparin, dermatan, chondroitin sulphate, 
perlecan, hyaluronic acid, biglycan and decorin (Gressner, 1983), are another 
key component in ECM. Proteoglycans are present in the intracellular space, 
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on the cell surface and in the extracellular space (Lozzo, 1985); however, their 
function is not clear as that of other ECM components. 
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1.2 Liver function and hepatic metabolism 
The liver has the ability to perform a vast array of functions. These include: 
x Metabolism - the regulated synthesis or degradation of a wide range of 
molecules. This includes the metabolism of carbohydrate, lipid, amino 
acid, nitrogen, vitamin, normal iron/copper and xenobiotics. It is also 
involved in mitochondria and energy formation, bile formation and 
secretion, ammonia and urea production, glutathione, haem 
biosynthesis and excretion of porphyrins.  
 
x Synthetic function. Albumin and other carrier proteins are synthesized 
in the liver, which bind to other molecules. In addition, most of 
coagulation factors, anticoagulant proteins and components of the 
fibrinolytic systems required for haemostasis are synthesized by hepatic 
parenchymal cells. Extracellular matrix proteins, mainly collagen, are 
also produced in liver and play an important role in liver function in 
health and disease. (Rodés et al., 2007) 
 
In terms of metabolic function of the liver, it can be summarized into several 
major categories, namely carbohydrate metabolism, fat metabolism and protein 
metabolism. Most of these compounds entering the body are lipophilic, which 
are not easily excreted. By transforming one substance to another water-soluble 
compound by increasing its polarity, the liver facilitates the excretion of toxins. 
Hepatocytes are the main cell type involved in the metabolism and the 
processes of it can be divided into two stages. 
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(i) Phase I reactions 
Phase I reactions are sometimes called "functionalization reactions", since they 
often introduce new hydrophilic functional groups to compounds by oxidation, 
reduction or hydrolysis. These groups are then recognized as the attachment 
points for other molecules in the process of conjugation. (Rang et al., 2007) 
The enzymes involved in phase I reactions include oxygenases and oxidases, 
reductase, hydrolytic enzymes and enzymes that scavenge reduced oxygen. 
They are mostly located on endoplasmic reticulum (microsomes), cytosol, 
mitochondria and lysosomes. (Kwon, 2001) 
 
Specifically, cytochrome P450 (CYP) monooxygenases are the major enzymes 
involved in the Phase I reactions. Their mechanism of action is rather complex, 
but the outcome of the reaction is relatively simple - that is formation of a 
hydroxyl group by the addition of an oxygen atom from molecular oxygen and 
formation of water by the other oxygen atom. (Rang et al., 2007) They are also 
regarded as the most important metabolizing enzymes for xenobiotics. More 
than 85% of the drugs in the market are metabolized by CYP enzymes. (Kwon, 
2001) 
 
(ii) Phase II reactions  
Phase II reactions mostly refer to "conjugation reactions", which are binding of 
a substance (parent compound), or its metabolites from a phase I reaction, with 
endogenous molecules (conjugation), and making more water soluble 
derivatives that may be excreted in the urine or bile. 
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The types of phase II reactions include glucuronidation, sulfation, glutathione-
conjugation, acetylation, methylation and conjugation with amino acids (e.g. 
glycine, taurine, glutamic acid). Most conjugation reactions are to replace a 
hydrogen atom present in a hydroxyl, amino or carboxyl group by conjugating 
agents. Among all of them, glucuronidation is the most common and 
quantitatively most important type of conjugation. (Figure 1.6) (Kwon, 2001) 
 
The Phase II enzymes, located on endoplasmic reticulum (microsomes), 
cytosol, mitochondria and nucleus, include uridine diphosphate-
glucuronosyltransferase (UDPGT), sulfotransferase (ST), N-acetyltransferase, 
glutathione S-transferase (GST), methyl transferase, and amino acid 
conjugating enzymes. Particularly, UDPGT is responsible for glucuronidation. 
(Kwon, 2001) 
 
 
 
Figure 1.6: The glucuronide conjugation reactions by UDP-
glucuronosyltransferase. A hydrogen atom present in a hydroxyl, amino or 
carboxyl group is replaced by glucuronic acid. 
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1.2.1 Cytochrome P450 enzymes 
1.2.1.1 Cytochrome P450 enzyme system 
The P450 system is made of three protein components set in the phospholipid 
environment of the endoplasmic reticulum. The first component is cytochrome 
P450, which is a three-dimensional structure arranged into a series of helices 
and folds and contains a ferroprotoporphyrin IX heme prosthetic group, and 
can directly contact substrates and molecular oxygen. Another component is 
NADPH-cytochrome P450 reductase, which transfers electrons from NADPH 
to the cytochrome P450-substrate complex. With the help of the other protein, 
cytochrome b5, together with the cytochrome b5 reductase, the second of the 
two electrons required for cytochrome P450 reactions is delivered to enhance 
the catalytic efficiency and proceed to the reduction step. (Figure 1.7) (Kwon, 
2001) 
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Figure 1.7: Schematic representation of catalytic cycle of cytochrome P450. 
P450 with Fe
3+
 combines with a molecule of drug (DH), reduces to Fe
2+ 
DH 
after receiving an electron from NADPH-P450 reductase and then combines 
with O2 to form Fe
2+
O2 DH. Fe
2+
OOH DH is then formed after combing with a 
proton and a second electron from NADPH-P450 reductase/Cytochrome b5. 
The addition of a second proton is to convert Fe
2+
OOH DH to (FeO)
 3+
 and to 
yield water. DOH is finally liberated from the complex of oxidised drug and 
P450 enzyme is regenerated. (Rang et al., 2007) 
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1.2.1.2 Nomenclature 
When the oxidised form of cytochrome P450 (Fe
+3
) is reduced to the ferrous 
(Fe
+ 2
) state, cytochrome P450 is able to bind ligands such as O2 and CO. The 
name of cytochrome P450 is derived from the ability of the enzyme to bind 
with carbon monoxide in the reduced form and then form a complex with the 
maximal absorbance between 447 and 452 nm (an average of 450 nm). 
However, when the heme moiety of cytochrome is disrupted, cytochrome P450 
is converted to a catalytically inactive form called cytochrome P420, which 
absorbs light maximally at 420 nm upon binding with carbon monoxide in the 
reduced form. (Kwon, 2001) 
 
1.2.1.2.1 Cytochrome P450 isoforms  
Classification of cytochrome P450 into gene families, subfamilies and isoforms 
does not depend on the catalytic activities or substrate specificity but on amino 
acid sequence homology. (Kwon, 2001) 
 
(i) Gene families (e.g. CYP1, CYP2, CYP3, etc): The genes of the enzymes 
sharing less than 40% amino acid homology are regarded as different gene 
families. 
(ii) Subfamilies (e.g. CYP2A, CYP2B, CYP2C, etc): The similarities of gene 
sequence of the enzyme between 40% and 55% are assigned to different 
subfamilies.  
(iii) Isoforms (e.g. CYP2C8, CYP2C9, etc): P450 enzymes with more than 
55% amino acid sequence identity are classified as members of the same 
subfamily. 
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Currently, there are possibly four P450 gene families involved in drug 
metabolism, namely CYP1, 2, 3 and 4 and the first three are the main P450 
gene families in the human liver. (Kwon, 2001) Table 1.1 illustrates all the 
CYP gene families, subfamilies and isoforms in human liver. Of these, 
CYP3A4 and CYP2D6 are the main metabolical isoforms for drug metabolism 
and CYP2C9, 2C19, 1A2, and 2E1 are less commonly involved. (Figure 1.8) 
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Table 1.1: Human cytochrome P450 isoforms 
Category                                       Cytochrome P450 isoforms  
Family 
Subfamily      
Isoforms  
CYP1   
1A 
1A1,1A2 
CYP2 
2A,B,C,D,E 
2A6 
2B6 
2C8,2C9,2C10,2C18,2C19
2D6 
2E1 
CYP3 
3A 
3A3,3A4,3A5,3A7 
CYP4 
4A 
4A9,4A11
 
 
 
Figure 1.8: Percentage of individual P450 isoforms in the total P450 in human 
(Kwon, 2001). 
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1.2.1.3 Variability of cytochrome P450 in human liver 
Human CYP enzymes, responsible for metabolism of xenobitics, are mainly 
localized in the membrane of endoplasmic reticulum (microsomes). However, 
during the last few decades, these microsomal CYPs have been reported to be 
present in other cellular organelles, such as at the extracellular face of plasma 
membrane (Loeper et al., 1990; 1993). CYP1A2. CYP3A4, CYP2C, CYP2D6 
and CYP2E1 were recognized in the human hepatocyte plasma membrane by 
three autoantibodies in the immunofluorescence and immunoperoxidase studies 
(Loeper et al., 1993). It was also demonstrated that this particular content of 
CYPs in the plasma membrane was 9% of that in microsomes. Moreover, 
Golgi apparatus, lysosome and mitochondria (CYP3A1 and CYP3A2) are the 
localizations of rat and mouse CYPs (Ronis et al., 1991; Neve et al., 1996; 
2001). 
 
In addition to variability of localization, phenotypic and genotypic differences 
in the expression of CYPs in human liver have been investigated. CYP2C9, 
CYP2C19 and CYP2D6 are the major enzymes with polymorphisms in the 
human liver (Gómez-Lechón et al., 2007). In particular, CYP2D6, which is 
responsible for the metabolism of 25% of drugs in clinical practice, has a high 
number of allelic variants, some of them resulting in significant changes in 
enzyme functions (Gómez-Lechón et al., 2007). However, other CYP isoforms 
such as CYP3A4, CYP1A1 and CYP2E1 are relatively well conserved, with 
only a few variants causing the enzyme functions (Ingelman-Soudberg, 2005). 
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The hepatocyte is the major cell type expressing the majority of CYPs in 
human liver. However, other cells such as Kupffer cells, endothelial cells and 
hepatic stellate cells may contribute to the expression of CYPs to some extent. 
It has been reported that CYP2C11, CYP3A2 and CYP2D1 have been 
recognized in rat HSCs, at levels of 14-38% of those in rat hepatocytes 
(Yamada et al., 1997). Also, CYP2E1 in Kupffer cells have been involved in 
alcoholic liver disease (Adachi et al., 1995). 
 
1.2.1.4 Cytochrome P450 in diseased human liver 
Significant alternations in the hepatic expression of CYPs have been observed 
in the patient with liver diseases. For example, in the non-alcoholic fatty liver, 
the level of CYP1A2, CYP2D6 and CYP2E1 mRNAs were decreased in 
parallel with the disease progression, while CYP2A6, CYP2B6 and CYP2C9 
mRNA expressions increased. At the protein level, CYP1A2, CYP2C19, 
CYP2D6, CYP2E1 and CYP3A4 expression tended to decrease with disease 
progression. (Fisher et al., 2009) Also, the level of both CYP1A2 mRNA and 
protein was reduced in the liver with hepatocellular and cholestatic types of 
cirrhosis, but the level of CYP3A4 mRNA and protein was only reduced in 
hepatocellular disease (George et al., 1995). Taking these observations together, 
the disease-specific CYP alternation is partly due to a pre-translational 
mechanism.  
 
In addition, cigarette smoking and alcohol drinking have great effects on the 
expression of microsomal CYPs. Cigarette smoking is known to cause 
clinically significant induction of microsomal CYP1A2 with the indication of 
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the N-demethylation of caffeine to paraxanthine (Rasmussen et al., 2002). The 
expression of microsomal CYP2E1 is greatly induced by alcohol consumption 
with the increased activity of 6-hydroxylation of chlorzoxazone (Girre et al., 
1994). However, other factors, either genetic or environmental, may contribute 
to the variations in CYP1A2 and CYP2E1 levels. For example, a strong 
correlation of CYP1A2 activity between identical twins was reported and 
certain drugs, vegetables and infectious diseases had effects on CYP1A2 
expression (Vistisen et al., 1991; Rasmussen et al., 2002). 
 
1.2.1.5 Cytochrome P450 inhibition and induction 
The inhibition or induction of CYP enzymes is regarded as the most common 
mechanism for drug-drug interactions (Lin and Lu, 1998). CYP inhibition 
results from competition between two drugs which are metabolised by the 
same CYP. It may cause an unexpected increase in the plasma concentration of 
one or both drugs and also lead to a variety of minor or severe adverse effects. 
On the other hand, the induction arises from an elevation in the total amount of 
CYP which may lead to a marked decreased in plasma concentrations of a drug 
metabolised by the induced CYP. It can have significant consequences in the 
pharmacokinetics and toxicity of drugs. Therefore, it is necessary to understand 
the regulatory mechanisms of enzyme inhibition and induction to prevent 
potential harmful drug-drug interactions. (Hollenberg et al., 2002) 
 
1.2.1.5.1 Cytochrome P450 inhibition 
The CYP inhibitors can be divided into three categories depending on their 
different mechanisms. Reversible inhibitors are those that take part in the 
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catalytic cycle before the formation of the activated-oxygen intermediate, while 
either quasi-irreversible or irreversible inhibitors are those that interfere during 
or after the formation of the activated-oxygen intermediate. Generally, 
reversible inhibition is regarded as the most common cause of drug-drug 
interactions, which exhibits only dose-dependent inhibition of substrate 
metabolism. However, quasi-irreversible and irreversible inhibitions show both 
dose-dependent and time-dependent inhibition. (Hollenberg et al., 2002) 
 
(i) Reversible inhibition 
In the reversible inhibition of CYPs, the normal metabolic functions of the 
enzymes will continue after the removal of the inhibitors from the body. It can 
be further classified as competitive, noncompetitive and uncompetitive 
inhibition. In competitive inhibition, binding of the substrate to the active site 
of the enzyme is stopped due to the interaction between inhibitor and the 
enzyme (e.g. quinidine); in the noncompetitive inhibition, the inhibitor binds to 
the enzyme at a site rather than the active site, but enzyme-substrate-inhibitor 
complex is unable to function catalytically (e.g. ketoconazole); uncompetitive 
inhibition seldom happens in drug metabolism. In this case, the inhibitor binds 
to the enzyme-substrate complex rather than the enzyme, which leads to a non-
productive formation. (Hollenberg et al., 2002) 
 
(ii) Quasi-irreversible inhibition 
In the quasi-irreversible inhibition, the inhibitors coordinate very tightly to the 
prosthetic heme in the CYP active site after the catalytic activation by the 
enzyme to transient intermediates. The interaction between the inhibitors and 
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CYP metabolic intermediates are so effective that it can covert the enzyme to a 
catalytically non-functional state. More importantly, the release of native 
catalytically active enzyme can be achieved only under special experimental 
conditions. Several different types of compounds are involved in this inhibition, 
including those containing a dioxymethylene function and nitrogen containing 
compounds like 1, 1-disubstituted hydrazines, acyl hydrazines, and a variety of 
alkylamines. (Hollenberg et al., 2002) 
 
(iii) Irreversible inhibition 
This final category of inhibitors is those compounds that bind irreversibly to 
the prosthetic heme, or the protein, or that their metabolites bind to the enzyme 
(e.g. gestodene). They can be referred to as "catalysis-dependent", "suicide" or 
"mechanism-based" inactivators. They are generally considered to be a 
relatively unusual occurrence with most enzymes. (Hollenberg et al., 2002) 
 
1.2.1.5.2 Cytochrome P450 induction 
Transcriptional gene activation, which is mediated by nuclear receptors, is the 
most common mechanism of CYP enzyme induction (Allen et al., 2001). 
Nuclear receptors, including arylhydrocarbon receptor (AhR), constitutive 
androstane receptor (CAR) and pregnane X receptor (PXR), serve as 
transcription factors in the whole process. In the absence of a ligand (drug), the 
nuclear receptor combines with co-repressor complexes, which gives a basal 
level of transcription. However, in the presence of a ligand (drug), the nuclear 
receptor binds to the ligand through the ligand binding domain (LBD), which 
leads to the release of co-repressor complexes and recruitment of co-activator 
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complexes. After the activated receptor binds to the dimerization partner, the 
chromatin of nuclear receptor is remodelled and then transcription is activated. 
The transcription of the respective CYP isoform is regulated through the DNA 
binding domain (DBD) of the nuclear receptor binding to the response element 
in the CYP gene promoters. Retinoid X receptor (RXR) is the partner for CAR 
and PXR and the AhR nuclear translocator (ARNT) is the one for AhR. (Wang 
and LeCluyse, 2003; Lemaire et al., 2004) 
 
AhR and CAR are mainly located in the cytoplasm of hepatocytes. Once they 
are activated, they are transolcated to the nucleus; while PXR is predominantly 
located in the nucleus. Figure 1.9 shows an example of AhR/CAR-mediated 
mechanism of enzyme induction. However, it should be noted that not all the 
enzyme inductions are due to this direct ligand binding mechanism. Both AhR 
and CAR can be activated by ligand binding independent mechanism. 
(Backlund and Ingelman-Sundberg, 2005; Hu et al., 2007) 
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Figure 1.9: Overview of the receptor-mediated mechanism of enzyme 
induction. 1) The drug enters the cell. 2) AhR and CAR are located in 
cytoplasm, and PXR is mainly located in nucleus. This schematic diagram 
shows AhR/CAR-mediated pathways only; but PXR is activated in the same 
way in the nucleus. 3) AhR and CAR are translocated to nucleus after binding 
to the drug. 4) The activated receptor binds to the dimerization partner to 
activate the transcription. 5) mRNA is translocated to cytoplasm and translated 
into CYP and other proteins. 
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1.3 Engineering liver tissue 
The 70% liver resection model was first described by Higgins and Anderson in 
1931. The regenerative response of the liver is proportional to the loss of tissue 
mass for resections. The removal of up to 70% of the tissue mass can allow the 
remaining tissue to enlarge. However, a greater than 70% resection leads to a 
remarkable decline in the regenerative response (Nagasue et al., 1987). In liver 
tissue engineering, the aim is to exploit and expand this liver regenerative 
potential in order to grow liver tissue in vitro. There are various potential 
applications of engineered liver tissue, particularly in bio-artificial liver devices 
and in vitro toxicology models. 
 
1.3.1 Bio-artificial liver device 
Liver transplantation is the only recognized curative therapy available for end 
stage liver disease (Schiff and Schiff, 1993).  However, due to donor shortages 
and substantial morbidity, it remains an unsatisfactory approach. According to 
the United Network for Organ Sharing (UNOS), only 5846 liver transplants 
were performed in 2004 against more than 17,000 patients on the national 
waiting list for liver transplantation in 2007 (Fiegel et al., 2008) The number of 
people on the liver transplant waiting list is increasing much faster than the 
number of transplants from deceased donors. Liver transplantation is also one 
of the most expensive surgical procedures available nowadays (Evans, 1993; 
Mendeloff et al., 2004). Consequently, work on engineering of liver tissue has 
attempted to develop extracorporeal liver support systems in order to either 
extend patient's period for bridge to liver transplantation or let the diseased 
liver regenerate itself. 
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Early research aimed to develop detoxification (artificial liver) devices, which 
are directed at removing toxins that cannot be removed by conventional 
dialysis. Biologic-DT (Aladag et al., 2004), molecular adsorbent recirculating 
system (MARS
®
) (Stange et al., 2002) and Prometheus (Kramer et al., 2003) 
have reached the clinical evaluation. However, even if the toxins are removed 
from blood stream for each of the systems, these systems are unsuccessful in 
maintaining the critical biochemical functions of liver.  
 
Due to the shortages of effective detoxification devices, cell-based (bio-
artificial liver, BAL) therapies and devices have been developed, aiming to 
combine the new techniques with previous methods to provide more support to 
the patients. The HepatAssist
TM
 is the first generation of BAL, which is based 
on the use of hollow fibre cartridges (Demetriou et al., 2004). It has been 
followed by the extracorporeal liver assist device (ELAD
®
) (Millis et al., 2002), 
the modular extracorporeal liver support (MELS) (Mundt et al., 2002; Saucer 
et al., 2002) and the bio-artificial liver support system (BLSS) (Mazariegos et 
al., 2002). Two more recent developments, the radial flow bioreactor (Morsiani 
et al., 2002) and the Academic Medical Centre (AMC)-BAL (Van de 
Kerkhove et al., 2002) have reached clinical evaluation. Both of these two 
BALs directly perfuse the patient's plasma over and around cultured primary 
porcine hepatocytes. However, the impact of these BALs on patients' survival 
and clinically significant outcomes still remains unclear. 
 
Cell transplantation is another cell-based therapy for liver disease. The method 
is to seed hepatocytes into the portal vein and then they are transported with 
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blood into liver sinusoids. Only a few studies have been reported because of 
the limited availability of human hepatocytes (Smets et al., 2008). 
 
Researchers have turned to bioreactors for hepatic cell culture. The most 
successful devices incorporate features of the native liver structure. Early 
hepatocyte tissue culture has been mostly in monolayer, where hepatocytes 
rapidly lose their specific functions (Bissell et al., 1987). Culture of 
hepatocytes in a static manner is also very unlike the natural condition where 
the nutrients and waste metabolites are continuously supplied and removed. 
The bioreactor perfusion setting, which overcomes the shortages of early 
hepatocyte tissue culture system, is supported by adequate levels of 
oxygenation, nutrient gradients to a more in vivo like liver structure. 3D 
hepatocyte culture, which maintains extended liver specific functions in 
comparison to monolayer, has shown great potential for bio-artificial liver 
support (Ijima et al., 1998). 
 
Appropriate cell sources for extracorporeal liver support remain as a 
controversial topic. The majority of bio-artificial liver support systems have 
used primary porcine hepatocytes, which show similar biochemical functions 
and activities to human hepatocytes. However, potential immunogenic 
response and unwanted transmission of pathogens have limited the use of these 
cells (Schrem et al., 2006). Due to limited human hepatocyte availability, cell 
lines including tumour-derived line and immortalized cell lines (Tsiaoussis et 
al., 2001) have been recommended as an alternative. However the cell lines 
have been demonstrated to express altered functions or reduced functions 
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compared to primary human hepatocytes. Therefore, stem cells may be the 
ideal cell source for cell-based therapies, since they have the potential to 
differentiate into mature cell types, benefiting to the damaged liver tissue 
(Odorico et al., 2001). The effects of growth factors, cytokines or mediators 
have been studied regarding to their roles on growth/differentiation of liver 
stem cell (Yoon et al., 1999). However, there are still many questions and 
challenges with regard to the use of stem cells in BAL. 
 
1.3.2 In vitro toxicology model 
In the drug development process, one of the major factors that delay the 
development is the potential for toxicity. The efficacy and safety of the 
compound in human have to be tested before clinical trials. Therefore, various 
in vitro toxicology models have been established to assess this factor, because 
traditional in vivo animal models are limited due to animal welfare/ethical 
concerns and inter-species differences between animal and human being. 
 
Current engineered liver tissue models for use in toxicology studies are of three 
major types, namely, isolated perfused organ, liver slices and isolated 
hepatocyte model. The major advantages of isolated perfused organ are to 
maintain the 3D structure of organ with tight cell-cell interactions and the 
potential for bile collection and analysis (Hobbs et al., 1968a, 1968b). 
However, it is very complex to keep the function of organs within the 
physiological ranges and it is hard to achieve the integrity of the function over 
a prolonged period.  In contrast to the complexity of isolated perfused organs, 
liver slices are relatively easy to prepare. This model retains tissue organization 
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and cell-cell and cell-matrix interactions and preserves the lobular structure of 
the liver as well (Hillesheim et al., 1995; Gandol et al., 1996); however, bile 
flow and portal flow cannot be analyzed. More importantly, poor diffusion of 
oxygen and nutrients cannot be fully solved. Although some of these problems 
have been improved due to the development of new slice model (Vickers, 
1994), the short viability and the lack of bile collection are still unresolved. 
 
The isolated hepatocyte model, however, is the most frequently used in vitro 
liver cell model (Acosta et al., 1985). Primary hepatocyte culture has been 
regarded as a golden standard in the study of drug metabolism and has been 
used to give predictive information on the pharmacokinetics of potential drug 
molecules (Butterworth et al., 1989; Guillouzo et al., 1993). Although the 
traditional monoculture rapidly loses the hepatocyte function, great progress 
has been made in terms of the methodology of liver cell cultures over the last 
few years. A variety of culture techniques for long-term in vitro culture have 
been established and evaluated. For example, poor preservation of native liver 
structure has been improved by introduction of three-dimensional spheroids 
formed by hepatocytes with non-parenchymal cells in specific basement 
membrane (Riccalton-Banks et al., 2003; Thomas et al., 2005, 2006); lack of 
exchange of oxygen and nutrients in static culture has been overcome by the 
novel bioreactor system (Morsiani et al., 2002; Van de Kerkhove et al., 2002). 
Therefore, well-differentiated hepatocytes in long-term culture would provide a 
major advantage in contrast to isolated perfused organ and liver slices for the 
metabolism and toxicology studies. 
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1.4 Approaches to engineering liver tissue 
Although the liver has extraordinary regenerative capacity in vivo, creation of 
long-term viable and functional liver tissue in vitro has not been achieved yet. 
The central problem is the determination of the environmental signals 
necessary to maintain hepatocyte specific functions. In simple primary cultures, 
the characteristic morphology of hepatocytes changes within the first few days 
and hepatocyte-specific functions rapidly diminish after isolation (Bissell et al., 
1987; Carr et al., 1986). Several approaches have been developed to recreate 
the microenvironment of hepatocytes, including soluble factors, cell-cell 
interaction and cell-matrix interaction. These are discussed below. 
 
1.4.1 Medium supplementation and long-term hepatocyte culture  
Many investigators have made significant advances toward the development of 
culture conditions which promote hepatocyte proliferation or preserve 
differentiated function of hepatocytes. Some of the most commonly used 
additives are described below. 
 
(i) Growth factors and cytokines 
Richman et al. first showed that epidermal growth factor (EGF) could induce 
DNA synthesis in primary hepatocytes in 1976. Interestingly, it is still the most 
commonly used polypeptide hormone for hepatocyte proliferation, since EGF 
can lead the hepatocytes to enter the cell cycle for two to three consecutive 
cycles, after DNA synthesis stops. TGF-Į, which shares the same receptor as 
EGF, is also mitogenic for hepatocytes and may be a stronger mitogen than 
EGF (Brenner et al., 1989; Mead and Fausto, 1989). HGF, which is purified 
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from rat platelets, has the ability to promote hepatocyte proliferation as well. 
Together with EGF, they are two main growth factors widely used in 
hepatocyte medium. However, both of these mitogens are inhibited by TGF-ȕ 
in hepatocyte culture (Carr et al., 1986). Other factors, such as soluble TGF-ȕ, 
IL-1ȕ, IL-6 (Nakamura et al., 1988) and hepatocytes growth inhibitor (HGI) 
(Huggett et al., 1987), are capable to inhibit EGF mitogenesis in the culture. 
 
(ii) Nicotinamide 
Nicotinamide can enhance the DNA repair synthesis of cultured hepatocytes 
caused by chemical carcinogens (Althaus et al., 1982) and stimulate 
proliferation of hepatocyes in vitro (Sato et al., 1999). Also, the presence of 
nicotinamide in cultured hepatocytes inhibits the loss of CYP activities (Paine 
et al., 1979) and mRNA expression of albumin (Inoue et al., 1989). The effects 
of nicotinamide on both proliferation and differentiation are probably due to 
the inhibitory effect on poly (ADP-ribose) polymerase activity, an enzyme 
which catalyses polymerization of the ADP-ribosyl moiety of NAD (Ueda and 
Hayaishi, 1985).  
 
(iii) Amino acids 
Amino acids mainly act as liver cell nutrients (Seglen and Solheim, 1978) and 
inhibitors of hepatic protein degradation (Schworer and Mortimore, 1979). 
Stimulation of protein synthesis by high concentration of amino acids could be 
further enhanced by the addition of insulin and glucocorticoid (Seglen et al., 
1983). Also, amino acids could be considered as a growth trigger, since hepatic 
DNA synthesis is observed in the starved rat followed by an amino acid meal 
 40
(Bucher et al., 1978). In particular, proline is necessary to induce DNA 
synthesis of hepatocytes and 30µg/ml in the medium is enough for the 
induction of the maximum DNA synthesis of cultured hepatocytes (Nakamura 
et al., 1984; Houck and Michalopoulos, 1985). Other amino acids, such as 
arginine, also play a role in hepatocyte growth. 
 
(iv) Insulin 
In vivo, the liver receives a continuous supply of insulin from the islets of 
Langerhans, so it is not surprising to see insulin is crucial for hepatocyte 
attachment, survival, protein synthesis and many specific functions (lipid and 
carbohydrate metabolism) in in vitro cultures (Agius et al., 1990). In particular, 
the glycogen storage is directly affected by insulin depending on the glucose 
concentration (Agius and Peak, 1993).  
 
(v) Dexamethasone 
Dexamethasone is usually applied to enhance matrix gene transcription 
(fibronectin and collagen) (Jefferson et al., 1985), and to increase protein 
synthesis, including albumin. In addition, phenobarbital induced hepatocyte 
DNA synthesis is further enhanced by certain concentrations of dexamethasone. 
However, it inhibits hepatocyte spheroid formation (Abu-Absi et al., 2005) and 
suppresses CYP 1A2 induction at a concentration of 1 µM (Harada et al., 
2003). Therefore, it may not be beneficial for long-term hepatocyte culture. 
 
 
 
 41
(vi) Trace metals 
Trace metals are usually added into chemically defined medium for 
hepatocytes culture in a prolonged period, although no evidence has shown 
they could improve hepatocyte proliferation (Block et al., 1996; Cable and 
Isom, 1997). However, the presence of selenium in the hepatocye culture 
medium could maintain the synthesis of CYP induced by phenobarbital 
(Newman and Guzelian, 1982). In addition, copper, iron and zinc are all 
required in the hepatocyes long-term culture (Cable and Isom, 1997), since 
prolonged absence of these metals causes the activity of ribonucleotide 
reductase in leukaemic lymphocytes to be decreased (Oblender and Carpentieri, 
1991a, 1991b). 
 
(vii) Dimethyl sulphoxide (DMSO) 
2% DMSO in the hepatocyte culture medium is considered as the most 
effective concentration in terms of cell morphology, proliferation and 
differentiation. Kojima et al. reported that typical cuboidal morphology, cell-
cell adhesion structures, gap junctions and bile-canaliculus-like structure were 
observed in the presence of 2% DMSO in 1997. In addition, DNA synthesis of 
hepatocytes stopped after removal of DMSO from the medium (Cable and 
Isom, 1997), but the proliferation ability could be regained by the presence of 
DMSO and trace metals. Also, secretion of albumin and transferrin was 
recovered by adding 2% DMSO to the medium after hepatocyte proliferation in 
vitro (Mizuguchi et al., 1996).  
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1.4.2 Culture surface 
The role of ECM in the control of development and differentiation of 
hepatocyte has been the subject of intense research for many years (Hay, 1981; 
Martin and Garbion, 1987). Numerous studies have demonstrated the 
importance of the extracellular matrix in the modulation of many aspects of 
cellular function including growth, adhesion, migration, differentiation and 
gene expression (Lee et al., 1993). The interactions between hepatocytes and 
ECM are complicated, which are involved in a variety of specific receptors. 
The significance of this relationship has been focused on by many researchers, 
who have attempted to restore the contact of hepatocytes with a range of 
culture surfaces to resemble the in vivo ECM. 
 
1.4.2.1 ECM and liver derived surfaces 
Several natural ECM proteins have been applied to liver tissue engineering, 
including type I collagen, type IV collagen, fibronectin and laminin, which are 
known to influence hepatocyte morphology and functions. In addition, liver 
derived biomatrix from rat, pig or human have been developed and compared 
with the natural ECM proteins in terms of hepatocyte morphology and function. 
 
(i) Collagen, fibronectin and laminin 
Collagen is the most abundant expressed protein in liver ECM and a variety of 
isoforms are distributed in different locations with distinct functions. Type I 
and type IV are the most common isoforms used as ECM in hepatocyte culture 
in vitro. Comparing to collagen, fibronectin and laminin contribute less to the 
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composition of liver ECM, but still are used widely as ECM for hepatocytes in 
vitro. 
 
The morphology, proliferation, migration, growth and survival of hepatocytes 
are relatively diverse when cells are cultured on fibronectin, laminin or 
collagen coated surfaces. Hepatocytes cultured on these three ECM proteins 
show spread morphology and mostly maintain in a monolayer. However, if the 
amount of fibronectin, laminin or collagen is limited on coated dishes, the 
spherical morphology, which is more like in vivo, is exhibited (Mooney et al., 
1992). Although the morphology of hepatocytes on these ECM proteins is quite 
similar, the responses to HGF are different. Cells are proved to undergo 
proliferation on the collagen type I and fibronectin coated surfaces by the 
stimulation of HGF, but no proliferation is shown from the cells on laminin 
(Schuppan et al., 1998). These different responses are dependent on the 
interaction between cells and ECMs, which is mainly mediated by integrin 
signalling, focal adhesion kinase (FAK) or extracellular-signal regulated kinase 
(ERK) (Giancotti and Ruoslahti, 1999; Hynes, 2002). In addition, the growth 
of stress fibres in hepatocytes cultured on these ECM proteins is dissimilar. 
The stress fibre is developed by hepatocytes on the collagen type I and 
fibronectin coated surfaces but not on the laminin coated surface (Kim et al., 
2003; Hoshiba et al., 2006). Moreover, only laminin, particularly laminin-
10/11, is demonstrated to enhance cell migration in hepatocyte culture in vitro. 
(Fujiwara et al., 2001; Gu et al., 2001) Furthermore, hepatocytes cultured on 
collagen type I are less protected from apoptosis than those cultured on 
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collagen type IV, fibronectin and laminin (Gomez-Lechon  et al., 1995; Morita 
et al., 1995). 
 
The CYP inductions on hepatocyte monolayers cultured on these ECM proteins 
are distinct to some extent. For example, CYP2B1/2B2 induction is poor in 
hepatocyte monolayers cultured on type I and IV collagen by phenobarbital. 
Also, the cells cultured on high concentration of laminin only display 
substantial induction (Caron, 1990; Brown et al., 1995), and the addition of 
soluble laminin to the media does not have any effects on the CYP induction 
by phenobarbital (Oda et al., 2008). On the contrary, cells cultured on low 
concentration of type I collagen and laminin exhibit greater CYP2B1/2B2, 
perhaps due to spherical morphology formation. (Oda et al., 2008) 
 
 (ii) Collagen sandwich & collagen-Matrigel sandwich 
Hepatocytes cultured on substrata like collagen or fibronectin exhibit spreading 
morphology with nearly no polarized structure. Cells also show deteriorating 
differentiated function after a few days in vitro. However, this process can be 
modulated by overlay of another layer of collagen or Matrigel. Matrigel, 
extracted from Engelbreth-Holm-Swarm (EHS) mouse sarcomas, contains 
several ECM proteins, including 61% laminin, 30% collagen I, 7% entactin, as 
well as several growth factors (BD Matrigel). This double layer sandwich 
culture has been demonstrated to maintain hepatic polarity (Musat et al., 1993; 
LeCluyse et al., 1994) and long-term stable differentiated functions (Dunn et 
al., 1992; Berthiaume, et al., 1996). Therefore, it has been used for liver 
physiology studies (Liu et al., 1999; Turncliff et al., 2006), drug 
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metabolism/toxicity testing (Nussler et al., 2001; Kemp and Brouwer, 2004; 
Kemp et al., 2005) and hepatocyte-based bioreactors (LeCluyse et al., 1994; 
Allen et al., 2001).  
 
Collagen sandwich configuration also has utility. Tuschl and Mueller reported 
that hepatocytes cultured in this sandwich culture with serum-free medium 
showed typically polygonal shaped cells with well-defined cell borders and 
plasma membrane over time. Also, the bile canaliculi-like network was 
relatively stable after 72 hours. More importantly, the CYP1A1 expression 
over time was much less reduced in the serum-free sandwich culture and the 
level of cellular stress was lower than the monolayer. (Tuschl and Mueller, 
2006) 
 
In addition to double layer of collagen culture, collagen-Matrigel sandwich has 
been used and applied widely to hepatocyte culture. Besides rat hepatocyte 
morphological and functional improvements in this culture configuration with 
low concentration of dexamethasone (Sidhu et al., 2004), the cultivation re-
establishes and maintains CYP expression levels (Omiecinski et al., 1999) as 
well as enhances the gene induction response to phenobarbital (Sidhu et al., 
2004). It has also been applied to human hepatocyte culture and demonstrated 
great achievements in cell morphology, exhibiting formation of cell-cell 
adhesion, bile canaliculi, microtubules and cytoskeletal elements (Hamilton et 
al., 2001; LeClyuse et al., 2001).  The effect of Matrigel on CYP induction in 
human hepatocytes is less clear. LeCluyse et al. reported in 2000 that induction 
of CYP3A4 activity by rifampicin was not affected by overlay of Matrigel. 
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However, Gross-Steinmeyer et al. (2005) demonstrated that the same CYP was 
greatly induced by phenobarbital in the collagen-Matrigel sandwich. The 
disparity between the two groups could be explained by differences in media 
and the effects of different cell densities (Hamilton et al., 2001). The molecular 
mechanism of the maintained hepatocytes differentiation in the presence of 
Matrigel are most likely regulated by ȕ-catenin (Monga et al., 2006) and /or 
integrin-linked kinase (ILK) (Gkretsi et al., 2007). 
 
1.4.2.2 Non-ECM-derived surfaces 
Synthetic ECMs, which mostly lead hepatocytes to a three-dimensional 
architecture, have been used widely in recent years due to their mechanical 
properties and processability (Gupta et al., 2002). Also, they replace several 
functions of natural ECM, for example, offering appropriate mechanical 
strength as well as providing the space to supply nutrients and oxygen (Putnam 
and Mooney, 1996). Two types of synthetic ECM are available, including 
synthetic polymer and natural polymer.  
 
Biodegradable synthetic polymers, mostly including polyester and 
polycarbonate, have a long history of use as scaffolds in liver tissue 
engineering. The ability of changeable structure to meet mechanical properties 
requirements and the kinetics of biodegradation to suit various applications are 
the key advantages of these synthetic polymers. Polyglycolic acids (PGA) 
(Mooney et al., 1996; Lee et al., 2003), polylactic acid (PLA) (Riccalton-
Banks et al., 2003; Thomas et al., 2005, 2006) and their copolymer (polylactic-
glycolic acid, PLGA) (Hasirci et al., 2001; Li et al., 2006) have been applied in 
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vitro. Natural polymers including alginic acid (Yang et al., 2002), chitosan 
(Park et al., 2003), xyloglucan (XG) (Seo et al., 2004), silk sibroin (Gotoh et 
al., 2004) and gelatine (Hong et al., 2003) have also been used for liver tissue 
engineering.  
 
In order to improve the cell attachment on poor adhesive polymer surfaces, a 
number of ECM-derived proteins or other bioactive components have been 
applied to coat polymers. The morphology and functions of hepatocytes are 
enhanced when cells are cultured on the polymer conjugated with ECMs. For 
example, Akon et al. (2005) reported that hepatocytes cultured on the 
membrane of polyvinyl alcohol (PVA) coated with ECM proteins showed 
higher albumin and urea secretion than cells on the membrane of polyvinyl 
alcohol-co-ethylamine (PVA-EA). Among all the ECMs, the viability of 
hepatocytes was higher on PVA coated with collagen than PVA coated with 
other ECM proteins, including laminin, fibronectin and vitronectin. (Akon et 
al., 2005) Also, hepatocytes cultured on gelatine with the presence of 
chondroitin sulphate and hyaluronic acid show higher viability and better 
functionalities comparing to those on gelatine scaffold without ECMs (Barbetta 
et al., 2008). 
 
A few advantages of synthetic ECMs over conventional ECMs include no 
variation of ECM from batch to batch, no non-uniformity in the gel thickness 
and no transport barrier for nutrients or metabolite waste. Particularly, in the 
conventional sandwich culture system, the top ECM not only holds back 
transport of nutrients or waste but also sheds during culture. Some researchers 
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demonstrate that synthetic sandwich culture is better than conventional 
collagen sandwich culture. For example, hepatocytes in a sandwich between a 
porous Si3N4 membrane conjugated with galactose (top) and a polyethylene 
terephthalate (PET) film (bottom) show improved differentiated functions than 
those of cells in collagen sandwich (Zhang et al., 2008). Also, RGD-modified 
PET (top) / PET coated with galacose (bottom) synthetic sandwich show better 
cell-cell interaction and functions than conventional collagen sandwich (Du et 
al., 2008). Furthermore, hepatocytes forming spheroids in a three-dimensional 
PuraMatrix scaffold demonstrate higher CYPIA1 activity than cells in collagen 
sandwich throughout the culture period (Wang et al., 2008).  
 
1.4.3 Co-cultures  
1.4.3.1 Patterned co-culture  
A limitation of random co-culture is the lack of controlling cell placement, 
cell-cell and cell-ECM interaction. Micropatterning technology has overcome 
this limitation, including photolithography (Ranucci et al., 2000), microfluidic 
channel (Ostuni et al., 2000), elastomeric membrane (Folch and Toner, 2000; 
Folch et al., 2000), microcontact printing (µCP) (Kumar and Whitesides, 1993; 
Xia and Whitesides, 1998) and layer-by-layer assembly technique (Decher, 
1997).  For example, a polyelectrolyte multilayer (PEM) template that is either 
resistant or adhesive to primary hepatocytes is prepared by coating poly 
(diallyldimethylammonium chloride) (PDAC) and sulfonated polystryrene 
(SPS) on the PEM surface. Hepatocyte co-cultured with NIH3T3 on this 
PDAC/SPS surface secretes higher albumin and urea than cells on the PEM 
surface alone. (Kidambi et al., 2007) 
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The success of this novel approach is dependent on the relative adhesiveness of 
two cell types to the substrates. The surfaces have been developed to switch 
from cell-repulsive to cell-adhesive by several mechanisms, including 
electroactive polymers (Jiang et al., 2003; Yeo et al., 2003), thermally 
responsive polymers (Yamato et al., 2002; Tsuda et al., 2005) and magnetic 
beads (Ito et al., 2004). However, these polymers or magnetic beads could be 
cytotoxic (Choksakulnimitr et al., 1995; Tiwari et al., 2003) and most of the 
patterned co-cultures are 2D, therefore, development of a biocompatible and 
3D versatile micropatterning approach is of interest. 
 
1.4.3.2 Co-culture with fibroblasts  
Fibroblasts, derived from the mesenchyme, are involved in formation of the 
intercellular substance of the connective tissue and fibres and play an important 
role in the regeneration of the liver. Since human fibroblasts offer a better 
attachment and enhance cyclophosphamide metabolism for hepatocytes 
(Kligerman et al., 1980), fibroblasts and their cell lines, such as NIH3T3, have 
been widely used for liver tissue engineering.  
 
Although random 2D co-culture systems of these two cell types have been 
demonstrated to provide better hepatocyte functions comparing to hepatocyte 
culture alone (Washizu et al., 2001; Kang et al., 2004), 3D structure is required 
to rebuild the liver as it is in vivo. Novel techniques, such as 3D biodegradable 
scaffolds (Seo et al., 2006), 3D microencapsulation (Chia et al., 2005), and 
multilayer cell sheets technique (Ito et al., 2007) have been applied for co-
culture of hepatocytes and 3T3. For example, magnetic forced based (MFB) 
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HepG2 monotypic cell sheet co-cultured with MFB NIH3T3 cell sheet and 
MFB HepG2 and NIH3T2 mixed cell double sheets are used to assess 
hepatocyte functions. The higher albumin in the mixed cell double sheets 
indicates more heterotypic cell contacts facilitate hepatocyte function. (Ito et 
al., 2007) Also, enhanced hepatocyte CYP activity is observed when cells are 
co-cultured with NIH3T3 in a 3D microcapsule formed with a hybrid matrix in 
the presence of soluble factor, TGF-ȕ1 (Chia et al., 2005). In addition to the 
3D environment, hepatocyte spheroids co-culture with NIH3T3 improves 
hepatocyte function by both homotypic and heterotypic cell-cell interaction (Lu 
et al., 2005; Fukuda et al., 2006). For example, albumin secretion and CYPIA1 
enzyme activity are enhanced by spontaneous adhesion of NIH3T3 on the rat 
hepatocyte spheroids on the galactosylated poly (vinylidene difluoride) (PVDF) 
surface (Lu et al., 2005). In addition to NIH3T3, other fibroblasts, like 3T3-J2, 
have been shown to offer better hepatocyte functions (Cho et al., 2008).  
 
1.4.3.3 Co-culture with sinusoidal endothelial cells 
Compared with endothelial cells from many other tissues, liver SECs do not 
adapt well and are notoriously difficult to culture in vitro. Traditional culture 
methods could maintain the differentiation functions of SECs for only 48 hours. 
Although some improvements have been achieved to maintain the cells with 
media supplemented with tumour cell-conditioned media (Irving et al., 1984; 
Gatmaitan et al., 1996), phorbol ester (De Zanger et al., 1997), vascular 
endothelial growth factor (VEGF) (Yamane et al., 1994) or hepatocyte-
conditioned media (Krause et al., 2000), SECs start to dedifferentiate after 5 or 
6 days. Only recently, it has been reported that endothelial fenestrae could be 
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induced in M1-SEC cells or primary cultured SECs using anti-actin agents 
(Braet et al., 2007; Saito et al., 2007). More recently, co-culture of SECs with 
hepatocytes improves the survival and function of SECs for a longer period. 
For example, rat liver SECs co-cultured with hepatocytes in a 3D microreactor 
survive after 13 days with the indication of SECs specific marker SE-1 (Hwa et 
al., 2007). In addition, SECs co-cultured with hepatocytes on ECM substrates 
scaffold derived from liver maintain a near-normal fenestration as well as 
SECs differentiation (Sellaro et al., 2007).  
 
Due to the extreme difficulty to culture in vitro, SECs have been hardly used 
for co-culture with hepatocytes for the purpose of enhancing hepatocyte 
functions. In the 1980s, random co-culture of rat hepatocytes with primary or 
cell line SECs was initially setup and demonstrated to maintain albumin 
secretion (Morin and Normand, 1986; Goulet et al., 1988).  Since then, several 
culture techniques have been developed. For instance, biodegradable polymers 
have been applied to co-culture rat hepatocytes with SECs under flow 
conditions; however, there is no effect of SECs on survival rate and or 
hepatocyte function as compared to hepatocyte culture alone (Kaihara et al., 
2000).  Only recently, patterned co-culture has been applied to these two cell 
types because of the development of thermo-responsive culture dishes. Before 
this, no other parameters for patterned co-culture are suitable, since similar 
substrates are required for both hepatocytes and SECs. For example, poly (N-
isopropylacrylamide) (PIPAAm) is utilized to achieve overlaying aortic 
endothelial cell sheets onto monolayer hepatocytes. Hepatocytes maintain the 
differentiated cell shape and express albumin for over 41 days of culture. 
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(Harimoto et al., 2002) In addition, rat hepatocytes and bovine endothelial cells 
are co-cultured on a dually patterned co-culture using the same polymer. 
Albumin secretion and ammonium metabolism are improved by the heterotypic 
cell-cell interaction. (Tsuda et al., 2006) The molecular mechanism underlying 
this co-culture is most likely regulated by the expression of Į2-macroglobulin 
(Talamini et al., 1998) and gap junctional intercellular communication (Saito et 
al., 2007). 
 
1.4.3.4 Co-culture with biliary epithelial cells 
Biliary epithelial cells (BECs), which are involved both in the biliary ductular 
morphogenesis and in efficient regeneration of bile drainage system, has 
received less attention relative to hepatocytes. However, many studies have 
focussed on the relationship between BECs and hepatocytes. In 1980s, addition 
of BECs into hepatocyte cultures enhanced hepatocyte function by showing 
stable high level of albumin more than 2 months. Type III collagen secreted by 
BECs was regarded as the key to correlate with the long-term survival. 
(Clement et al., 1984) A few years later, liver-regulating protein (LRP) was 
found to be involved in maintenance of hepatocyte differentiation (Corlu et al., 
1991) IL-6 was then showed to be secreted by BECs and had mitogenic and 
anti-apoptotic effects on hepatocytes. (Matsumoto et al., 1994; Sakamoto et al., 
1999)  
 
Since then, hepatocytes co-cultured with BECs have been demonstrated to 
maintain many differentiated liver functions and may provide a useful model 
for studying enzyme regulation. Hepatocyes are induced to undergo several 
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waves of division without loss of differentiation when cells co-culture with 
BECs in the presence of both TNF-Į and HGF/EGF (Sérandour et al., 2005). 
In another study, albumin synthesis, urea production and CYP activities 
maintain over 3 three weeks when human hepatocytes are co-cultured with 
human BECs (Auth et al., 2005). In addition, the effects of phenobarbital and 
3-methylcholanthrene on the expression of monooxygenase activities as well as 
mRNA levels in co-cultures of BECs and rat hepatocytes have been examined 
(Lerche et al., 1997). Direct and indirect effects of various hormones on 
glutathione S-transferases (GSTs), which play a role in the detoxification of 
xenobiotics or metabolites of xenobiotics by oxygenases, have been further 
investigated (Coecke et al., 2000).   
 
1.4.3.5 Co-culture with Kupffer cells  
In vivo, KCs have direct contact with hepatocytes through their cytoplasmic 
extension. Cellular communication between these two cell types is mainly 
considered to produce cytokines and excrete inflammatory mediators such as 
eicosanoids, nitric oxide, and reactive oxygen species (Decker, 1998). In 
particular, TNF-Į, IL-1 and IL-6 have been regarded as early mediators for the 
hepatic inflammatory response.  Biosynthesis of acute phase proteins and down 
regulation of xenobiotic metabolizing enzyme systems is mainly induced by 
these cytokines (Andus et al., 1988; Hartung et al., 1997). Hepatocyte structure 
is dramatically changed in co-culture with KCs and cortisol, low density 
lipoproteins (LDL) and lipolysaccharides (LPS). Ribosomes on the rough ER 
membrane, the volume of smooth ER and the number of lysosomes all increase 
due to KCs' derived pro-inflammatory cytokines (Panin et al., 2002). In 
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addition, KCs release pro-inflammatory cytokines such as IL-1, IL-6 and TNF-
Į, which are responsible for directly suppressing CYP3A activity (Abdel-
Razzak et al., 1993; Muntane-Relat et al., 1995). For example, a 50-70% 
suppression of CYP3A activity dependent on the concentration of KCs was 
observed by Jeffrey et al. and KCs-mediated IL-2 is the key to alter CYP3A 
expression (Sunman et al., 2004).  LPS-induced hepatic injury can be observed 
in the co-culture of hepatocytes and KCs with almost complete suppression of 
CYP3A activity by the extensive expression of TNF-Į (Hoebe et al., 2001) 
mediated by reduction of AhR/Arnt (Wu et al., 2006). Therefore, the direct 
interaction between KCs and hepatocytes supports the extensive cytokines 
production but in turn suppresses hepatocyte function. 
 
1.4.3.6 Co-culture with hepatic stellate cells 
Due to the close interaction of HSCs with hepatocytes in vivo, HSCs are 
regarded as an ideal candidate for an in vitro co-culture component. They play 
a profound role in the pathogenesis of liver disease (Gressenger, 1998; 
Friedman, 2000) and, on a cellular level, are considered as the key in the 
development of liver fibrosis (Bedossa and Paradis, 2003). Many co-culture 
studies have been focused on the activation of HSCs (Nieto et al., 2001; 
Myung et al., 2006), deposition of ECM (Arthur, 2000; Bedossa and Paradis, 
2003), or any other fibrogenesis related parameters (Nieto et al., 2002; Nieto 
and Cederbaum, 2003; Xu et al., 2005). For example, the activation of HSCs is 
regulated by activation of TGF-ȕ through the induction of thrombospondin-1 
by bile acids treatment in the co-culture of Huh-BAT and LX-2 cell lines 
(Myung et al., 2007). Also, an abundant extracellular matrix, including laminin, 
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fibronectin, and collagen proIII and IV is observed when hepatocytes are co-
cultured with HSCs (Loreal et al., 1993). Moreover, MMP-13 mRNA is up-
regulated and collagen type I is down-regulated when HSCs are co-cultured 
with hepatocytes (Schaefer et al., 2003). 
 
In addition, HSCs contribute to both proliferation and differentiation of 
hepatocytes in vitro. Co-cultures with rat primary HSCs supports rat 
hepatocyte DNA synthesis by HSCs' derived factors, including HGF, 
extracellular sulphate (HS) and HS proteoglycan (Uyama et al., 2002). HSCs 
induce the expression of connexion 43, a gap junction protein, and lead to 
enhanced hepatocyte albumin mRNA expression (Rojkind et al., 1995). More 
importantly, 3D spheroids formed by co-culturing primary rat hepatocyes and 
HSCs on PDLLA coated surface, show enhanced albumin secretion and CYP 
activities (Riccalton-Banks et al., 2003; Thomas et al., 2005, 2006). 
 
Besides primary HSCs, HSCs cell lines, such as spontaneous or genetically 
immortalized cell lines, have been applied to improve hepatocyte functions. 
For example, hepatocytes co-cultured on gene-transferring HSCs on 
CFSC/HGF feeder layers maintain higher viability, albumin and urea secretion 
than hepatocytes monoculture on collagen type I coated surface. c-Met, which 
is highly expressed in the co-culture system, is considered as the key to the 
enhanced function (Wang et al., 2005). Also, immortalized human hepatocytes 
NKNT-3 show increased CYP3A4 and CYP2C9 activity with increased urea 
synthesis co-cultured with TWNT-1 cell line, one of SSR#197-immortalized 
HSCs (Watanabe et al., 2003). However, not all the HSCs cell lines are 
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beneficial to hepatocyte function. For example, activated CFSC-2G HSCs cell 
line affects negatively the proliferation, functionality and ECM production of 
hepatocytes (Arnaud et al., 2003). 
 
1.4.3.7 Co-culture with NPC fraction 
A co-culture system involving only two cell types does not represent the 
complexity of cross regulation of all cell types in vivo. This is supported by 
successful co-culturing of hepatocytes and non-parenchymal cell (NPC) 
fraction in vitro. A special isolation method is used by Schmelzer et al. to get 
an approximately 20-30% NPCs fraction compared to only 1% NPCs from the 
conventional Percoll purification method. This co-culture in collagen sandwich 
shows the level of biotransformation of cyclosporine corresponding to the 
respective in vivo metabolism. (Schmelzer et al., 2006) Also, a method of co-
culturing of rat hepatic parenchymal cells (PCs) and NPCs (stromal) in a 3D 
mesh has been developed (Naughton et al., 1995). Fresh isolated PCs are 
cultured on pre-cultured stromal cells to show dioxin-inducible CYP activity 
for 56 days and albumin, fibrinogen, transferrin and fibronectin expression for 
48 days. Ries et al. then demonstrate that HSCs and KCs are the prominent cell 
types of stromal cells after 8 days in a specific medium condition. 
Phosphoenolpyruvate carboxykinase activity and urea production are increased 
in this co-culture system for a long period. (Ries et al., 2000) The mechanism 
of the co-culture effect of stromal cells has been investigated by using a 
micromachined silicon substrate with moving parts. Cell direct contact for a 
limited time followed by soluble signal is required to maintain hepatocellular 
phenotype. (Hui and Bhatia, 2007) 
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1.4.4 Spheroids  
Various types of 3D culture techniques in the liver tissue engineering have 
been developed including spheroid formation, biodegradable polymer scaffolds, 
sandwich culture configuration and microspheres (Brieva and Moghe, 2004). 
Among all of these methods, spheroids are the most commonly used method to 
form 3D cell constructs. The physiological state of hepatocytes is changed 
when they form spheroids, resulting in a series of changes in the morphology 
and function. In other words, hepatocytes in either homo-spheroids or hetero-
spheroids display higher viability and exhibit higher level of liver-specific 
functions than monoculture of hepatocytes. This enhanced functionality of 
spheroids is probably due to the extensive cell-cell interaction as well as 
soluble factors in 3D structures. (Kim et al., 2001; Lu et al., 2003; Yin et al., 
2003) 
 
In particular, hetero-spheroids are of great interest due to the combination of 
the benefits of a 3D microenvironment and improved hetero-cell-cell 
interaction. Conventional preparation of spheroids requires a suitable culture 
substratum and a large surface area for initial attachment as well (Takezawa et 
al., 1992), which are the limitations for bio-artificial device development. 
However, suspension co-culture of self-organization hetero-spheroids has 
overcome these limits (Lee et al., 2004). For example, spheroids are formed by 
suspension co-culture of hepatocytes and rat prostate endothelial cell line 
(RPEn) in a spinner vessel and then sub-cultured in a Ca-alginate gel bead after 
20 hours. Significantly higher albumin secretion and ammonia removal 
activities are observed in hetero-spheroids than those in homo-spheroids. 
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Similar to in vivo location of SECs and hepatocytes, RPEn cells are located on 
the surface of hetero-spheroids. (Lee et al., 2004) Also, hetero-spheroids 
developed by hepatocytes and whole NPCs fraction in the presence of Eudragit 
S100 on a untreated dish or spinner flask show higher albumin secretion, 
ammonia removal and CYP1A1 activity as well for over 4 weeks in vitro. 
NPCs are randomly distributed in the hetero-spheroids, either on the surface or 
inside the spheroids. (Yamada et al., 2001)  
 
However, these above suspension hetero-spheroids do not favour the cell-ECM 
interaction. Lu et al. report a type of hetero-spheroids with not only higher 
degree of cell-cell interaction but also maintenance of cell-ECM interaction. 
Rat hepatocytes self-form into spheroids covered with NIH3T3 on the poly 
(vinylidene difluoride) (PVDF) surface. Albumin synthesis and CYPIA1 
activity are maintained over 15 days and then decline afterwards due to 
detachment of spheroids because of over-confluence of NIH3T3. (Lu et al., 
2005) 
 
The size of the spheroids is critical due to the limited oxygen and nutrient 
supply in the centre of spheroids if they are bigger than 100 µm in diameter 
(Takabatake et al., 1991). Spheroids formed in the patterned co-culture could 
control the size, shape and space between them (Fukuda et al., 2006). For 
example, thousands of hetero-spheroids 100 µm in diameter are formed by 
bovine aortic endothelial cells and rat primary hepatocytes on micro-patterned 
surface with glass domains 100 µm in diameter and surrounded by 100 µm 
spacing of a-lactosyl-PEG/PLA. (Otsuka et al., 2004) In addition to patterned 
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co-culture, another novel method for rapid spheroid formation is reported by 
Okubo et al. They demonstrate mixed liver cells spheroids 60 µm in diameter 
could be developed using an isolation method without EGTA and calcium in 6 
hours. The ultra-structure of these spheroids shows bile canaliculi, tight 
junctions and mitochondria, which is identical to in vivo liver tissue. (Okubo et 
al., 2002) 
 
1.4.5 Bioreactor  
Hepatocytes in conventional cultures do not operate under continuous 
perfusion conditions and, gradients and vectors for metabolite transfer are 
significantly altered, which is not corresponding to cells in vivo. However, the 
use of bioreactors for liver tissue engineering, which overcomes the limitations 
of conventional culture, has been considered as the most successful application 
to mimic liver in vivo situation.   
 
Several critical engineering designs of bioreactor, including maximum of long-
term hepatocyte specific functionality, ability of cell scale-up, minimum of 
preparation volume and elimination of transport limitations, should be 
considered. In terms of maintaining the long-term hepatocyte function, oxygen 
transport, which cannot be achieved well in the conventional culture, is one of 
the most vital parameters in the design of bioreactor due to high oxygen uptake 
of hepatocytes (Foy et al., 1994) and relative low efficiency of oxygen carrier 
(oxygen ECM). In addition to oxygen transport, shear stress induced by flow 
rate is another crucial factor to influence hepatocyte function (Kan et al, 2004), 
 60
since reduction of shear stress could allow higher medium flow rate in order to 
supply sufficient oxygen. 
 
There are several different types of bioreactors, including hollow fibre 
bioreactors, monolayer bioreactors, perfused scaffolds and cell suspension. 
Hollow fibre technology can protect the cells from shear stress and provide a 
high number of cells in a small volume (Obermayer et al., 2001); monolayer 
bioreactor and perfused scaffold expose the cells under the medium flow 
induced shear stress, but 3D architecture, co-culture with NPCs or scale-up cell 
number could be easily achieved (Fiegel et al., 2006; Wen et al., 2008); 
suspension culture demonstrated poor cell viability but good transfer between 
plasma and hepatocytes (Doré  and Legallais, 1999).  In addition, radial flow 
bioreactor has recently been developed using stacked microfabricated grooved 
substrates instead of hollow fibre (Park et al., 2008). Co-culture of hepatocytes 
and 3T3-J2 is applied to the system and the albumin synthesis is about 250 
µg/10
6
 hepatocyes per day, which is higher than other bioreactors in 
development (De Bartolo et al., 2000). The success of this bioreactor is 
probably due to the reduction of shear stress by microgrooves to provide high 
medium flow with enough oxygen. The bioreactor is the basis for the 
extracorporeal liver assist device (ELAD) (Millis et al., 2002), HepatAssist 
(Stadlbauer and Jalan, 2007), modular extracorporeal liver support (MELS) 
(Sauer et al., 2003), Amsterdam Medical Centre (AMC)-BAL (Van de 
Kerkhove et al., 2002) and bio-artificial liver support system (BLSS) (Patzer et 
al., 2002). 
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1.4.6 Stem cells  
Although liver cell transplantation (LCT) has emerged with some success to 
replace the gold standard treatment, orthotropic liver transplantation (OLT), for 
end-stage liver failure (Najimi and Sokal, 2005; Stephenne et al., 2006), it is 
still limited by the cell viability, tissue supply and engraftment techniques. The 
recent demonstration of stem cells' plasticity has led to the increasing interest 
in applying them in the tissue regenerative medicine (Verfaillie et al., 2002). 
Some key theoretical advantages of stem cells include easy harvest, high level 
of proliferation, efficient in vitro transfection and potential autologous cell 
usage. However, many questions are still opened in this area and stem cell 
therapies need further development to become competitive. The morphology of 
stem cell-derived hepatocyte-like cell is rarely similar to that of the mature 
hepatocyte. Also, the functional characterization of stem cell-derived 
hepatocyte-like cells has not been standardized and normalized. More 
importantly, liver repopulation after stem cell transplantation in vivo remains 
limited. In this context, the development of several types of hepatic stem cells 
in liver tissue engineering is briefly described. 
 
1.4.6.1 Fetal hepatic stem cells 
The origin of the fetal hepatic stem cell has been a controversial topic. 
Hematopoietic cells were regarded as the major components in the fetal liver in 
early development (Lemmer et al., 1998; Zaret, 2000; Monga et al., 2001), but 
others suggest hepatic progenitor cells are an independent stem cell population 
(Nierhoff et al., 2005). In addition, the subject of markers is as controversial as 
the origin of the fetal hepatic stem cells. However, some potentially useful 
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markers have been identified in the fetal liver, including Thy-1 (Fiegel et al., 
2003), CK18 (Fiegel et al., 2003) and c-kit (Fujio et al., 1994). 
 
A few types of hepatic progenitors have been identified during fetal liver 
development. With the help of fluorescence activated cell sorting (FACS), liver 
hepatic progenitors are isolated, which display clonogenetic potential and have 
a bipotential differentiation to liver or biliary cells (Taniguchi, et al., 2000). 
Fetal liver epithelial cells are also identified (Sandhu et al., 2001). They are 
proved to have bipotential differentiation by forming both hepatocytes and 
cholangiocytes after transplanted into adult liver (Tateno et al., 1996). 
 
1.4.6.2 Bone marrow derived stem cells 
Petersen et al. first described that bone marrow cells transplanted into lethally 
irradiated mice could differentiate into liver stem cells or mature liver cells 
(hepatocytes) (Petersen et al., 1999). This observation has been confirmed in 
patients who receive a bone marrow transplantation or peripheral blood stem 
cell transplantation for haematological disorders (Korbling et al., 2002). 
Several in vitro data also demonstrate that certain types of bone marrow 
cells/stem cells could differentiate to hepatocytic cells in the presence of 
appropriate culture conditions (Fiegel et al., 2003; Kakinuma et al., 2003). 
Hematopoietic stem cells (HemSCs) were initially considered to be able to 
differentiate into hepatocytic cells when FACS-sorted mouse HemSCs showed 
liver-specific gene expression and function after transplantation into FAH-
deficient mice (Lagasse et al., 2000). The potential differentiation ability of 
these HemSCs is further confirmed by the expression of albumin and CK genes 
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in cultured human CD34-positive HemSCs induced by HGF (Fiegel et al., 
2003).  
 
Besides HemSCs, the possibility of mesenchymal stem cells (MSCs) 
differentiated into hepatocytic cells is indicated by the fact that MSCs can 
express the liver specific marker, alpha-fetoprotein (AFP) and cytokeratin-18 
(CK-18), produce albumin and urea as well as display CYP activity under 
certain conditions (Hong et al., 2005; Kang et al., 2005). Co-culture with other 
cell types has a strong influence on the induction of liver specific gene 
expression of MSCs. Adult rat liver cells used to co-culture with MSCs 
enhance the differential potential of MSCs (Lange et al., 2005). This co-culture 
influence is highlighted by the finding by Okumoto et al. that immune-selected 
bone marrow cells co-cultured with hepatocytes express HNF-1Į and CK-8 in 
the presence of HGF and FBS (Okumoto et al., 2003). Fetal liver cells, 
however, cause a faster differentiation of MSCs in to hepatocytic cells 
compared to adult liver cells (Lange et al., 2006). Overall, MSCs have the 
characteristics to be highly proliferative in vitro and to display a large in vitro 
and in vivo differentiation potential.  
 
1.4.6.3 Adult liver stem cells 
Four main types of hepatic progenitors are described in this context, namely, 
oval cells, small hepatocytes, liver epithelial cells and mesenchymal-like cells.  
The activation of oval cells has been regarded as the most promising process to 
facilitate liver regeneration (Oh et al., 2002). Oval cells were observed by 
microscopy in experimental hepatic degeneration in 1961 (Grisham and 
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Hartroft, 1961) and they were small in size with a large nucleus-to cytoplasm 
ratio. In the rodents, they are believed to be potential liver progenitor cells and 
express immature markers (Į-fetoprotein), mature hepatic markers (e.g. 
albumin) and biliary markers (e.g. cytokeratin-19) (Wang et al., 2003). The 
cells are responsible for liver regeneration after the treatment of 2-
acetylaminofluorene (2-AFF) in the injury model (Alison et al., 1996). 
However, in the human, the concept of the bipotential oval cells is still 
controversial.  OV-6-positive oval cells are analogous to those seen in rodent 
model and might be characterized as human liver progenitor, which could 
differentiate into OV-6-positive ductal cells or lobular hepatocytes in Heather's 
experiments (Crosby et al., 1998). In addition, the appearance of "ductular 
reactions", which is described as the proliferative response to several types of 
liver injury, has been considered as the most common evidence to support the 
existence of oval cells in human (Kiss et al., 2001).  
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1.5 Aims 
The development of systems for the long term in vitro culture of functional 
liver tissue is a major research goal. The central limitation of experimental 
systems to date has been the early de-differentiation of primary hepatocytes in 
cultures. Rat primary hepatocytes and hepatic stellate cells have been isolated 
and co-cultured on Poly (DL-lactic acid) (PDLLA) surface to form three-
dimensional spheroids successfully (Riccalton-Banks et al., 2003; Thomas et 
al., 2005, 2006). It has been previously demonstrated that this co-culture model 
maintains tight cell-cell interaction and enhances long-term growth and 
hepatocyte specific functions. However, it is reported that not only cell-cell 
interaction but also cell-matrix interaction has great effects on hepatocyte 
morphology and functionality. Therefore, the aim of this project is to compare 
this model to other best available systems using collagen and/or Matrigel. It is 
hypothesised that this model can be further enhanced by the inclusion of 
extracellular matrix. We also wished to compare the function of the Fa2N-4 
cell line to our primary cell models.  
 
To test this hypothesis, the studies described in this thesis aim to: 
x Apply and optimize common primary hepatocyte function assays 
x Optimize cell density and culture conditions for co-culture of rat 
hepatocytes and hepatic stellate cells in collagen-Matrigel sandwich 
x Compare the established 3D model to the co-culture of rat hepatocytes 
and hepatic stellate cells in collagen-Matrigel sandwich using albumin 
secretion, urea production and testosterone metabolism assays 
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x Use Mass spectrometry to confirm and extend our observations on  
CYP enzyme functions 
x Establish the co-culture of human hepatocytes and hepatic stellate cells 
in 3D spheroids 
x Compare CYP induction potential in the Fa2N-4 cell line via activity 
and mRNA endpoints for a range of prototypical compounds with 
known induction potential in primary human hepatocytes 
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2.1 Introduction 
2.1.1 Why use primary hepatocytes? 
Primary cultured hepatocytes can be isolated from liver and maintained in vitro 
for a few days, where they retain their adult function and phenotype for a 
variable length of time. Primary cells have evident inherent advantages that 
make them the closest model to in vivo (Nagaki et al., 1995; Margarita et al., 
2005). Good preservation of plasma membrane and active uptake/excretion 
mechanisms and metabolisms is similar to hepatocytes in vivo (Berthiaume et 
al., 1996; Jigorel et al., 2005). Also, maintenance of metabolism pathways 
(both phase I and phase II enzymes), physiological cofactor-enzyme levels and 
active gene expression remains well conserved for several days in culture 
(Gomez-lechon et al., 2003, 2004).  Comparison of CYP expression in cultured 
hepatocytes with hepatic tissue demonstrates that the metabolic capabilities of 
primary cultured cells are comparable in important ways to those of intact liver 
(Martin-Aragon et al., 2001). However, common use of human hepatocytes is 
held back by the restricted access to human liver tissue and the limited 
proliferation abilities of the differentiated hepatocytes in in vitro culture.  
Therefore, other primary cells including rat, mouse, pig, as well as hepatic cell 
lines are used as alternative options in most laboratories. 
 
2.1.2 The effects of seeding density on hepatocyte morphology and 
functionalities 
Cell seeding is one of the key procedures in the construction of a long-term 
culture system that maintains several hepatic functionalities, and therefore a 
necessary component of a tissue-engineered bioartificial liver that can replace 
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liver functions in patients with severe liver insufficiency. Due to inability to 
proliferate under the usual culture conditions and rapid loss of cell viability 
after a few days in vitro, a variety of efficient culture techniques applied to 
achieve highly-maintained hepatic function by using proper seeding density is 
vital. Primary 3D culture of hepatocytes with non-parenchymal cells, which is 
considered as a highly stable long-term culture as well as a more physiologic 
environment, has to be achieved at the appropriate densities of both cell types. 
Rat hepatocytes (200,000 cells/cm
2
) are co-cultured with NIH/3T3 mouse 
fibroblasts at the ratio of 1:1 to enhance hepatocyte functional maintenance (Lu 
et al., 2005), while in another research paper using the same two cell types, the 
densities are 1.1 x10
5
 cells/cm
2
 and 1.0 x10
5
 cells/cm
2
 respectively, but in a 
double-layer culture pattern (Nishikawa et al., 2008); When rat hepatocytes 
were co-cultured with primary rat HSCs at the ratio of 2:1 on a PDLLA coated 
6-well plate, CYP450 functions were prolonged compared to monoculture 
(Riccalton-Banks et al., 2003; Thomas et al., 2005, 2006). Instead of primary 
HSCs, a HSC-T6 cell line co-cultured with rat hepatocytes on scaffolds in a 
perfusion bioreactor, at the same ratio as that of primary HSCs to hepatocytes, 
also achieved higher albumin, urea and CYP450 functions (Wen et al., 2008).  
These diverse systems illustrate the importance of using the right seeding 
density. 
 
 
 
 
 
2.1.3 Assessments of hepatocyte function in vitro 
2.1.3.1 7-ethoxyresorufin O-dealkylase (EROD) activity assay 
The assay was adapted from an assay originally described by Burke and Mayer 
in 1974. It is mainly based on a CYP1A-catalysed O-dealkylation of 7-
ethoxyresorufin (ER).  The resorufin metabolite formed can be measured 
fluorometrically. The EROD assay is now a widely used indicator of 
hepatocyte functionality (Figure 2.1). 
 
 
 
 
 
Figure 2.1: Chemical structure of the substrate 7-Ethoxyresorufin and the 
resulting fluorescent metabolite resorufin by CYP1A. 
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2.1.3.2 Testosterone metabolism assay  
One of the major metabolic pathways in hepatocytes is cytochrome P450-
dependent monooxygenase activity, which is assessed by testosterone 
metabolism (Donato et al., 1994; Thomas et al., 2005). The 6ȕ-hydroxylation 
of testosterone is mainly catalysed by CYP3A1 and the oxidation of 
testosterone to 4-androstene-3, 17-dione is predominately mediated by CYP2B 
and CYP2C.  High-performance liquid chromatography (HPLC) is applied to 
assess the CYP activities in this chapter. HPLC is a form of liquid 
chromatography to separate compounds which are dissolved in solution. 
Compounds are separated by injecting a plug of the sample mixture onto a 
column, which pass through it at different rates due to differences in their 
partitioning behaviour between the mobile liquid phase (solvent) and the 
stationary phase (column) (Figure 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 2.2: A flow scheme for HPLC. The pump provides a steady high 
pressure and can be programmed to vary the composition of the solvent. The 
liquid sample containing different material is injected and each material is 
separated through the different attraction between column and solvent. Each 
material travels in different retention time (the time taken for a particular 
compound to travel through the column to the detector) and each particular 
material can absorb UV light of specific wavelengths by the detector (UV 
absorption). Finally, the output is shown in the peak proportional to the amount 
of each material. 
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2.1.3.3 Albumin secretion assay 
The amount of albumin was identified and measured by enzyme-linked 
immunosorbent assay (ELISA). Cell culture media, where albumin is secreted, 
are collected and transferred to a high protein-binding plate. An anti-rat 
albumin antibody conjugated with horseradish peroxidase (HPO) is then added 
to the plate. The HPO enzyme converts the o-phenylenediamine 
dihydrochloride (OPD) substrate to a detectable coloured product. The enzyme 
activity and albumin concentration can then be quantified by the colour change 
(Figure 2.3). 
 
 
 
Figure 2.3: Schematic diagram of ELISA assay. An anti-rat albumin antibody 
conjugated with horseradish peroxidase (HPO) is bound to albumin from the 
medium in cell culture. The HPO enzyme converts the o-phenylenediamine 
dihydrochloride (OPD) substrate to a detectable coloured product. 
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2.1.3.4 Urea secretion 
The QuantiChrom Urea assay kit (Centaur), which is an improved Jung’s 
method (Jung et al., 1975), utilizes a chromogenic reagent that forms a 
coloured complex specifically with urea. The intensity of the colour, measured 
at 520 nm, is directly proportional to the urea concentration in the sample. 
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2.1.4 Aims 
The preliminary studies described in this chapter were designed to confirm the 
method of isolation of primary rat hepatocytes and HSCs using a two-step 
collagenase perfusion method, followed by monoculture of hepatocytes and co-
culture of hepatocytes with HSCs in different in vitro culture systems, 
especially in collagen- Matrigel sandwich configuration and on a PDLLA coated 
surface. Also, hepatic function assays including albumin secretion, urea 
secretion, EROD and testosterone metabolism applied to monoculture of 
hepatocytes were optimized. The chapter specifically aims to study: 
x isolation of primary rat hepatocytes and HSCs; 
x seeding density of hepatocytes in monoculture and co-culture; the 
ratio of hepatocytes and HSCs in co-culture; 
x effects of Matrigel overlay on morphology of hepatocytes 
monoculture and co-culture; and 
x effects of plate change on hepatic function assays: albumin 
secretion, urea secretion, EROD and testosterone metabolism. 
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2.2 Material and Methods 
2.2.1 Animals 
Male Wistar rats (Charles River, UK), weighing between 180-250 g were used. 
The animals were fed commercial food and tap water and were housed in small 
groups on soft wood bedding. 
 
2.2.2 Chemicals 
Bovine serum albumin (BSA), H2SO4, 2, 2, 2-trifluoroethanol (TFE), rat tail 
collagen type I and polyoxyethylene sorbitan monolaurate (Tween 20) were 
purchased from Sigma, UK. Crystals of polymer poly (DL-lactic acid) (PDLLA) 
were from Alkermes Inc., USA. Matrigel was from BD Biosciences, UK. 
Methanol, ethanol and industrial methylated spirit (IMS) were from Fisher 
Chemicals, UK. Formal buffered saline (10% v/v) and Cryo-M-bed embedding 
compound were purchased from Bright, Huntington, UK. Rat Albumin ELISA 
Quantification Kit was from Bethyl Laboratories Inc., UK. QuantiChrom Urea 
Assay Kit was purchased from Gentaur, Belgium.  
 
2.2.3 Plasticware 
12-well tissue culture treated dishes and tissue culture flasks (75 cm
2
) were 
bought from Nunclon, Denmark. 12-well collagen type I coated dishes were 
bought from BD Biosciences, UK. Costar 96-well flat bottom, non-treated, 
polystyrene assay plates and enzyme immunoassay high binding plates were 
purchased from Corning, USA.  
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(i) PDLLA coating of culture plates 
PDLLA (Polyscience Inc) was dissolved in 2,2,2-Trifluoroethanol at a 
concentration of 1.5 mg/ml. 500 µl of PDLLA solution was added to each      
962 mm
2
 nunclon dish. The dishes were placed in an oven at 70ºC for 
approximately 40 minutes to evaporate the solvent and then exposed under a 
sterilising UV lamp for 30 minutes before being stored at -20ºC. 
 
2.2.4 Primary rat hepatocyte isolation 
The hepatocyte isolation was based on the two-step collagenase perfusion 
method described by Seglen in 1976 using the apparatus shown in Figure 2.4A 
and 2.4B. A Millipore peristaltic pump was set at a flow rate at 20 ml/minute 
and the water bath was maintained at 40ûC during the perfusion so that the 
perfusion buffer temperature was approximately 37ûC when it reached the 
tissue. Hepatocytes were isolated from male Wistar rats (Section 2.2.1). After 
the rat was killed by cervical dislocation, the right and middle liver lobes were 
carefully removed and placed on the perfusion platform. The liver lobes were 
cannulated with a 1.5-inch, 21 gauge winged needle infusion set (Venisystem, 
UK) through a vein of an exposed cut surface on top of the Buchner funnel. In 
order to flush out the blood and to destroy cell-cell interaction, the lobes were 
perfused with chelating buffer (Appendix 1.5) for 10 minutes followed by a 20 
minute perfusion with collagenase perfusate buffer (Appendix 1.6) to break 
down cell-extracellular matrix interaction. The lobes were then removed 
carefully and placed in a pertri dish containing hepatocyte complete medium 
(Appendix 1.8.1). The cells were released from the extracellular matrix of the 
tissue by breaking the capsule and agitating the tissue with sterile scissors and 
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forceps (Figure 2.4C). The tissue suspension was filtered through 64 ȝm sterile 
cotton gauze placed over a funnel into two 50 ml falcon tubes. The filtrate was 
centrifuged at 50 ×g for 5 minutes. The resulting pellets were resuspended in 
10 ml hepatocyte complete medium diluted with the same amount of 90% 
percoll solution (Appendix 1.7) and centrifuged at 50 ×g for a further 5 
minutes. All the viable hepatocytes were eventually harvested in the pellets. 
The supernatants from both spins were poured off and kept for the use of 
isolation of hepatic stellate cells.  
 
The viable hepatocytes were resuspended in appropriate amount of hepatocyte 
complete medium and the viability of the cells was assessed using Trypan Blue 
exclusion. 100 ȝl of cell suspension and an identical amount of Trypan Blue 
solution were gently mixed together. The solution was placed on a 0.0025 mm
2
 
haemacytometer (Sigma, UK) covered with a slide. Under the examination of 
light microscope, the number of cells taking up the blue dye were counted and 
regarded as non-viable cells. The proportion of viable cells was calculated as a 
percentage of the total number of cells. A viability of at least 85% (viable 
cells/total cells) was considered necessary for experimental work. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: The setup for rat hepatocyte isolation (A); perfusion of the liver 
lobes with a 1.5-inch, 21 gauge winged needle infusion set (B); release of 
hepatocytes from tissue by mincing with forceps (C). 
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2.2.5 Primary rat hepatic stellate cell isolation 
The supernatants from primary hepatocyte isolation were centrifuged at 50 × g 
for 5 minutes. The resulting pellets were discarded, and the preceding two steps 
repeated so as to get rid of the hepatocytes remaining in the supernatants. After 
that, the supernatant from the second spin was centrifuged at 250 × g for 10 
minutes and the pellets, containing HSCs, were collected and re-suspended in 
the proper amount of HSCs medium (Appendix 1.8.3). 
 
2.2.6 Culture conditions 
Cell culture was carried out using aseptic techniques in a class II biosafety 
cabinet for primary rat hepatocytes and HSCs (Envair, UK). All cell cultures 
were maintained at 37ûC in a humidified atmosphere with 5% CO2 / 95% O2 in 
air.  
 
(i) Cell culture: overlay with extracellular matrix - Matrigel 
The stock Matrigel was thawed out slowly and fully by placing in slushy ice 
for 2 to 3 hours. The Matrigel was then diluted in ice-cold hepatocyte 
incomplete medium (Appendix 1.8.2) to give a final concentration at 0.25 
mg/ml using an ice-cold pipette. The medium was removed from 12 well plates 
after the cells initial attachment, 2 hours for rat hepatocytes and 4 hours for 
human cells respectively. 1 ml of Matrigel-containing medium was added to 
each well using ice-cold pipette and the cells were returned to the incubator 
immediately. The cells were undisturbed until 24 hours. After this time, the 
Matrigel-free medium was replaced for subsequent experiments and treatments.  
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2.2.7 Functional analysis 
2.2.7.1 Cytochrome P-450 enzyme activity assays 
(i) 7-ethoxyresorufin O-dealkylase (EROD) activity assay 
The mediums were aspirated and the cells were washed with PBS buffer before 
the assay was started. The required amount of Krebs buffer (Appendix 2.1.1) 
was created to wash the cells, which contained 10 ȝM dicoumarol (Appendix 
2.1.3) and 5 ȝM substrate 7-ethoxyresorufin (Appendix 2.1.2), and the cells 
were incubated for 30 minutes at 37ûC, 5% CO2 in air.  No cells controls with 
Krebs buffer containing 10 ȝM dicoumarol and 5 ȝM substrate 7-
ethoxyresorufin permitted assessment of cell independent substrate breakdown 
to resorufin. No substrate controls with Krebs buffer containing 10 ȝM 
dicoumarol only provided non-resorufin fluorescence. After incubation, 200 ȝl 
of the buffer was removed from each well and transferred to another 96-well 
plate in triplicate containing 40 ȝl of 1600 units/ml ȕ-glucuronidase (Appendix 
2.1.5) in 0.1 M sodium acetate buffer (Appendix 2.1.4). After that, the cells 
were washed with sterile PBS buffer, resuspended in fresh medium and then 
returned to the incubator at 37ûC, 5% CO2 in air. The 96-well plates containing 
buffer with ȕ-glucuronidase were incubated at 37ûC for a minimum of 2 hours 
before the reaction was terminated by adding 50 ȝl of 0.1 M sodium hydroxide 
to each well. Finally, fluorescence of samples was measured by using either a 
Hitachi F-4500 fluorescence spectrophotometer or a Bio-Tek FL600 plate 
reader at 530 nm excitation and 590 nm emission. The fluorescence readings 
from no cell controls were subtracted from the sample readings. A standard 
curve of resorufin (0-100 pmol/ml) was prepared in Krebs buffer (Appendix 
2.1.6).  
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(ii) Testosterone metabolism assay  
Analysis of testosterone metabolism by HPLC has been established by the 
Tissue Engineering Group, School of Pharmacy, University of Nottingham. Rat 
hepatocyte cultures were incubated at 37ûC for 1 hour with 1.5 ml EBSS, 
supplemented with 1 mM Ca
2+
 and 1 mM Mg
2+
, containing 100 ȝM 
testosterone. The supernatant was centrifuged at 250 ×g for 5 minutes to 
remove cell debris and then analyzed using a Beckman high-performance 
liquid chromatography (HP 1090) fitted with a Zorbax 300 SB-C18 4.6 mm x 
15 cm column at 50ûC. Mobile phase A (Appendix 2.3.1) and mobile phase B 
(Appendix 2.3.2) started at 15% B / 85% A and reached to 50% B / 50% A 
gradually over 10 minutes at a consistent speed of 1 ml/min. Sample injection 
volume was 40 ȝl and UV absorbance was detected at 245 nm with an integral 
diode array detector. The activities of CYP3A and CYP2B/2C were measured 
by the amount of 6ȕ-hydroxytestosterone and 4-androstene-3, 17-dione 
metabolised by CYP3A and CYP2B/2C, respectively. The standard of 6ȕ-
hydroxytestosterone and 4-androstene-3, 17-dione were run intermittently as 
controls. 
 
2.2.7.2 Urea secretion assay  
At each day points the medium was removed from the wells and centrifuged at 
13000 rpm for 5 minutes by using a MSE Microcentaur centrifuge. The 
supernatant was kept in 1.5 ml eppendorf tube and stored at -20ûC until needed. 
5 ȝl of each sample was incubated with 100 ȝl reagent A mixed with the same 
volume of reagent B in a 96-well plate for 10 minutes at room temperature and 
read at 492 nm in a plate reader (Bio-Tek FL600).  
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2.2.7.3 Albumin secretion assay 
The capture anti-rat albumin antibody (1 mg/ml) was diluted with coating 
buffer (Appendix 2.2.1) to the concentration of 10 ȝg/ml and 100 ȝl aliquots 
were added to each well of a 96-well high affinity binding plate. The plate was 
then incubated for 60 minutes at room temperature or kept at 4ûC overnight. 
After incubation, the captured antibody from each well was aspirated. The 
plates were then washed by wash solution (Appendix 2.2.2) three times 
followed by the addition of 200 ȝl of blocking solution (Appendix 2.2.3) to 
each well. The plate was then incubated for another 30 minutes at room 
temperature. After aspirating the block solution, the plate was washed three 
times as before. 100 ȝl of each sample, together with standards with 
appropriate dilutions (Appendix 2.2.6) by sample/conjugate diluents (Appendix 
2.2.4), were transferred to each well and incubated for 60 minutes at room 
temperature. After that, the standards and samples were removed and washed 
as in the previous steps for five times. 100 ȝl of HRP conjugated antibody (1 
mg/ml) (Appendix 2.2.7), diluted to the concentration of 25 ng/ml, was added 
to each well and covered with foil and incubated for 60 minutes at room 
temperature. After the incubation, the HRP conjugated antibody from each well 
was aspirated and the plates were then washed as in the previous steps for five 
times. Finally, 100 ȝl of TMB was added to each well and the reaction was 
terminated by adding 100 ȝl of 2 M H2SO4 (Appendix 2.2.5) after 10 minutes 
(with foil present at all times). The samples were read at 450 nm in the plate 
reader. 
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2.2.8 DNA content analysis HOECHST 33285 
Cells were freeze-dried and stored at -70ûC until needed. Cells were washed 
with PBS buffer before 500 ȝl of papain solution (Appendix 2.4.7) was added 
to each well and incubated at 37ûC for 1 hour to lyse the cells. After that, 500 
ȝl of working solution (Appendix 2.4.3) was added and mixed well with papain 
solution. 100 ȝl mixed solution was then transferred to a fresh 96-well plate. 
Finally, the cells were read at excitation 360 nm and emission 460 nm on a 
plate reader. 
 
2.2.9 Rat hepatic stellate cells stain 
2.2.9.1 Lipid staining  
10% formalin solution (approximately 4% formaldehyde) was used to fix the 
HSCs for 5 minutes and then sterile distilled water was used to wash the cells. 
The cells were incubated with oil red O staining solution (Appendix 2.5.2) for 
10 to 15 minutes at room temperature and then washed with sterile distilled 
water before examination by light microscopy. Lipid droplets were visible as 
pink/red vesicles. Other techniques, such as immunocytochemistry for desmin 
and glial fibrillary acidic protein (GFAP), will also be used in future within the 
Tissue Engineering Group, School of Pharmacy, University of Nottingham. 
 
2.2.10 Experimental design and data analysis 
In order to optimize the hepatocyte specific function assays, including albumin 
secretion, urea secretion, EROD and testosterone metabolism, and to assess 
whether hepatocyte functions are effected by the repeated assays, hepatocyte 
monolayers were cultured on collagen type I coated 12-well plates at the 
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density of 500, 000 per well. The medium was changed every 24 hours and 
replaced by fresh medium. Hepatocyte functions were assessed on seven day 
points, namely day 1, 3, 5, 7, 9, 11, 14 and 21. The assays were applied to the 
same plate on seven day points (one plate), to seven different plates on each 
day point (daily plate), or to four different plates on every two day points 
(every two day plate). Each hepatocyte function assay was carried out three 
times in duplicate on 12 well plates. Duplicates were averaged to create 
independent data points for statistical analysis. Data was analysed using one 
way ANOVA for differences in three different ways of applying hepatocyte 
function assays. Post tests with Tukeys error control were conducted to identify 
these differences. All data analysis was done in Excel and Prism. Graphs show 
mean values ± the standard error of the mean.  
 
Testosterone metabolism CYP activities are expressed as percentage of initial 
activity, not per mg protein, while both albumin and urea secretion assays were 
normalized to mg/ml/24 hours on 12 well plates by the assumption that the 
number of hepatocytes on monoculture was 500,000 through the whole culture 
period.  
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2.3 Results  
2.3.1 Morphology 
The first objective of the study was to determine the optimum seeding density 
for hepatocytes in monoculture and to then assess the impact of Matrigel 
overlay on hepatocyte morphology in monocultures and co-cultures. All the 
following experiments have been repeated at least three times. 
 
2.3.1.1 Rat hepatocyte seeding density on 12 well collagen type I coated 
plates 
Rat hepatocytes were obtained as described previously (Section 2.2.4) and 
were plated onto 12 well collagen type I coated plates at a density of 500,000 
to 700,000 cells per well in the complete medium for two hours initial 
attachment. The floating cells were then removed and the remaining cells were 
washed and cultured in the incomplete medium. Figure 2.5 shows the 
morphology of hepatocytes in different densities on 12 well collagen type I 
coated plates by light microscope.  
 
An assessment of the ratio of well coverage to the numbers of floating cells 
(Figure 2.5) indicated that high seeding densities led to excess cell death. 
Cultures at seeding densities of 500,000 and 550,000 appeared healthier and 
these cultures were examined after 48 and 72 hours (Figure 2.6). The 
hepatocytes cultured at both these densities showed more than 80% confluence 
after 48 hours, however, less viable cells were observed when the hepatocytes 
were cultured at the density of 550,000 after 72 hours. Therefore, rat 
hepatocytes cultured at 500,000 per well would be used in the future study. 
  
 
 
 
 
 
Figure 2.5: Phase contrast microscope images of rat hepatocyte cultures on 12-
well collagen type I coated plates after 24 hours. Images A to E show rat 
hepatocytes at the density of 500,000, 550,000, 600,000, 650,000 and 700,000 
cells per well respectively. Floating (dead) cells are shown by white arrows. 
There are less of these in Image A and B. 
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Figure 2.6: Phase contrast microscope images of rat hepatocyte cultures on 12-
well collagen type I coated plates after 48 and 72 hours, respectively. Images A 
and B are hepatocytes at a density of 500,000 cells per well after 48 and 72 
hours, respectively. Images C and D are hepatocytes at the density of 550,000 
cells per well after 48 and 72 hours, respectively. Floating (dead) cells are 
shown by black arrows. There are more of these in Image D than Image B. 
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2.3.1.2 Impact of Matrigel overlay 
Rat hepatocytes were cultured on a 12 well collagen type I coated plate at the 
density of 500,000 per well. After 2 hours initial attachment, Matrigel was 
overlaid on the top of the cells described previously (Section 2.2.6). The cells 
without overlaying Matrigel were used as controls. Figure 2.7 shows 
morphology of hepatocytes in the collagen-Matrigel sandwich configuration.  
 
After 24 hours of isolation, rat hepatocytes in the collagen-Matrigel sandwich 
configuration reached approximately 90% confluence and cells retained 
hepatocyte characteristic morphology (well-defined cell borders, distinct nuclei 
and bile canaliculi-like structure) after 48 hours, while the cells without 
Matrigel overlay showed less confluence after 24 hours and started to spread 
and lose cuboidal shape after 48 hours. Therefore, Matrigel overlay had great 
effects on the confluence and morphology of rat hepatocytes. 
 
 
 
 
 
 
 
 
 
  
Figure 2.7: The morphology of hepatocytes after 24 and 48 hours of isolation. 
Images A and C are hepatocytes cultured on the collagen type I coated plates 
after 24 and 48 hours, respectively. Cells are spread out and lose the cuboidal 
shape in Image C. Images B and D are hepatocytes cultured in the collagen-
Matrigel sandwich configuration after 24 and 48 hours respectively. Distinct 
cell borders (black arrows) and bile-canaliculi-like structures (red arrows) are 
shown in Image D. 
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2.3.1.3 Co-culture of hepatocytes with HSCs in the collagen-Matrigel 
sandwich configuration and PDLLA coated surface 
Rat hepatocytes and HSCs were isolated as described previously (Section 2.2.4 
and 2.2.5). Co-culture of hepatocytes and HSCs at the ratio of 2:1 in total 
number of 500,000 was cultured in collagen-Matrigel sandwich and PDLLA 
coated surface. The medium for the cells in sandwich configuration were used 
as described previously (Section 2.3.1.1). 
 
For the cells on PDLLA surface, incomplete medium was used all the time and 
the medium was not changed until the formation of 3D spheroids. The 
morphology of co-culture of hepatocytes and HSCs in collagen-Matrigel 
sandwich was showed in Figure 2.8A and 2.8B. Three-dimensional self-
organizing spheroids were formed on the PDLLA surface plates (Figure 2.8D).  
 
 
 
 
 
 
 
 
 
 
  
Figure 2.8: Co-culture of hepatocytes and HSCs in collagen-Matrigel sandwich 
after 24 and 48 hours, respectively (Image A and B), on PLA surface after 24 
hour and 72 hours, respectively (Image C and D). A spheroid is shown in 
Image D. 
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2.3.2 Function analysis 
The experiments presented in Section 2.3.1 provide a basis for comparing the 
function of hepatocytes maintained as either monocultures or co-cultures in 
collagen/Matrigel overlays and as 3D co-cultures within spheroids. In order to 
ensure that functional assays were working consistently and in optimal 
conditions, the effects of repeated assays on hepatocyte functions were first 
examined. 
 
Rat hepatocytes were consistently isolated at >85% viability and cultured on 
collagen I coating plate. The effects of different protocols for assay application 
were examined in terms of albumin secretion assay, urea secretion assay, 
EROD assay and testosterone metabolism. Data from all four assays are shown 
in Figures 2.9, 2.10, 2.11 and in Table 2.1. The medium from all plates was 
changed every day at the similar time point. Old medium was used for albumin 
and urea secretion assays, and then it was replaced by the fresh medium. Three 
different ways of assay application were used to assess the effects of repeated 
assay application on hepatocyte function. Assays were only applied on one 
plate during the whole period of experiment, or assays were applied on 
different plate for every single day point, or assays were applied on the same 
plate only for two day points. 
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2.3.2.1 Albumin secretion 
Albumin levels in the medium were measured by sandwich ELISA. Cultures 
were assayed 24 hours (day 1) after cell seeding and then on days 2, 3, 4, 5, 7, 
9, 11, 14 and 21 days of culture. The method for this procedure was described 
in Section 2.2.7.3  
 
The amount of albumin secreted was calculated from the standard curve of 
known rat albumin concentrations by Prism software (Figure 2.9A). The 
amount of albumin reached the peak on day 1 and afterwards, the amount 
decreased dramatically. No albumin could be detected after day 7. Also, no 
obvious difference of amount of albumin could be assessed from three different 
methods of changing plates (Figure 2.9B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) 
B) 
Figure 2.9: A representative albumin standard curve (A), albumin secretion per 
ml of medium of hepatocyte cultures over 7 days in a 24-hour period (B). 
Medium were changed every 24 hours. The assays were applied to the same 
plate on six day points (one plate), to six different plates on each day point 
(daily plate), or to three different plates on every two day points (every two day 
plate) (n=3, error bars indicate ±SD) 
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2.3.2.2 Urea secretion 
Urea levels in the medium after 24 hours of cultures were measured by 
quantitative colorimetric determination at 520 nm. Cultures were assayed the 
same way as described in Section 2.3.2.1. The method was introduced in 
Section 2.2.7.2. 
 
The amount of secreted urea was calculated from the standard curve of known 
urea concentration by Microsoft Excel (Figure 2.10A). The amount of urea 
kept at a similar level from day 1 to day 9, although the peak was on day 1, 
indicating that the ability of primary cells to secrete urea may require less 
hepatocyte specific differentiation than the secretion of albumin (Figure 2.10B).  
 
No urea was detected on day 7 and 9 from the plates that were changed every 
two-day points and no amount was detected on day 9 from the plates that were 
not changed at all. The possible reason to explain this phenomenon might be 
the internal error of plating rat hepatocytes on different wells. Except day 7 and 
9, there was no major difference in the amount of secreted urea between 
different plates. 
 
 
 
 
 
A) 
Figure 2.10: A representative urea standard curve (A), urea secretion per ml of 
medium of hepatocyte cultures over 9 days in a 24-hour period (B). Medium 
were changed every 24 hours. The assays were applied to the same plate on 
seven day points (one plate), to seven different plates on each day point (daily 
plate), or to four different plates on every two day points (every two day plate) 
(n=3, error bars indicate ±SD) 
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2.3.2.3 EROD assay 
CYP-450 mono-oxygenase activity was assessed via an EROD assay (Section 
2.2.7.1 (i)). Cultures were assessed 2 hours after cell seeding and then after 1, 2, 
3, 4, 5, 7, 9, 11, 14 and 21 days of culture. The amount of ethoxyresorufin (ER) 
converted by the hepatocytes was calculated from a standard curve, measuring 
the fluorescence of various concentrations of resorufin in solution (Figure 
2.11A). 
 
The CYP-450 mono-oxygenase activity of rat hepatocytes in monoculture 
reached its highest value at day 2 and decreased sharply on day 3. After that, 
the activity remained relatively constant at between 4 and 7 pmol resorufin/ml 
until 7 days after seeding. No apparent difference of amount of resorufin was 
detected from different plates (Figure 2.11B). 
 
 
 
 
 
 
 
 
A) 
re 2.11: A representative resorufin standard curve (A), the CYP-450 Figu
monooxygenase activity of rat hepatocytes (B). Medium were changed every 
24 hours. The assays were applied to the same plate on seven day points (one 
plate), to seven different plates on each day point (daily plate), or to four 
different plates on every two day points (every two day plate) (n=3, error bars 
indicate ±SD) 
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2.3.2.4 Testosterone metabolism  
he culture system was further assessed by 
o 6ȕ-hydroxylation of testosterone was detected during the whole experiment, 
igure 2.12: The oxidation of testosterone to 4-androstene-3, 17-dione of rat 
primary hepatocytes by CYP2B on day 0 (straight after isolation) and day 1. 
Medium is changed every 24 hours. (n=3, error bars indicate ±SD) 
 
Function of CYP-450 enzymes in t
hydroxylation of testosterone. The method, which was run by HPLC, was 
shown in Section 2.2.7.1 (ii). Both 6ȕ-hydroxylation of testosterone and the 
oxidation of testosterone to 6ȕ-hydroxytestosterone and 4-androstene-3, 17-
dione respectively was assessed at 1, 2, 3, 4, 5, 7, 9, 11, 14 and 21 days of 
culture. In rats, 6ȕ-hydroxylation of testosterone was mediated by CYP3A1 
and oxidation of testosterone was mediated mainly by CYP2B1 with minor 
contribution by 2C11and 2B2. 
 
N
while the oxidation of testosterone to 4-androstene-3, 17-dione only remained 
on day 1 (Figure 2.12). 
 
F
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2.3.3 DNA content analysis Hoechst 33258 
A cell number standard curve was prepared by a series of number of cells, 
namely 0.125, 0.25, 0.5, 1, 2, 4, and 8 million cells. Each of them was 
 2.4.7) at 60ûC overnight. After 
, 10, 15 and 
0 ȝg/ml in papin buffer (Appendix 2.4.6). The same amount of HOECHST 
incubated in 2 ml papain solution (Appendix
cells were washed with PBS buffer, the same amount of HOECHST 33285 
working solution (Appendix 2.4.3) was added in each solution. 100 ȝl mixed 
solution was then transferred to a fresh 96-well plate. Finally, the cells were 
read at excitation 360 nm and emission 460 nm on a plate reader.  
 
A DNA standard curve was prepared by stock DNA (sodium salt from salmon 
testes, Sigma, UK) at the concentration of 0, 0.5, 1, 1.5, 2, 3, 4, 5
2
33285 working solution was mixed with each DNA solution before read on the 
plate reader in the above condition. 
 
 
 
 
 
 
 
 
 
 
 
A) 
B) 
 
Figure 2.13: DNA standard curve for DNA content analysis Hoechst 33285 (A), 
cell number standard curve for DNA content analysis Hoechst 33285 (B). (n=3, 
error bars indicate ±SD) 
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2.3.4 Hepatic stellate cells 
2.3.4.1 Morphology 
HSCs were isolated by the method mentioned in Section 2.2.5. The cells were 
 after isolation. The characteristic morphology of 
d by phase contrast light microscope was shown in the 
ad begun to project fine processes on the tissue culture plastic 
urface (Figure 2.14A). After approximately 7 days in the culture, the HSCs 
cultured in the HSCs medium
active HSCs examine
Figure 2.14.  
 
Phase contrast microscope revealed that within 48 hours of seeding, HSCs had 
adhered and h
s
became confluent and showed longer, thicker processes, which had increased 
in number (Figure 2.14B). 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: Phase contrast light microscope images of primary rat HSCs in 
culture. (A) Cells show quiescent state after 48 hours in culture, (B) cells are 
activated and confluent after 7 days in culture. 
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2.3.4.2 Lipid staining 
The method was described in Section 2.2.9. The visible lipid droplets could be 
seen in Figure 2.15. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.15: Visualization of lipid droplets within the HSCs (10 days in 
culture). HSCs incubated with Oil Red O to stain lipid vesicles pink/red. Arrow 
indicates lipid vesicle.  
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2.4 Discussions 
2.4.1 The effects of seeding density on morphology of hepatocyte 
monoculture 
The key variables controlling differentiated functions of hepatocytes are 
believed to be cell-cell and cell-ECM interactions. The role of homotypic cell-
cell interactions is typically studied by varying cell seeding density. It has been 
reported that the cell density of 500,000 to 700,000 is recommended for 12-
well plates (LeCluyse et al., 2005). In this study, the lowest density was 
demonstrated to be the most suitable density in terms of morphology. 
Considering both good coverage and apoptosis, cells at a seeding density of 
500,000 had more than 90% confluence, with the least non-viable cells after 48 
hours post-isolation. The observation suggests that the disadvantages of the 
limitation of nutrients, oxygen supply and the removal of waste products at 
high seeding density may outweigh the advantages of the increase in cell-cell 
contacts which accompany higher densities. 
 
2.4.2 The effects of ECM on morphology of hepatocyte monoculture as 
well as co-cultures 
The role of cell-ECM interaction on hepatocyte morphology was studied by the 
method of Matrigel overlay. The cells with Matrigel overlay reached above 
90% confluence more quickly and retained round shape with well-defined cell 
borders, distinct nuclei and bile canaliculi-like structure longer when compared 
with the cells with no overlay of Matrigel. Matrigel is well known to contain a 
mixture of ECM including type IV collagen (Rojkind and Ponce-Noyola, 1982), 
type I collagen, heparan sulfate proteoglycan (Stow et al., 1985), fibronectin 
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(Oh et al., 1981) and laminin and it provides the cells with a more in vivo-like 
microenvironment, which might have great effect on hepatocyte specific 
functions. 
 
It has been demonstrated in this study that 3D self-organizing spheroids formed 
on PDLLA surface but not in the collagen-Matrigel sandwich configuration on 
12 well plates. It is believed that the formation of spheroids on static cultures 
of hepatocytes is a result of poor cell attachment and repulsion of the cells from 
the culture surface (Tzanakakis et al., 2001). The PDLLA surface is more 
hydrophobic than collagen surface and consequently, cell to surface 
interactions are not as strong as on PDLLA, which results in poor adherence of 
the cells to the surface. In addition, TGF-ȕ has previously been shown to play a 
role in the detachment of cardiac cells from the endothelium (Brown et al., 
1985) and is known to be secreted by HSCs (Pinzani et al., 1995). Therefore, a 
non-adhesive surface as well as HSCs contributes to form spheroids.  
 
However, in addition to hydrophobicity of PDLLA surface and HSCs, other 
factors, such as surface area, HSCs status and NPCs (e.g. Kupffer cells and 
endothelial cells), might contribute to spheroid formation to some extent, 
which have not been considered in this study. For the self-assembled spheroids, 
which depend on the culture substratum, a large surface area is required for 
initial cell attachment (Kamihira et al., 1997), therefore, 6 well plates with 
bigger attachment area might be applied in future work. In addition, HSCs used 
in this study are not completely pure isolation by the two-step collagenase 
perfusion method and they are contaminated with different portion of other 
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NPCs from isolation to isolation. It has been reported that rat prostate 
endothelial cell line is used to co-culture with hepatocytes to form hetero-
spheroids in a spinner vessel in approximately 20 hours (Lee et al., 2004) and 
spheroids are formed by co-culture of hepatocytes and NIH3T3 on the poly 
(vinylidene difluoride) (PVDF) surface as well (Lu et al., 2005). Therefore, the 
contribution of spheroid formation from these NPCs cannot be excluded 
completely. Also, the ratio of quiescent and activated status of HSCs and 
repeated trypsinisation of HSCs may play a role in the spheroid formation. A 
certain range of passage number of HSCs used for spheroid formation need to 
be considered. Taken these observations together, the reproducibility of 
spheroid formation on PDLLA coated plate or non-spheroid formation in 
collagen-Matrigel sandwich need further experiments. 
 
2.4.3 The effects of repeated assay application on hepatocyte functionality 
Four common hepatocyte function assays have been applied successfully and 
optimized in this study. The initial question addressed was the pragmatic issue 
of the effects of repeated assay applications on hepatocyte functions. There are 
no apparent effects on the ability of hepatocytes in monoculture to secrete 
albumin, urea and the activity of CYP1A-catalysed O-dealkylation of 7-
ethoxyresorufin. The effects of repeated assay applications on the 
metabolisation of testosterone cannot be assessed due to lack of data shown 
after day 1. The hepatocytes lost their CYP mono-oxygenase activity rapidly 
after short period in vitro. This could be explained by a rapid down-regulation 
of degradation pathways relative to enzyme expression and the initial rise is 
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part of the de-differentiation process as opposed to a general recovery of cell 
function (Robert et al., 2005). 
 
It is notable that, while the secretion of urea was well preserved, the secretion 
of albumin was rapidly lost in monoculture, which shows similar trend 
compared to other data of albumin and urea secretion (Bissell et al., 1987; 
Sivaraman et al., 2005) 
 
In terms of CYP enzyme activity tested by EROD assay, diminished activity on 
day 0 and day 1 after hepatocyte isolation was confirmed on three time 
occasions. The reason for this initial reduction in the activity of hepatocytes 
has yet to be elucidated, but may be a result of some environmental factors 
causing the down regulation of genes transcribing for CYP-450 enzymes 
immediately following cell isolation. After the peak on day 2, the activity 
decreased markedly on day 3. It has been suggested that declining levels of 
CYP may be a result of decreased synthesis or increased degradation (Paine et 
al., 1980). 
 
The accuracy and specificity of the EROD and testosterone metabolism assays 
has been considered. Although hepatocyte is not the only cell type contributing 
to the expression of CYPs, CYP1A by EROD and CYP2B by testosterone 
metabolism are unique to hepatocytes. HSCs play a role mainly in the 
expression of CYP2C11, CYP3A2 and CYP2D1 (Yamada et al., 1997) and 
Kupffer cells are basically involved in CYP2E1 expression (Adachi et al., 
1995). 
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2.4.4 Conclusions and future work 
The development of systems for the long term in vitro culture of functional 
liver tissue is a major research goal. The central limitation of experimental 
systems to date has been the early de-differentiation of primary hepatocytes in 
cultures. Rat primary hepatocytes and hepatic stellate cells have been isolated 
and co-cultured on PDLLA surface to form 3D spheroids successfully. It has 
been previously demonstrated that this co-culture model enhances long-term 
growth and maintenance of hepatocyte specific functions. However, it is 
important to compare this model to the best available other systems and to 
assess whether the model can be further enhanced by the inclusion of 
extracellular matrix proteins. Therefore, the effect of Matrigel, which contains 
key ECM components, and collagen, will be assessed on the morphology and 
functions of hepatocyte. The successful completion of these experiments will 
identify an effective model for the preservation of rat hepatocyte functions. 
  
This chapter specifically has achieved confirmation of: 
x the method of isolation of primary rat hepatocytes and HSCs 
previously established by Tissue Engineering Group; 
x successful spheroids formation by co-culture of rat hepatocytes and 
HSCs on PDLLA coated surface; 
x the specific hepatocyte functions assays including albumin secretion, 
urea secretion, EROD and testosterone metabolism; 
and demonstration of:  
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x seeding density of hepatocytes in monoculture  and co-culture 
(500,000 cells per well on 12-well plate); the ratio of hepatocytes 
and HSCs in co-culture (2:1); 
x great effects of Matrigel overlay on confluence and morphology of 
hepatocyte monoculture and co-culture with HSCs; and 
x no specific effects of plate change on albumin secretion, urea 
secretion, EROD except testosterone metabolism. 
 
The next stage of the project will compare rat hepatocyte functions in the 
following culture systems, including monoculturing hepatocytes on collagen 
gel and in collagen-Matrigel sandwich, as well as co-culturing hepatocytes 
with HSCs on collagen gel, in collagen-Matrigel sandwich and on PDLLA 
coated surface. Mass spectrometry for the simultaneous measurement of 
multiple CYP functions (DMPK, Charwood, AstraZeneca) will be used to 
facilitate future work on both rat and human cells. 
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Chapter Three: 
Co-culture of Primary Rat 
Hepatocytes and Hepatic 
Stellate Cells (HSCs) 
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3.1 Introduction 
3.1.1 The advantages of 3D cell culture  
There have been long-recognized difficulties in maintaining the survival and 
differentiated function of hepatocytes in in vitro cultures. 3D spheroids have 
been proposed as an important system for the preservation of hepatocyte 
morphology and liver specific functions. Ultrastructural characteristics of liver 
tissue, such as indistinguishable cell-cell boundaries, abundant cytoplasmic 
organelles, bile canaliculus-like structures, and space of Disse-like architecture 
are observed at the surface of, or within, spheroids (Abu-Absi et al., 2002; Lee 
et al., 2004; Fukuda et al., 2006). Spheroids exhibit higher levels of 
homologous and cell-cell interactions than hepatocyte monocultures and permit 
heterologous interactions in spheroids containing more than one cell type. This 
increased intercellular contact is a potentially important mechanism for 
regulating cell communication and reconstructing cellular polarity. In addition, 
accumulation and deposition of specific ECM generated by co-culture of 
hepatocytes and non-parenchymal cells can be found at the surface of hetero-
spheroids, but cannot be observed in homo-spheroids (Lee et al., 2004) or 
hepatocyte monoculture (Landry et al., 1985). Moreover, higher levels of liver 
specific functions have been maintained for extended period in spheroids in 
comparison to 2D monocultures (Fukuda et al., 2003; Tamura et al., 2008). 
Overall, 3D spheroids provide an environment in which some of the 
complexity of the spatial organisation found in vivo can be reproduced and 
there is evidence that this is reflected in improved function.   
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3.1.2 Methods of formation of 3D spheroid 
Since hepatocyte spheroids are considered to maintain hepatocyte functions for 
a longer period than hepatocyte monolayer culture, various cultivation methods 
and techniques for hepatocyte spheroid formation have been investigated.      
These methods can be generally separated into two groups. The first group is 
dependent on the surface property of the culture substratum. The spheroids 
using this method are usually formed in a stationary environment. The culture 
substrata include extracellular matrix or synthetic components, such as 
proteoglycan (Koide et al., 1990), positively charged culture dishes (Hasebe et 
al., 2003), porous polyurethane foam (Ijima et al., 1998; Fukuda et al., 2003), 
poly-N-isopropyl acrylamide (Takezawa et al., 1992), and titanium dioxide gel 
surface (Nakazawa et al., 2006). 48 to 96 hours is required for production of 
hepatocyte spheroid using these methods. The second group depends on a non-
stationary dynamic culture system, such as rotation culture with shaking 
(Surapaneni et al., 1997) or spinning culture, using a spinner vessel (Lee et al., 
2004) or spinner flask (Yang et al., 2000; Okubo et al., 2002). Hepatocyte 
spheroids are formed in 24 to 48 hours in dynamic cultures. The speed of 
spheroid formation is not only critical for establishing cell-cell contact but also 
necessary for the maintenance of liver-specific function (Glicklis et al., 2000). 
Other methods for the production of spheroids include both growth factor 
supplementation and extracellular matrix (Semler et al., 2001), 3D scaffold 
(Wang et al., 2008), application of microfabrication and microcontact printing 
(Fukuda et al., 2006; Nakazawa et al., 2006). 
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3.1.3 Mechanisms of formation of 3D aggregates 
One of the key mechanisms of spheroid formation in a stationary environment 
is the attachment substratum. Most attachment substrata require non-adhesive 
surfaces, which cause poor cell attachment and repulsion of the cell from the 
culture surfaces. In the situation using scaffold as a substratum, in addition to 
its chemical composition, its physical property, and especially the pore size and 
the pliability, profoundly influences cell organization (Semler and Moghe, 
2001; Haouzi et al., 2005). Cell-cell interaction is critical for spheroid 
formation, since it is believed that the intercellular forces (e.g. F-actin and 
connexin-32) in hepatocyte spheroids modulate the works of adhesion and 
cohesion (Liu et al., 2007). Although some soluble factors (e.g. MMPs), 
generated by cell-cell interaction play a role in cell-ECM interaction (Sato et 
al., 2003), spheroid formation always occurs when cell-cell interaction is 
greater than cell-ECM interaction (Powers et al., 1997). In other words, 
reduction of cell-ECM interaction can promote spheroid formation, which is 
probably modulated by fibrinolytic factors and filamentous actin network 
(Tzanakakis et al., 2001; Hasebe et al., 2003). Two fibrinolytic factors, namely 
tissue-type plasminogen activator (tPA) and urokinase-type plasminogen 
activator (uPA) are expressed in the hepatocytes (Hasebe et al., 2003). Plasmin 
generated by plasminogen via these two activators is involved in the regulation 
of ECM remodelling. This process has a great effect on the initial adhesion of 
hepatocytes to culture dishes and then migration and detachment of 
hepatocytes from culture dishes in the formation of hepatocyte spheroids. 
Besides fibrinolytic factors, an intact filamentous actin (F-actin) network is 
required for the reorganization of cytoskeleton in self-assembly spheroids 
  
117 
(Tzanakakis et al., 2001). Consequently, attachment substratum, cell-cell 
interaction and cell-ECM interaction are the keys for spheroid formation in a 
stationary environment.  
 
However, the mechanism of spheroid formation in a non-stationary culture 
system has not been completely understood. It is believed that cell density, 
collision frequency, oxygen supply, and cell-cell interaction play significant 
roles in spheroid production. (Wu et al., 1995)  
 
3.1.4 The effects of HSCs and Matrigel on 3D structures 
The contribution of HSCs to the formation of 3D structures is likely to vary in 
different stages of the whole process. HSCs form tight adhesion to hepatocytes, 
which results in a well-defined hepatic ultrastructure, and this cell-cell 
interaction triggers HSCs activation during early liver regeneration in the rat 
(Mabuchi et al., 2004). Then, the expression of actin filaments and 
microtubules of activated HSCs helps to change the shape of rat hepatocyte and 
rearrange the cytoskeletal structure of the hepatocytes into self-assemble three-
dimensional spheroids (Tzanakakis et al., 2001). Next, intercellular 
communication between activated HSCs via gap junction, mainly regulated by 
connexin-43, may enhance the coordination of HSC contraction in vitro, which 
plays a role in assembling hepatocyte monolayer to groups of aggregates 
(Fischer et al., 2005). Endothelin (ET)-1 and other contraction stimulating 
cytokines secreted by activated HSCs are highly responsible for the 
contractility as well, since ET-1 has been reported to promote the ability of 
contraction in normal dermal fibroblasts (Appleton et al., 1992) and lung 
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fibroblasts  (Shi-Wen et al., 2004). After that, the expression of various MMPs 
of activated HSCs is required for matrix degradation, particularly MMP-2 and 
MMP-3 (Li et al., 2008). Together with the expression and activity of different 
forms of activator protein (AP)-1, a fine balance between the activity of AP-1 
proteins and their target genes (MMP and TIMP) promotes the activated HSCs 
to remodel the hepatic ECM in cultured HSCs (Smart et al., 2001). This step of 
remodelling ECM is necessary for spheroid formation, since spheroid 
formation always occurs when cell-cell interaction is greater than cell-ECM 
interaction (Powers et al., 1997). Taking these observations together, HSCs are 
likely to play a key role in the formation and maintenance of spheroids. HSCs 
provide a series of cell signals for the regulation of formation of hepatocyte 3D 
structure (Sato et al., 2003).  
 
The specific factors in Matrigel leading to spheroid formation are not known, 
although Matrigel, which contains various growth factors and ECM 
components produced by sarcoma cells, is considered the most effective 
substratum for hepatocyte differentiation (Bissell et al., 1987; Takashi et al., 
2007).  In 1993, Mackay et al. hypothesized that inactive proteases derived 
from Matrigel, but not from hepatocytes, contribute to spheroid formation.  In 
particularly, epimorphin found in Matrigel (Hirai et al., 1993) induced MMP9, 
MMP3 and urokinase type plasminogen activator (uPA) in hepatocytes 
(Segawa et al., 2005). These epimorphin regulated proteases were required to 
induce hepatocyte aggregation to spheroids (Miura et al., 2007), as evidenced 
by the fact that an epimorphin-neutralizing antibody blocked the development 
of the cystic ductal structures of hepatocytes cultured on Matrigel (Tulachan et 
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al., 2006). Consequently, the proteases of Matrigel contribute to spheroid 
formation at least to some extent.  
 
Self-forming 3D spheroids by co-culture of hepatocytes and HSCs on PDLLA 
coated surface has been previously established by the Tissue Engineering 
Group, School of Pharmacy in the University of Nottingham (Riccalton-Banks 
et al., 2003; Thomas et al., 2005, 2006). This 3D model shows better 
hepatocyte functions than monoculture on tissue culture plastic. In this chapter, 
we test the hypothesis that the inclusion of extracellular matrix in the form of 
Matrigel can further enhance the capacity of our established 3D model to 
maintain hepatocyte specific functions in culture.  
 
3.1.5 Methods of measuring cytochrome P450 enzyme activity  
A variety of methods could be used to analyse CYP activities. Generally 
speaking, the amount of one metabolite of the related substrate, which is 
metabolized by the specific enzymes, is measured either by a plate reader (i.e. 
metabolism of ethoxyresorufin to resorufin by CYP1A1 activity) or by a more 
accurate analytical method like HPLC (i.e. 6ȕ- hydroxylation of testosterone 
and oxidation of testosterone mainly mediated by CYP3A and CYP 2B1). 
However these methods measure the activity of metabolic pathways, rather 
than the activity of individual enzymes, and it is difficult to reach conclusions 
about specific CYP activity. For this reason, a more accurate and specific 
method, high performance liquid chromatography - tandem mass spectrometry 
(LC-MS/MS), was selected and is introduced in this chapter. Both methods are 
used to detect the quantity of respective metabolites in the incubation media. A 
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new cassette of CYP substrates for several specific CYP measurements was 
used in LC- MS/MS (Kenny et al., 2009). CYP1A2, CYP3A1 and CYP2B6 
enzyme activities are measured by their capacity to metabolise specific probes, 
namely: phenacetin deethylation (CYP1A2) (paracetamol); bupropion 
hydroxylation (CYP2B6) (1’-hydroxybuproprion); midazolam 1’-
hydroxylation (CYP3A1) (1’-hydroxymidazolam). This technique therefore 
provides detailed information, not only about the major enzyme CYP3A1, but 
also other enzymes CYP1A2 and CYP2B6 activities. 
 
3.1.6 High performance liquid chromatography - tandem mass 
spectrometry (LC-MS/MS)  
LC-MS/MS is potentially the most useful technique for the characterization of 
drug metabolites, and combines a high resolution chromatography step with a 
further analysis giving both molecular weight and structure information on 
trace components. The remarkable advantage of LC-MS/MS is the capacity to 
simultaneously analyze a much wider range of compounds, including those 
which are thermally labile, of high polarities or of high molecular mass.   
 
The sample solution is injected onto an HPLC column that consists of a narrow 
stainless steel tube filled with fine, chemically modified silica particles. 
Compounds are separated on the basis of their relative attraction (stationary 
phase) either between polar silica and non-polar solution (normal phase HPLC), 
or between non-polar silica and polar solution (reverse phase HPLC), which is 
the most commonly used form of HPLC; non-polar and polar compounds in 
solution travel through the column more quickly (mobile phase). Components 
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eluting from the chromatographic column are then introduced to the mass 
spectrometer via a specialized interface. The two most common interfaces used 
for HPLC/MS are the electrospray ionization (ESI) and the atmospheric 
pressure chemical ionization (APCI) interfaces. 
 
In electrospray ionization, the compound is introduced to the source at typical 
flow rates of 1µl min
-1
 and the compound solution passes through an 
electrospray needle, the end of which is maintained at a high negative or 
positive potential at the range from 2.5V to 4V. This creates a strong electric 
field to produce a fine spray of tiny droplets and then to charge the droplets 
with the same polarity as on the needle. The droplets are forced towards the 
source sampling cone on the counter electrode and solvent evaporation occurs. 
The droplets then start to evaporate and shrink until the densities of electrical 
charge on the surfaces increase and reach the point that the surface tension can 
no longer sustain the charge (the Rayleigh limit). Then the droplets come apart. 
This produces smaller droplets that can repeat the process as well as naked 
charged compound molecules. Eventually, the ions are sorted in the mass 
analyzer according to their mass to charge (m/z) ratios and collected by a 
detector. An electrical signal is then generated proportional to the number of 
ions from the detector.  It is the measurement of mass to charge ratio rather 
than mass per se that allows high molecular weight components such as 
proteins to be analyzed. Therefore, CYP metabolites are analyzed using this 
interface in this chapter. 
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APCI is an equivalent ionization method to ESI. The major difference is the 
process of ionization. In ESI, the ionization is created by the potential 
difference between the spray needle and cone; while in APCI, the compound 
solution is introduced into a pneumatic nebulizer and evaporated in a heated 
quartz tube before interacting with cone to create ions. Low mass compounds 
are primary applications of APCI.  
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3.1.7 Aims 
The principal aims of the work presented in this chapter are: 
x to test whether our established model of spheroid co-cultures on PDLLA 
coated plates could be further enhanced by supplementation with ECM 
proteins, including collagen and Matrigel, and  
x to assess whether HSCs, ECM or both were the cause of any observed 
effect by measuring hepatocyte functions using albumin secretion, urea 
secretion, testosterone metabolism by HPLC and LC-MS/MS. 
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3.2 Material and Methods 
3.2.1Chemicals 
Midazolam was purchased from Sequoia Research Products Ltd. (Oxford, UK). 
Paracetamol, diclofenac and buproprion were purchased from Sigma-Aldrich 
(Gillingham, UK) and were of the highest grade available. 1 x DPBS was 
bought from Introvigen, UK. QIAamp
®
 DNA Mini Kit was purchased from 
QIAGEN, UK. Other chemicals were listed in Chapter 2 (Section 2.2.2). 
 
3.2.2 Plasticware  
PDLLA coated 12 or 6 well plates were prepared as described in Chapter 2 
(Section 2.2.3). 12 well and 6 well collagen type I coated dishes were bought 
from BD Biosciences, UK. Other plasticware were shown in Chapter 2 
(Section 2.2.3). 
 
3.2.3 Cell isolation and culture conditions 
Primary rat hepatocytes and HSCs were isolated as described in Chapter 2 
(Section 2.2.4) and they were co-cultured on either 12 or 6 well plates. Rat 
hepatocytes were seeded in five different culture systems, including hepatocyte 
monocultures on collagen gel and in collagen-Matrigel sandwiches, as well as 
hepatocytes co-cultured with HSCs on collagen gel, in collagen-Matrigel 
sandwiches and on PDLLA coated surface. The method for Matrigel overlay 
was described in Chapter 2 (Section 2.2.6). The seeding density of hepatocyte 
monocultures on 12 and 6 well plates was 500,000 cells per well and 900,000 
cells per well respectively; co-culture of hepatocytes and HSCs at the ratio of 
2:1 in total number of 500,000 cells per well and 900,000 cells per well was 
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cultured on 12 and 6 well plates, respectively. Cells on 12 and 6 well plates 
were maintained in 1 ml and 2 ml culture medium, respectively. 
 
3.2.4 Passage of HSCs 
HSCs were isolated as described previously. After the HSCs reached 80% 
confluence on a normal T75 flask, they were passaged using a trypsin/ EDTA 
method. Before the cells were trypsinized by 3 ml trypsin/EDTA, warm PBS 
buffer was used to wash the cells. After 5 minutes incubation, 5ml of HSCs 
medium was added to stop the trypsin/EDTA reaction and the cells were 
scraped from the flask using a cell scraper. The cell suspension was centrifuged 
at 250 g for 5 minutes and the pellets were re-suspended in fresh HSCs 
medium. Finally, the cells were placed on a new flask with fresh medium and 
then were passaged again when they were confluent. Different passage 
numbers of HSCs were used to test the effects on spheroids formation on 6 
well PDLLA coated plates. Passage number 0, 3, 4, 6, 7, 14, 17 and 30 of HSCs 
were created by the above method. 
 
3.2.5 Disaggregation of spheroids  
The medium and spheroids from each well were aspirated and centrifuged at 50 
g for 5 minutes. Each pellet was then re-suspended in 2 ml pre-warmed PBS 
and added back to matching wells briefly to wash. PBS and loose spheroids 
from each well were aspirated and centrifuged again at 50 g for 5 minutes. 
After that, each aliquot was re-suspended in 2 ml pre-warmed accutase, added 
back to matching well and incubated at 37ºC for 10 minutes. After retrieval 
from the incubator, the cells were scraped in order to detach residual cells or 
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adherent spheroids and then returned to incubator for a further 30 minutes. 
Finally, each cell suspension was aspirated, centrifuged at 350 g for 5 minutes 
and re-suspended in PBS. 
 
3.2.6 DNA quantification 
QIAamp
®
 DNA Mini Kit was used to isolate the total DNA from cell cultures. 
The cell suspension from each well of 6 well plates was obtained either by a 
cell scraper or disaggregation of spheroids as described in Section 3.2.5. After 
the cell suspension was centrifuged at 50 g for 5 minutes, the cell pellets were 
re-suspended in 200 µl PBS. DNA was then isolated according to 
manufacturer’s instructions (QIAamp
®
) and the amount of DNA obtained from 
each well was measured by NanoDrop
®
 ND1000 UV-Vis Spectrophotometer 
to give a final concentration in ng/µl. 
 
3.2.7 Function analysis 
Testosterone metabolism, albumin secretion assay, and urea secretion assay 
have been previously described. For this section, EROD assay for CYP activity 
was supplemented by the more sensitive and reproducible LC-MS/MS.  
 
(i) CYP activity measurements by LC-MS/MS 
The medium from each well was aspirated and the cells washed with PBS 
buffer prior to assay. CYP1A2, CYP3A1 and CYP2B6 enzyme activities were 
measured by their capacity to metabolise specific probes, namely phenacetin 
deethylation, midazolam 1’-hydroxylation and bupropion hydroxylation. Probe 
stocks were prepared in methanol at the concentrations of 0.6, 0.2 and 1 mg/ml, 
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respectively. Three probe mixed solutions was mixed, evaporated to dryness 
under nitrogen gas, and reconstituted in PBS to give final incubation 
concentrations of 4.48, 9.06 and 23.7 ȝg/ml respectively. 2 ml of the diluted 
mixed substrate cassette was added to each well of cultured rat hepatocyte 
monocultures and co-cultures after day 1, 3, 5, 7, 9, 11, 14 and 21. Cells were 
then incubated on an orbital shaker for gentle agitation (~ 30 rpm; 37qC). 
Aliquots (100 ȝl) were removed at 20 minutes and 60 minutes after adding the 
probe substrates and the samples were quenched in ice-cold methanol (100 ȝl). 
The samples were then stored at -30qC until analysis by LC-MS-MS as 
described below. A 4 CYP metabolite standard curve was prepared from 1, 2, 5, 
10, 20, 50, 100, and 200 to 500 ng/ml, which was used to quantify the amount 
of metabolite produced by samples at each point of time. Following the 
completion of the activity assay, cells were lysed in RLT buffer (600 ȝl; 
Qiagen, West Sussex, UK) containing E-mercaptoethanol (10 ȝl/ml) and stored 
at -80ûC until required for mRNA analysis. 
 
The samples stored at -30qC were thawed and then centrifuged at 2000 g for 15 
minutes at 4ûC and the supernatant (10 ȝl) was injected from a 96-well plate 
onto a Symmetry C18 (3.5 µm) column (2.1×100 mm, Waters, Hertfordshire, 
UK) maintained at 40qC. HPLC separation was performed using Jasco PU-
2085 plus semi-micro pumps coupled to Jasco DG-2080-54 degasser, MX-
2080-32 dynamic mixer and a CO-2067 plus column oven (Jasco, Essex, UK).  
The mobile phase consisted of solvent A (0.1% formic acid in acetonitrile) and 
solvent B (0.1% formic acid in water), using a linear gradient of 10% A (0-0.1 
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min), 54% A (0.1-3.0 min), 100% A (3.0-3.5 min), 10% A (3.51 min) with a 
run time of 5.5 minutes and flow rate 0.5 ml/min.  This procedure allowed 
chromatographic separation of all probe substrates and their respective 
metabolites. This was coupled to a triple quadruple Platinum Ultima (Waters, 
Hertfordshire, UK) operating in ESI+ mode, with Masslynx v.4.1 running in 
MRM mode monitoring for paracetamol (transition 152.27 > 110.24, cone 
voltage 59 V, collision energy 17 eV), hydroxybupropion (256.32 > 139.26, 24 
V, 31 eV), 4’-hydroxydiclofenac (312.26 > 231.22, 52 V, 17 eV) and 1’-
hydroxymidazolam (342.35 > 203.23, 31 V, 24 eV). These metabolites were 
subsequently quantified by the standards prepared as above. Results were 
calculated as pmoles of metabolite formed per million cells per minute of 
incubation. Representative control wells were trypsinsed and counted to ensure 
cell number was accurate. 
 
3.2.8 Experimental design and data analysis 
In order to test the hypothesis that our previous co-culture model could be 
further enhanced by addition of ECM components, and to assess whether NPCs, 
ECM or both were the cause of any effect, we  established five distinct cultures 
including: hepatocyte monoculture on collagen gel; hepatocyte monoculture in 
a collagen-Matrigel sandwich; co-culture of hepatocytes with HSCs on 
collagen gel; co-culture of hepatocytes and HSCs in collagen-Matrigel 
sandwiches; co-culture of hepatocytes and HSC on PDLLA coated plates 
(Chapter 2, Section 2.3.1.3). Cells were firstly cultured on 12 well plates and 
the morphology and function were assessed. However, expected spheroids did 
not form on PDLLA coated plates after 72 hours. The influence of passage 
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number of HSCs on spheroid formation and morphology was then interrogated. 
6 well plates were then applied for cell cultures with greater initial attachment 
area and correct range of passage numbers of HSCs were also used on 6 well 
plates. The morphology and hepatocyte functions were assessed as well. Each 
culture system was carried out three times in duplicate on 12 well plates but 
only once in duplicate on 6 well plates due to the development of difficulties in 
isolating viable primary rat hepatocytes as described in the Appendix 3. 
Duplicates were averaged to create independent data points for statistical 
analysis. Data was analysed using one way ANOVA for differences in 
metabolite production between the various culture conditions. Post tests with 
Tukeys error control were conducted to identify these differences. All data 
analysis was done in Excel and Prism. Graphs show mean values ± the 
standard error of the mean.  
 
Testosterone metabolism CYP activities are expressed as percentage of initial 
activity, not per mg protein, while CYP activities analyzed by LC-MS/MS are 
expressed as pmol/min/µg DNA. For testosterone metabolism, the value for 
initial function used to calculate the percentage function is an average value 
from all experiments. Albumin and urea secretion assays were normalized to 
ng/ml/cell on 12 well plates by the assumption that the number of hepatocytes 
on monoculture and co-culture was 500,000 and 333,333 respectively through 
the whole culture period. However, DNA content analysis was subsequently 
applied to normalize these two assays on 6 well plates to mg/ml/µg DNA and 
ng/ml/µg DNA respectively. 
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3.3 Results  
3.3.1 Morphology of rat hepatocytes on 12 well plates  
Rat hepatocytes and HSCs were isolated as described previously (Chapter 2, 
Section 2.2.4 and 2.2.5). Hepatocytes were plated onto 12 well plates at a 
density of 500,000 cells per well for monoculture on collagen gel and in 
collagen-Matrigel sandwich, since this density has previously been 
demonstrated to be optimal (Chapter 2, Section 2.2.6).  Co-culture of 
hepatocytes with HSCs was seeded at the density of 333,333 and 166,667 cells 
per well of 12 well plates for each of: collagen gel; collagen-Matrigel sandwich; 
PDLLA coated plates.  
 
The morphology of both monocultures was similar to that observed in previous 
experiments (Chapter 2, Section 2.3.1.1). However, spheroids were not 
observed in co-cultures on PDLLA coated plates. Most of the cells on PDLLA 
coated plates maintained a monolayer (Figure 3.1A), except for a few small 
aggregates after 72 hours (Figure 3.1B). These small aggregates did not go on 
to become the multicellular islands which are the precursors of freely floating 
spheroids. No spheroids formed in the co-cultures on collagen gel and in 
collagen-Matrigel sandwich. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Rat hepatocytes co-cultured with rat HSCs (passage number 2) on 
12 well PDLLA coated plates. Medium was not changed until 72 hours. Most of 
the cells maintained in a monolayer after 72 hours (A), but a few small 
aggregates (white arrows) were observed in some wells after 72 hours (B). 
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3.3.2 Functional analysis of cultures on 12 well plates 
Functional analysis of albumin secretion, urea secretion and testosterone 
metabolism was carried out 24 hours after cell seeding (day 1) and then on day 
3, 5 and 7 of cultures using the methods described previously. 
 
3.3.2.1 Albumin secretion and urea secretion 
Overall, the amount of albumin in each of the five different culture systems 
showed a similar pattern of reaching a peak on day 3 and decreasing on day 5 
without further falls on day 7 (Figure 3.2A).  In terms of hepatocyte 
monocultures, cells cultured in collagen-Matrigel sandwich showed higher 
albumin activity than cells cultured on collagen gel from day 3 to day 7; while 
among three hepatocyte co-cultures, cells cultured on PDLLA coated plates 
demonstrated the highest activity through the whole culture period. Particularly, 
the amount of albumin secreted by hepatocytes co-cultured on PDLLA coated 
plates was similar to that of albumin produced by cells mono-cultured in 
collagen-Matrigel sandwich on day 7, although cells of the monoculture 
revealed higher albumin amount than those co-cultured on PDLLA coated plates 
on day 5. (Figure 3.2A)  
 
Comparing to albumin secretion data, the amount of urea showed much less 
variation in the different culture systems from day 1 to day 7, although cells of 
the co-cultures showed higher urea production than those of the monocultures 
(Figure 3.2B). 
 
 
A) 
 
Figure 3.2A: The amount of albumin (ng/ml/cell/24h) secreted by rat 
hepatocytes on 12 well plates after 24 hours. Passage number 2 HSCs was used 
for the co-cultures and medium was changed every 24 hours. The error bars 
marked * on day 3 where data of cells of monoculture on collagen and co-
culture in collagen-Matrigel sandwich are statistically significant than that of 
cells of co-culture on collagen (P < 0.05, 95% confidence). The error bars 
marked * on day 5 where data of cells of monoculture in collagen-Matrigel are 
statistically significant than that of cells of monoculture on collagen, co-culture 
on collagen and in collagen-Matrigel (P < 0.05, 95% confidence).  
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B) 
 
 
Figure 3.2B: The amount of urea (ng/ml/cell/24h) secreted by rat hepatocytes 
on 12 well plates after 24 hours. Passage number 2 HSCs were used and 
medium was changed every 24 hours. The error bars marked ** on day 1 
where data of cells in the co-cultures are statistically significant than that of 
cells in monocultures at P < 0.01 (99% confidence) and the error bars marked 
*** on day 3, 5 and 7 where data of cells in the co-cultures are statistically 
significant than that of cells in monocultures at P < 0.001 (99.9% confidence).  
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3.3.2.2 Testosterone metabolism 
Two testosterone metabolites, 6ȕ-hydroxytestosterone and  
4-androstene-3, 17-dione were measured by incubation of testosterone in the 
culture medium for 1 hour. The data have been normalized to percentage 
activity of freshly isolation cells (day 0).  
 
6ȕ-hydroxytestosterone production by CYP3A1 on day 1 only showed about 
50% of day 0 activity in all five culture systems but subsequently increased to 
100% ~ 300% activity of day 0 activity on day 3 and then decreased on day 5.  
The production of 6ȕ-hydroxytestosterone could only be detected in three 
culture systems on day 5, namely monoculture in collagen-Matrigel sandwich, 
co-culture in collagen-Matrigel sandwich and co-culture on PDLLA coated 
plates. Among these three cultures, co-culture on PDLLA coated plates showed 
the highest CYP3A1 activity. (Figure 3.3A) 
 
CYP2B1 activity, as assessed by 4-androstene-3, 17-dione production, was 
similar in all culture systems from day 1 (about 100% activity of day 0 cells) to 
day 3 (approximately 150% activity of day 0 cells) (Figure 3.3B). However, on 
day 5 cells co-cultured on PDLLA coated plates showed the highest activity, 
although the activity is not statistically significant compared to that of cells 
mono-cultured in collagen-Matrigel sandwich. 
 
 
A) 
 
 
Figure 3.3A: 6ȕ-hydroxytestosterone (CYP3A activity) production by rat 
hepatocytes on 12 well plates after 24 hours. Passage numnber 2 HSCs were 
used in the co-cultures and medium was changed every 24 hours. The error 
bars marked * on day 5 where data of cells of monoculture and co-culture in 
collagen-Matrigel are statistically significant than that of cells of co-culture on 
collagen (P < 0.05, 95% confidence).  
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B) 
 
 
Figure 3.3B: 4-androstene-3, 17-dion (CYP2B activity) production by rat 
hepatocytes on 12 well plates after 24 hours. Passage number 2 HSCs were 
used in the co-cultures and medium was changed every 24 hours. The error 
bars indicating the differences between cells monocultured in collagen-
Matrigel sandwich and those co-cultured on PDLLA coated surface are not 
statistically significant  on day 5 (P >0.05, 95 % confidence).  
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3.3.3 The effects of different passage numbers of HSCs on spheroids 
formation on 6 well PDLLA coated plates 
Passage number 0, 3, 4, 6, 7, 14, 17 and 30 HSCs were used to co-culture with 
rat hepatocytes on PDLLA coated 6 well plates instead of 12 well plates. 
Spheroid formation was observed in the co-cultures using passage number 0, 3, 
4, 6 and 7, but hepatocytes co-cultured with passage number 14 (Figure 3.4F), 
17 (Figure 3.4G) and 30 (Figure 3.4H) HSCs mainly maintained in a 2D 
monolayer.  
 
The size and number of spheroids formed by various passage number HSCs 
were dissimilar. In terms of the size of spheroids, those formed by passage 
number 0 (Figure 3.4A) and 3 (Figure 3.4B) HSCs (>200 µm) were bigger than 
others formed by passage number 4 (Figure 3.4C), 6 (Figure 3.4D) and 7 
(Figure 3.4E) HSCs (<100 µm). However, the number of spheroids was vice 
versa. It was roughly less than 10 spheroids formed by passage number 0 and 3 
HSCs and approximately 30 spheroids at maximum developed by passage 
number 4, 6 and 7 HSCs. Also, the morphology of spheroids was variable 
between those developed by passage number 0, 3 and 4, 6, 7. Better defined 
cell borders and tighter cell conjunctions were observed in the spheroids co-
cultured by passage number 0 and 3 HSCs. In addition to the morphology, the 
time for spheroids formation was different. Spheroids formed by passage 
number 0 and 3 HSCs were observed within 48 hours, spheroids structured by 
passage number 4 and 6 HSCs were formed within 72~96 hours, and 144 hours 
(6 days) was necessary for spheroid formation using passage number 7 HSCs.  
  
Figure 3.4: Formation of spheroids on 6 well PDLLA coated plates after 48 
hours in co-cultures of rat hepatocytes with rat HSC passage number 0 (A) and 
3 (B). 
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Figure 3.4: Formation of spheroids on 6 well PDLLA coated plates after 72~96 
hours in co-cultures of rat hepatocytes with rat HSC passage number 4 (C), and 
6 (D). Formation of spheroids on 6 well PDLLA coated plates after 6 days using 
rat HSC passage number 7 (E). 
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Figure 3.4: Rat hepatocytes co-cultured with rat passage number 14 HSCs (G) 
and 17 HSCs (H) and 30 HSCs (I) mainly maintain a monolayer on 6 well 
PDLLA coated plates after 6 days.  
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3.3.4 Morphology of rat hepatocyte on 6 well plates  
Rat hepatocytes were plated onto 6 well plates at a density of 900,000 cells per 
well for monoculture on collagen gel and in collagen-Matrigel sandwich; co-
culture of hepatocytes with passage number 4 HSCs were seeded at the density 
of 600,000 and 300,000 cells per well of 6 well plates on collagen gel, in 
collagen-Matrigel sandwich and on PDLLA coated plates.  
 
The morphology of hepatocytes monocultured on collagen gel on 6 well plates 
showed exactly like that of cells cultured on 12 well plates. However, 
spheroids were surprisingly displayed in the monoculture of collagen-Matrigel 
sandwich and all three co-culture systems. Spheroids on PDLLA coated plates 
were formed in 72 hours (day 3), while spheroids on other culture systems 
were showed on day 6. Spheroids formed on PDLLA coated plates were smaller, 
denser and more numerous that those formed in other systems.  
 
3.3.5 Functional analysis on 6 well plates  
Functional analysis of albumin secretion, urea secretion and CYP activity by 
LC-MS/MS were measured after 24 hours (day 1) cells seeding and then on 
day 3, 7, 9, 11, 14 and 21 of cultures. The methods for these procedures were 
described previously. All the data in this section were normalized to DNA level. 
 
3.3.5.1 DNA content analysis 
The amount of DNA for each well for each day point was averaged by two 
experiments. The results were showed in Table 3.1. 
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Table 3.1: The amount of DNA (µg) for each well from day 1 to day 21 
measured by Nanodrop (n=2) 
 
  Time/DNA 
(µg) C/H  C/H/M C/H&S C/H&S/M  P/H&S  
 
Day 1 12.90 21.82 17.96 21.83 16.32 
 
Day 3 6.98 13.26 10.76 15.42 10.46 
 
Day 7 8.58 11.74 7.05 6.28 6.20 
 
Day 9 4.21 5.17 3.37 3.40 3.41 
 
Day 11 3.21 4.16 3.12 3.22 3.33 
 
Day 14 3.21 2.17 2.37 2.40 2.41 
 
Day 21 1.22 2.11 1.37 1.40 1.41 
 
C/H = Hepatocytes monoculture on collagen gel 
C/H/M = Hepatocytes monoculture in collagen-Matrigel sandwich 
C/H&S = Hepatocytes co-cultured with HSCs on collagen gel 
C/H&S/M= Hepatocytes co-cultured with HSCs in collagen-Matrigel sandwich 
P/H&S = Hepatocytes co-cultured with HSCs on PDLLA 
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3.3.5.2 Albumin secretion and urea secretion 
On the whole, cells in all five culture systems exhibited comparable albumin 
on day 1, increasing albumin on day 3 and gradually decreasing albumin from 
day 7 to day 21. All the co-culture systems showed higher albumin amount 
than both monoculture systems all the times except on day 1. Cells co-cultured 
in collagen-Matrigel sandwich and PDLLA coated plates demonstrated to 
maintain high albumin through the whole culture period. (Figure 3.5A) 
 
The amount of urea in all culture systems was similar from day 1 to day 7. 
After day 7, cells of co-culture systems secreted more urea than those of the 
monocultures until day 21. In addition, higher urea secretion was displayed 
from day 7 to day 21 comparing to the amount from day 1 to day 7. However, 
there were no differences among three co-culture systems reached significance 
(Figure 3.5B). 
 
 
 
 
A) 
 
 
 
Figure 3.5A: The amount of albumin (mg/ml/µg DNA/24h) secreted by rat 
hepatocytes on 6 well plates after 24 hours.  Passage number 4 HSCs were 
used in the co-cultures and medium was changed every 24 hours. 
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Table 3.2: Tukey's multiple comparison test for the amount of albumin secreted 
by rat hepatocytes on 6 well plates after 24 hours.  
 
Tukey's 
Multiple 
Compari
son Test
 
P value on 
day 1 
 
P value 
on day 3 
 
P value 
on day 7 
 
P value 
on day 9 
 
P value 
on day 
11 
 
P value 
on day 
14 
 
P value 
on day 
21 
 
A Vs B P < 0.001 P < 0.001 P < 0.001 P > 0.05 P > 0.05 NA NA 
A Vs C P < 0.001 P > 0.05 P < 0.001 P < 0.001 P < 0.01 NA 
 
NA 
A Vs D 
 
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 NA NA 
A Vs E 
   
P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 NA NA 
B Vs C 
   
P < 0.01 P < 0.001 P < 0.001 P < 0.001 P > 0.05 NA NA 
B Vs D 
   
P < 0.01 P < 0.001 P < 0.001 P < 0.001 P < 0.001 NA NA 
B Vs E 
 
P < 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 NA NA 
C Vs D 
   
P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
C Vs E 
 
P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P > 0.05 
D Vs E 
 
P > 0.05 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
 
A = mono-culture on collagen gel 
B = mono-culture in collagen-Matrigel sandwich 
C = co-culture on collagen gel 
D = co-culture in collagen- Matrigel sandwich 
E = co-culture on PDLLA coated surface 
P > 0.05, not statistically significant 
P < 0.05, significant 
P < 0.01, very significant  
P < 0.001, highly significant 
NA =  not available 
 B) 
 
 
 
Figure 3.5B: The amount of urea (ng/ml/µg DNA/24h) secreted by rat 
hepatocytes on 6 well plates after 24 hours. Passage number 4 HSCs were used 
in the co-cultures and medium was changed every 24 hours. 
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Table 3.3: Tukey's multiple comparison test for the amount of urea secreted by 
rat hepatocytes on 6 well plates after 24 hours 
 
Tukey's 
Multiple 
Compari
son Test
 
P value on 
day 1 
 
P value 
on day 3 
 
P value 
on day 7 
 
P value 
on day 9 
 
P value 
on day 
11 
 
P value 
on day 
14 
 
P value 
on day 
21 
 
A Vs B P > 0.05 P < 0.001 P < 0.05 P > 0.05 P < 0.05 P < 0.001 P < 0.001
A Vs C 
 
P > 0.05 P < 0.01 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001
A Vs D 
 
P > 0.05 P < 0.001 P < 0.01 P > 0.05 P < 0.001 P < 0.001 P < 0.001
A Vs E 
   
P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.001 P < 0.001 P < 0.001
B Vs C 
   
P > 0.05 P > 0.05 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001
B Vs D 
   
P > 0.05 P > 0.05 P < 0.001 P < 0.01 P < 0.001 P < 0.001 P < 0.001
B Vs E 
 
P > 0.05 P < 0.05 P < 0.01 P < 0.01 P < 0.001 P < 0.001 P < 0.001
C Vs D 
   
P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P < 0.05 
C Vs E 
 
P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
D Vs E 
 
P > 0.05 P < 0.05 P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 
 
A = mono-culture on collagen gel 
B = mono-culture in collagen-Matrigel sandwich 
C = co-culture on collagen gel 
D = co-culture in collagen- Matrigel sandwich 
E = co-culture on PDLLA coated surface 
P > 0.05, not statistically significant 
P < 0.05, significant 
P < 0.01, very significant  
P < 0.001, highly significant 
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3.3.5.3 CYP activity measurements by LC-MS/MS 
CYP1A2, 2B6 and 3A1activities were measured by metabolism of phenacetin 
deethylation, bupropion hydroxylation and midazolam 1’-hydroxylation of 
respective metabolites paracetamol, 1’-hydroxybuproprion and  
1’-hydroxymidazolam.  All the data were normalized to pmol/min/µg DNA. 
 
Paracetamol production by CYP1A2 was maintained for 7 days. The activities 
of cells of monocultures were only detectable on day 1. Cells co-cultured in 
collagen- Matrigel sandwich illustrated gradually increased activity from day 1 
(0.08 pmol/min/µg DNA) to day 7 (0.15 pmol/min/µg DNA); while cells co-
cultured on PDLLA coated plates showed decreased activity from day 1 (0.1 
pmol/min/µg DNA) to day 3 (0.07 pmol/min/µg DNA) and no activity was 
shown on day 7. (Figure 3.6A) 
 
1’-hydroxymidazolam production by CYP3A1 was maintained in monoculture 
for a longer period to day 3. However, the co-culture of collagen-Matrigel 
sandwich was the only culture system revealing the activity on day 7. Cells of 
other co-culture systems had no CYP3A1 activity after day 3. (Figure 3.6B) 
 
1’-hydroxybuproprion production by CYP2B6, all five culture systems 
exhibited the CYP2B6 activity until day 7 and the activities of cells cultured on 
collagen-Matrigel sandwich and PDLLA coated plates were extended until day 
9. Although cells co-cultured on collagen-Matrigel sandwich demonstrated 
much higher CYP2B6 activity than those co-cultured on PDLLA coated plates 
on day 7, they were similar on day 9. The reason why cells cultured on 
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collagen-Matrigel sandwich had much higher activity than cells cultured on 
other culture systems on day 7 was probably due to the big number and size of 
spheroids on that particular dish. (Figure 3.6C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) 
 
 
 
Figure 3.6A: Paracetamol production (CYP1A2 activity) by rat hepatocytes on 
6 well plates after 24 hours. Passage number 4 HSCs were used in the co-
cultures and medium was changed every 24 hours. 
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Table 3.4: Tukey's multiple comparison test for paracetamol production 
(CYP1A2 activity) production by rat hepatocytes on 6 well plates after 24 
hours 
Tukey's Multiple 
Comparison Test 
 
P value on day 1 
 
P value on day 3 
 
P value on day 7 
 
A Vs B P < 0.001 NA NA 
A Vs C 
 
P < 0.001 NA NA 
A Vs D 
 
P < 0.001 NA NA 
A Vs E 
   
P < 0.001 NA NA 
B Vs C 
   
P > 0.05 NA NA 
B Vs D 
   
P < 0.01 NA NA 
B Vs E 
 
P < 0.05 NA NA 
C Vs D 
   
P > 0.05 P < 0.001 NA 
C Vs E 
 
P > 0.05 P < 0.001 NA 
D Vs E 
 
P > 0.05 P < 0.01 P < 0.001 
 
A = mono-culture on collagen gel 
B = mono-culture in collagen-Matrigel sandwich 
C = co-culture on collagen gel 
D = co-culture in collagen- Matrigel sandwich 
E = co-culture on PDLLA coated surface 
P > 0.05, not statistically significant 
P < 0.05, significant 
P < 0.01, very significant  
P < 0.001, highly significant 
NA = not available 
 
B) 
 
 
 
 
Figure 3.6B: 1’-hydroxymidazolam production (CYP3A1 activity) by rat 
hepatocytes on 6 well plates after 24 hours. Passage number 4 HSCs were used 
in the co-cultures and medium was changed every 24 hours. 
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Table 3.5: Tukey's multiple comparison test for 1’-hydroxymidazolam 
production (CYP3A1 activity) by rat hepatocytes on 6 well plates after 24 
hours  
Tukey's Multiple 
Comparison Test 
 
P value on day 1 
 
P value on day 3 
 
P value on day 7 
 
A Vs B P < 0.001 P < 0.001 NA 
A Vs C 
 
P < 0.001 P < 0.001 NA 
A Vs D 
 
P < 0.001 P < 0.001 NA 
A Vs E 
   
P < 0.001 P < 0.001 NA 
B Vs C 
   
P > 0.05 P > 0.05 NA 
B Vs D 
   
P > 0.05 P < 0.001 NA 
B Vs E 
 
P > 0.05 P < 0.01 NA 
C Vs D 
   
P > 0.05 P < 0.001 NA 
C Vs E 
 
P > 0.05 P < 0.01 NA 
D Vs E 
 
P > 0.05 P > 0.05 NA 
 
A = mono-culture on collagen gel 
B = mono-culture in collagen-Matrigel sandwich 
C = co-culture on collagen gel 
D = co-culture in collagen- Matrigel sandwich 
E = co-culture on PDLLA coated surface 
P > 0.05, not statistically significant 
P < 0.05, significant 
P < 0.01, very significant  
P < 0.001, highly significant 
NA = not available 
 
C) 
 
 
 
Figure 3.6C: 1’-hydroxybuproprion (CYP2B6 activity) production by rat 
hepatocytes on 6 well plates after 24 hours. Passage number 4 HSCs were used 
in the co-cultures and medium was changed every 24 hours. 
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Table 3.6: Tukey's multiple comparison test for 1’-hydroxybuproprion 
(CYP2B6 activity) production by rat hepatocytes on 6 well plates after 24 
hours 
Tukey's 
Multiple 
Comparison 
Test 
 
P value on day 1
 
P value on day 3 
 
P value on day 7 
 
P value on day 9
 
A Vs B P < 0.05 P < 0.01 P > 0.05 NA 
A Vs C 
 
P < 0.01 P > 0.05 P > 0.05 NA 
A Vs D 
 
P < 0.001 P > 0.05 P < 0.001 NA 
A Vs E 
   
P < 0.001 P < 0.001 P > 0.05 NA 
B Vs C 
   
P > 0.05 P > 0.05 P > 0.05 NA 
B Vs D 
   
P > 0.05 P < 0.001 P < 0.001 P < 0.05 
B Vs E 
 
P < 0.05 P < 0.001 P > 0.05 P < 0.01 
C Vs D 
   
P > 0.05 P < 0.01 P < 0.001 NA 
C Vs E 
 
P < 0.05 P < 0.001 P > 0.05 NA 
D Vs E 
 
P > 0.05 P < 0.01 P < 0.001 P < 0.05 
 
A = mono-culture on collagen gel 
B = mono-culture in collagen-Matrigel sandwich 
C = co-culture on collagen gel 
D = co-culture in collagen- Matrigel sandwich 
E = co-culture on PDLLA coated surface 
P > 0.05, not statistically significant 
P < 0.05, significant 
P < 0.01, very significant  
P < 0.001, highly significant 
NA = not available 
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3.4 Discussion 
3.4.1 The morphology of rat hepatocytes on 12 well plates 
The spheroids on 12 well PDLLA coated plates did not form as expected. There 
are two potential reasons to explain this phenomenon in this study. Firstly, 
surface area and seeding density could play an important role in self-forming 
spheroids. For the self-assembled spheroids, which depend on the culture 
substratum, a large surface area is required for initial cell attachment (Kamihira 
et al., 1997). In other words, a minimum cell number is necessary for the 
initiation of spheroids formation. The cell number of hepatocytes on a 12 well 
plate is approximately 333,000 in comparison to 500,000 in a 6 well plate. 
Secondly, different passage numbers of HSCs were used in this chapter. 
Passage number 1 and 2 of HSCs were co-cultured with hepatocytes to form 
spheroids successfully in previous studies, but passage number 4 and 5 were 
applied to the co-culture this time. The cytokine expression and responsiveness 
and the ability of remodelling ECM of activated HSCs from different passage 
numbers were possibly changed by the effects of several rounds of 
trypsinization in vitro. Therefore, the effects of different passage numbers of 
HSCs and the effects of seeding density were further studied for spheroid 
formation in the following section.  
 
3.4.2 Functional analysis of rat hepatocytes on 12 well plates 
The data of rat hepatocyte functions on 12-well plates are summarized in Table 
3.7. It is demonstrated that the secretion of albumin exhibited an initial loss on 
day 1, reached the peak on day 3, and decreased dramatically after that. The 
initial loss of albumin secretion is probably a consequence of the recovery 
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process of cells after isolation. However, the amount of urea was maintained at 
a constant level from day 1 to day 7.  
 
From the urea data, it is noticeable that all three co-cultures revealed higher 
secretion than the two monocultures during the whole culture period, but this 
urea assay is not sensitive enough to demonstrate which co-culture system is 
the best; while from the albumin data, among five culture systems, cells 
monocultured on collagen-Matrigel sandwich and co-cultured on PDLLA 
surface displayed similar activities during the whole time. The statistical 
analysis found no significant differences between them.  
 
In terms of testosterone metabolism, CYP3A1, which is the most abundantly 
expressed CYP enzyme protein in the rat, was measured by the production of 
6ȕ-hydroxytestosterone. A reduced CYP3A1 activity after hepatocyte isolation 
was shown on day 1, most likely to represent, as with albumin, down 
regulation of CYP gene transcription immediately after cell recovery. After the 
peak on day 3, the activity of cells co-cultured on PDLLA surface was slightly 
higher than that of cells mono-cultured in collagen-Matrigel sandwich. In 
addition, the metabolism of testosterone to 4-Androstene-3, 17-dione was 
mainly metabolized by CYP2B1 with minor contributions by CYP2C11 and 
CYP2B2 (Sonderfan et al., 1989). The activities of all five culture systems 
were well preserved from day 1 to days 3, but the activity could only be 
observed in two culture systems on day 5, namely, monoculture in collagen-
Matrigel sandwich and co-culture on PDLLA. The cells cultured on PDLLA 
displayed higher activity.  
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It is not easy to compare culture systems between different research groups 
because of a large number of variables such as isolation methods, medium 
supplements and different endpoints. For co-culture of hepatocytes and HSCs 
on PDLLA coated surface, the percentage activity of CYP3A1 and CYP2B1 of 
fresh isolated cells on day 5 is around 200% and 130% respectively in this 
study, which is higher than only approximately 15% and 55% respectively 
from Thomas et al. 2005. For albumin and urea secretion, hepatocytes 
patterned co-cultured with NIH 3T3 on the polyelectrolyte multilayer template 
showed approximately 0.065 ng/cell/day and 0.07 ng/cell/day on day 5 
respectively (Kidambi et al., 2007), which is similar to our albumin data and a 
slightly lower to our urea data from hepatocytes co-cultured with HSCs. In 
addition, our co-culture on PDLLA plates showed almost 1000 times and 100 
times higher amount of albumin and urea secretion than the co-culture of 
hepatocytes and endothelial cells on P(IPAAm-BMA) patterned surface on day 
3 (Tsuda et al., 2006), and co-culture of hepatocytes and Kupffer cells on 
PDMS micropatterned surface on day 5 (Yekaterina et al., 2005) respectively.  
 
 
 
 
 
 
 
 
 
Table 3.7: a summary of data of hepatocyte function assays on 12-well plates 
 
Summary of 
data on 
12-well plates 
Albumin 
secretion 
(ng/ml/cell/24h)
Urea secretion
(ng/ml/cell/24h)
CYP3A 
activity 
(% of fresh 
isolated cells) 
CYP2B/2C 
activity 
(% of fresh 
isolated cells)
A= Monoculture 
on collagen gel 
Shown on day 7 
at about 0.034 
not shown on 
day 5 
not shown on 
day 5 
B= Monoculture 
in collagen-
Matrigel sandwich 
Shown on day 7 
at about 0.042 
Maintained at 
around 0.8 from 
day 1 to day 7 Shown on day 
5 at about 
160% 
Shown on day 
5 at about 90%
C= Co-culture on 
collagen gel 
Shown on day 7 
at about 0.004 
Not shown on 
day 5 
not shown on 
day 5 
D= Co-culture in 
collagen-Matrigel 
sandwich 
Shown on day 7 
at about 0.008 
Shown on day 
5 at about 60% 
not shown on 
day 5 
E= Co-culture on 
PDLLA 
Shown on day 7 
at about 0.038 
 
Maintained at 
around 1.2 from 
day 1 to day 7 
Shown on day 
5 at about 
210% 
Shown on day 
5 at about 
125% 
 
 
Conclusions 
B/E higher than 
the others      
(P>0.05) 
C/D/E higher 
than A/B  
(P<0.01) 
E higher than 
the others 
(P<0.05) 
E higher than 
the others 
(P>0.05) 
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3.4.3 Potential mechanisms of maintenance cultured rat hepatocytes on 12 
well plates 
Cell-cell interaction, cell-ECM interaction, soluble factors and 3D spheroids 
are the main potential mechanisms to explain maintenance of cultured 
hepatocytes function in vitro. It has been reported that hepatocytes mono-
cultured in collagen-Matrigel sandwich maintained the differentiated functions 
through 2D homotypic cell-cell interaction and 3D cell-ECM interaction. 
Collagen is a major ECM component and is widely used as a substratum for 
hepatocyte in in vitro culture. Matrigel, however, contains not only collagen IV 
but also other ECM proteins including laminin and entactin. Besides ECM 
proteins, Matrigel also contains several growth factors, namely ȕ-FGF, EGF, 
IGF-Į, NGF, TGF-ȕ etc. It is likely that these factors all contribute to the 
capacity of Matrigel to maintain hepatocyte function in monoculture, and 
underpin its utility for studies of drug metabolism and enzyme induction 
(Hewitt et al., 2007). 
 
The molecular mechanisms of maintenance of liver specific functions of 
hepatocytes co-cultured with HSCs on 12 well PDLLA coated plates were not 
studied in this chapter. However, since in vivo hepatocytes make contact, not 
only with other neighbour hepatocytes, but also with non-parenchymal cells, 
the co-culture of hepatocytes and HSCs in vitro, which are two major cell type 
in the liver, provides a closer approximation to the in vivo environment. Further, 
soluble factors, including cytokines and MMPs, and ECM components secreted 
from HSCs could contribute to ECM remodelling and 3D structure formation 
(Section 3.1.4). More importantly, ECM remodelling might be a prerequisite 
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for hepatocyte proliferation after isolation (Galli et al., 2000). Other soluble 
factors including EGF, TGFĮ and HGF secreted from HSCs also promote 
hepatocyte proliferation (Martinez-Hernandez and Amenta, 1995). Therefore, 
HSC participation may promote the formation of small aggregates, although 
not big spheroids, on a non-adhesive surface, PDLLA, which mimics the hepatic 
intercellular environment.  
 
The finding on 12-well plates that cells co-cultured on PDLLA coated plates 
showed better hepatocyte specific functions than those mono-cultured in 
collagen-Matrigel sandwich suggests that combination of 3D aggregates 
formed by hetero-cell-cell interaction and soluble factors from NPCs might 
play a more important role in maintenance of hepatocyte function than cell-
ECM interaction. 
 
3.4.4 The effects of different passage number HSCs on spheroids 
formation on 6 well PDLLA coated plates 
In order to test what is the appropriate range of passage number of HSCs for 
spheroids formation, different passage numbers of HSCs were used in the co-
cultures on PDLLA surface. This variable was shown to have great effects on 
the size, number, morphology and generation time of spheroids on 6 well 
PDLLA coated plates (Figure 3.4). 
 
100 µm to 200 µm in diameter is considered to be the ideal spheroid mean size. 
In spheroids of more than 200 µm in diameter, hepatocytes in the central 
section become necrotic (Takabatake et al., 1991). This is likely to be due to 
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hypoxia as oxygen is thought to directly permeate only up to 100 µm depth in 
the liver tissue (Smith et al., 1986; Lipinski, 1989). The sizes of spheroids 
formed by passage number 4, 6 and 7 HSCs were smaller than 100 µm in 
diameter, and would therefore maintain oxygenation throughout the spheroid.  
Also, the number of spheroids in each well of 6 well plates has not been 
calculated precisely in this study. However, about 30 spheroids at maximum 
formed by passage number 3, 4 and 7 was observed under the microscope, 
which shows a good agreement with the method using 20-30 spheroids per well 
of 6 well plate to prevent merge of adjacent two cell colonies (Lee et al., 2004). 
Efficiency of spheroid formation calculated by the number of cells that form 
into spheroids divided by the total number of cells can be used in future work 
(Wu et al., 1995). In addition, it has been reported that fast aggregation could 
be important in preventing early cell death and increasing the cell viability 
(Okubo et al., 2002). The spheroids formed by passage number 4 and 6 HSCs 
took less time than those generated by passage number 7 HSCs. Therefore, the 
combination of ideal size and rapid formation suggests that passage number 4 
to 6 HSCs may best support viable and functional tissue aggregates.  
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Table 3.8: a summary of spheroid formations by different passage numbers of 
HSCs on PDLLA coated plates 
 
 Spheroid 
formation 
Spheroid size Time for 
spheroid 
formation 
Spheroid 
morphology 
Passage 0 HSCs Yes >200 µm 48 hours 
Passage 3 HSCs  
Yes 
 
>200 µm 
 
48 hours 
Better defined 
cell borders and 
tighter cell 
conjunctions 
Passage 4 HSCs Yes <100 µm 72-96 hours 
Passage 6 HSCs Yes <100 µm 72-96 hours 
Passage 7 HSCs Yes <100 µm 114 hours 
Less defined cell 
borders and less 
cell 
conjunctions 
Passage 14 HSCs No 
Passage 17 HSCs No 
Passage 30 HSCs No 
 
 
Not Available 
Conclusions  
Best spheroids formed by passage 4/6 
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3.4.5 The morphology and functional analysis of rat hepatocytes on 6 well 
plates 
Although a few small aggregates formed on PDLLA coated 12 well plates, 
spheroids appeared in all culture systems on 6 well plates except on 
monoculture of collagen-Matrigel sandwich. Apart from spheroids on PDLLA 
coated plates established in 72 hours, all other spheroids were developed in 6 
days. 
 
The secretion of both albumin and urea was exhibited through the whole 
culture period of 21 days. All three co-cultures showed higher activities than 
two monocultures during the whole time. For the urea data, it is not sensitive 
enough to analyze the differences in three co-cultures like previous data; while 
for the albumin data, cells co-cultured in collagen-Matrigel sandwich and on 
PDLLA coated plate revealed higher activity all the times. Cells on both these 
co-cultures showed almost 1,000 times higher amount of albumin but 
approximately 100 times lower amount of urea than those in a 3D microarray 
perfusion bioreactor (Powers et al., 2002). The reason why the urea secretion is 
much lower in our model is most likely because of the great ability of waste 
and toxin removal in the bioreactor. 
 
Due to less sensitivity, less accuracy and less specificity of testosterone 
metabolism by HPLC, LC-MS/MS was applied to measure 3CYP activities at 
the same time. CYP3A1 activity showed in all five culture systems on day 1 
and day 3. However, it could be only observed from cells co-cultured in 
collagen-Matrigel sandwich on day 7. CYP1A2 activities were not detectable 
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in cells of both monocultures and the co-culture on collagen gel on day 3 and 
only cells co-cultured in collagen-Matrigel sandwich maintained it on day 7. 
CYP2B6 activities were maintained in cells of all culture systems until day 7, 
but cells mono-cultured on collagen gel and the co-cultured on collagen gel lost 
the activities on day 9. Cells co-cultured on PDLLA surface and collagen-
Matrigel sandwich showed similar activities on day 9. 
 
The observation that hepatocytes co-cultured with HSCs in collagen-Matrigel 
sandwich and on PDLLA coated plates exhibited better CYP functions than 
cells mono-cultured in collagen-Matrigel sandwich on 6 well plates is most 
likely to be attributable to the formation of the 3D spheroids in these two co-
cultures. This further supports the notion that 3D spheroids produced by the 
combination of hetero-cell-cell interaction and soluble factors from NPCs have 
greater effects on hepatocyte function than cell-ECM interactions. However, 
while spheroids formed in both co-culture systems, hepatocytes co-cultured 
with HSCs in collagen-Matrigel sandwich showed slightly higher functions. 
This suggests that hepatocyte functions can be further enhanced by cell-ECM 
interaction within 3D spheroids and this suggestion will be interrogated in 
further experiments.  
 
The spheroids formed by co-culture of hepatocytes and HSCs in collagen-
Matrigel sandwich in this study are hetero-spheroids, which are closer to in 
vivo environment than other homo-spheroids formed by hepatocytes only 
(Fukuda et al., 2003; Nakazawa et al.,2006). These spheroids also maintain 
both high degrees of cell-cell interaction and cell-ECM interaction, while other 
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spheroids do not favour the cell-ECM interaction (Yamada et al., 2001; Lee et 
al., 2004). LC-MS/MS, an advanced method of measuring CYP450 enzyme 
activity, is applied to assess specific CYP activities including CYP1A2, 
CYP2B6 and CYP3A1, which shows more accurate data in mass to charge 
(m/z) ratios than HPLC technology (Thomas et al., 2005). Taken together these 
observations, this spheroid system developed by co-culture of hepatocytes and 
HSCs in collagen-Matrigel sandwich is a potential candidate for in vitro liver 
development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.9: a summary of data of hepatocyte function assays on 6-well plates 
 
 Albumin 
secretion 
(mg/ml/µg 
DNA/24h) 
Urea secretion 
(ng/ml/ µg 
DNA/24h) 
CYP1A2 
activity 
(pmol/min/ µg 
DNA/24h) 
CYP3A1 
activity 
(pmol/min/ µg 
DNA/24h ) 
CYP2B6 
activity 
(pmol/min/µg 
 
DNA/24h ) 
A Not shown on 
day 3/7 
Not shown on 
day 7 
Not shown on 
 
day 9 
B 
Shown 
maximum on 
day 1, 
decreased to 
about 0.5 on 
day 3 and 
maintained at 
about 0.5 till 
day 11 
Increased from 
about 0.01 to 
0.04 from day 1 
to day 7 and 
maintained at 
about 0.06 till 
day 21 
Not Shown on 
day 3/7 
Not shown on 
day 7 
Shown on 
 
day 9 at about 
0.13 
C Not shown on 
day 3/7 
Not shown on 
day 7 
Not shown on 
day 9 
D Shown on day 7 
at about 0.15 
Shown on day 7 
at  about 0.07 
Shown on 
day 9 at about 
0.25 
E 
Shown 
maximum on 
day 3 and 
decreased 
gradually from 
day 7 to day 
21 
 Increased from 
about 0.01 to 
0.04 from day 1 
to day 7 and 
maintained at 
about 0.08 till 
day 21 
Shown on day 3 
at about 0.13 
Not shown on 
day 7 
Shown on 
day 9 at about 
0.35 
F C/D/E higher 
than A/B   
(P<0.01), 
 
E higher than 
C/D (P<0.01) 
C/D/E higher 
than A/B from 
day 9 to day 21 
(P<0.01) 
D higher than 
the others 
(P<0.01) 
D higher than 
the others 
(P<0.01) 
E higher than 
D (P>0.05), E 
 higher than B
(P<0.01) 
A= Monoculture on collagen gel 
B= Monoculture in collagen-Matrigel sandwich 
C= Co-culture on collagen gel 
D= Co-culture in collagen-Matrigel sandwich 
E= Co-culture on PDLLA 
F= Conclusions 
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3.4.6 Conclusion 
The key question in this chapter is to answer whether the model of spheroids 
formed from co-culture of hepatocytes with HSCs on PDLLA coated plates 
could be further improved by the addition of ECM components, collagen and 
Matrigel. Hepatocytes co-cultured with HSCs on PDLLA surface showed the 
best functions on 12 well plates, which is consistent with the formation of 3D 
aggregates formed by hetero-cell-cell interaction and soluble factors from 
HSCs. However, on 6 well plates, hepatocytes co-cultured with HSCs in 
collagen-Matrigel sandwich showed better function than cells co-cultured with 
HSCs on PDLLA, although spheroids formation existed in both co-cultures. 
This suggests that the addition of ECM (collagen-Matrigel sandwich) can 
further enhance hepatocyte functions. The experiment on 6 well plates was, 
however, completed only once and has not been repeated successfully due to 
difficulties of isolation of primary rat hepatocytes, although a great deal of 
work has been put to solve the problem (Appendix 3).  However, it is 
reasonable to expect this co-culture system is better than the previous co-
culture on PDLLA surface. It combines the benefits of monotypic and 
heterotypic cell-cell interactions, soluble factors from non-parenchymal cells, 
3D spheroids structure, and cell-ECM interaction, which is precise enough to 
mimic the environment of liver in vivo. 
 
 
  
 
Chapter Four: 
Cytochrome P450 Induction 
Studies in Immortalised 
Human Cell Line: Fa2N-4 
 
 
 
 
 
 
 
 
 
 
 
170
4.1 Introduction 
4.1.1 CYP induction and inhibition 
The modification of the cytochrome P450 (CYP) enzyme activities by 
inhibition, induction, or activation is of great interest to drug discovery and 
development scientists, since these modifications represent common causes of 
drug interactions. CYP inhibition can result from competition between two 
drugs which are metabolised by the same CYP. It may cause an unexpected 
increase in the plasma concentration of one or both drugs and also lead to a 
variety of minor or severe adverse effects. On the other hand, the induction 
arises from an elevation in the total amount of CYP which may lead to a 
marked decrease in plasma concentrations of a drug metabolised by the 
induced CYP. Common tools for the in vitro study of drug metabolism and 
disposition include liver slices, primary hepatocytes and hepatic cell lines. 
(Hollenberg et al., 2002) 
 
4.1.2 Why use hepatic cell lines for CYP induction study? 
One of the main obstacles using primary hepatocytes in vitro has been the lack 
of prolonged maintenance of liver specific function. A variety of cell culture 
methods have been developed to preserve drug-metabolising functions of liver 
under in vitro conditions. These include culturing hepatocytes on or in different 
basement membranes, co-culturing with other liver-derived or non-liver cell 
types and culturing in media containing growth factors and cytokines 
(Riccalton-Banks et al., 2003; Tuschl and Mueller, 2006). However, the goal of 
creating enduring tissue that fully retains its liver-specific function has yet to 
be achieved.  
 
 
171
Dramatic changes in CYP gene expression are observed during the early 
culture of human hepatocytes possibly because of a perturbation in the levels of 
transcription factors (Gomez-lechon et al., 2004). Additionally, large inter- 
individual variability in CYP expression occurs in human beings due to 
genotypic and phenotypic variability (Ingelman-sundberg, 2004). These, 
coupled with limited accessibility, mean that cultured primary human 
hepatocytes might not be the best model of long-term liver cell culture in terms 
of liver specific functions. 
 
In contrast to primary hepatocyes, hepatic cell lines have a few advantages, 
namely, almost unlimited lifespan, stable phenotype, good availability and 
simple culture conditions. Several hepatic cell lines have been developed and 
used in liver tissue engineering, including cell lines isolated from human 
hepatomas, immortalized hepatocytes, cell lines isolated from transgenic 
animals expressing viral transforming genes, oncogenes or growth factors, 
hepatocye/hepatoma hybrid cells and 'humanised' metabolically competent 
hepatocytes. Several hepatic cell lines including HepG2, BC2 and HepaRG 
(Vermeir et al., 2005; Castell et al., 2006; Kanebratt and Andersson, 2008) and 
the immortalized Fa2N-4 cell line (Mills et al., 2004; Ripp et al., 2006; 
Youdim et al., 2007; Hariparsad et al., 2008) have recently been assessed as 
replacements of primary human hepatocytes in CYP induction studies.  
 
4.1.3 A novel immortalized human cell line: FA2N-4 
Fa2N-4 cells are non-tumorigenic and derived from primary human 
hepatocytes immortalized by transfection with the SV40 large T-antigen (Steen, 
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2004; Vermeir et al., 2005).  Other hepatic human cell lines produced by 
transfection of hepatocytes with oncogenes (Ha-rasEJ, met, c-Ha-ras, 
telomerase) lack the complex spectrum of liver specific gene expression of 
hepatic cells in vivo (Hohne et al., 1993; Sirica, 1997; Wege et al., 2003). 
However, the Fa2N-4 cell line maintains morphological characteristics of 
primary human hepatocytes as well as stable expression and inducibility of 
various drug-metabolising enzymes (Mills et al., 2004). More recently, this 
Fa2N-4 model system has been used to predict the in vivo induction response 
(potency (EC50) and magnitude of effect (Emax)) of CYP3A4 inducers (Ripp et 
al., 2006). Furthermore, a higher throughput cocktail assay for assessment of 
CYP1A2, 2C9, 2C19, 2D6 and 3A4 levels in Fa2N-4 cells has been published 
(Youdim et al., 2007; Kenny et al., 2008).  
 
4.1.4 Mechanisms of expression and transcription of CYP genes  
CYP enzymes are major players in the phase I oxidative metabolism of a wide 
range of xenobiotics and endobiotics (steroids, fatty acids) (Guengerich, 1993). 
Only a few CYP genes, out of total 57 in the human genome, are responsible 
for xenobiotic metabolism. In the human liver a limited number of CYPs, 
namely CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A4 are responsible for drug 
biotransformation (Gonzalez et al., 1990). Among them, CYP3A4 is the most 
abundantly expressed, comprising approximately 30 - 40% of the total CYP in 
human adult liver (Guengerich et al., 1999). CYP1A2, 2B6, 2C9 and 3A4, the 
major inducible CYPs, are selected for this study. 
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Transcription of CYP genes is regulated by several key liver enriched 
transcription factors (LETFs) including CCAAT/enhancer binding protein 
(C/EBP) (Rodriguez-antona, et al., 2003) and hepatocyte nuclear factor (HNF) 
1, 3 and 4 (Schrem et al., 2002, 2004). Control is exercised by repressors 
including the small heterodimeric partner (SHP) (Lee et al., 2000) and the 
chicken ovalbumin upstream promoter transcription factors (COUP - TFs) 
(Tsai et al., 1997) as well as two main co-repressors,  silencing mediator of 
retinoid and thyroid receptor (SMAT) and nuclear receptor co-repressor 
(NCoR) (Burke et al., 2000). In addition, the transcriptional activation of CYP 
genes is regulated by nuclear receptor-dependent mechanisms: the 
arylhydrocarbon receptor (AhR), constitutive androstane receptor (CAR) and 
pregnane X receptor (PXR), which regulate genes CYP1A2, CYP2B6 and 
CYP3A4, respectively (Tirona and Kim, 2004). Recently, the expression of 
PXR and AhR has been showed to be similar between Fa2N-4 cells and human 
hepatocytes; however both CAR and several hepatic uptake transporters 
including the OATPs are significantly lower in the cell line compared to 
primary hepatocytes (Hariparsad et al., 2008).   
 
4.1.5 CYP induction in Fa2N-4 at mRNA expression levels 
Analysis of mRNA levels is considered the most sensitive method of 
determining liver specific function in hepatocytes in vitro. The transcription 
and translation of mRNA for a single CYP enzyme is a complex process 
mediated by cross-regulated components and it is therefore essential to 
understand the patterns of gene transcription underlying function and 
ultimately to control them in order to achieve prolonged hepatocyte function in 
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vitro. In this chapter, assessments of both CYP activity and mRNA level are 
made. 
 
4.1.6 Reverse transcription polymerase chain reaction (RT - PCR) 
Four methods are in common use for the analysis of gene transcription: 
northern blotting, in situ hybridization, RNAse protection assays (RPAs) and 
reverse transcription polymerase chain reaction (RT-PCR). Northern blotting 
and RPAs are gold standards but they require more RNA than is sometimes 
available, whereas in situ hybridization is qualitative rather than quantitative. 
RT-PCR is particularly valuable when amounts of RNA are low, since an 
amplification step is involved. It is an in vitro method for enzymatically 
amplifying defined sequences of RNA and permits the analysis of different 
samples from as little as one cell in the same experiment. It is the most 
sensitive and the most flexible of the quantification methods and it can 
discriminate closely related mRNA.  
 
Currently four different methods, TaqMan® (Applied Biosystems, Foster City, 
CA, USA), Molecular Beacons, Scorpions® and SYBR® Green (Molecular 
Probes), are available for real-time PCR. In this chapter the use of TaqMan® is 
described. TaqMan probes are sequence-specific oligonucleotides with a 
fluorophore and a quencher. The fluorophore is at the 5’ end of the probe and 
the quencher is usually located at the 3’ end or internally. During the PCR 
extension step, the probe is cleaved by the 5’-3’ exonuclease activity of Taq 
DNA polymerase, separating the fluorophore and quencher. This results in 
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detectable fluorescence that is proportional to the amount of accumulated PCR 
product (Figure 4.1). 
 
In this chapter, experiments are described that use QuantiTect® Multiplex RT-
PCR Kit (QIAGEN) for the RT-PCR technique. This allows one-step 
quantitative RT-PCR (qRT-PCR), which permits both reverse transcription and 
PCR to take place in a single tube, so there is no need to open the tube once the 
reverse transcription reaction has been started and the contamination of other 
non-related RNA is greatly reduced. Also, it contains omniscript and 
sensiscript reverse transcriptases, which are designed for reverse transcription 
of RNA amounts greater than 50 ng and smaller than 50 ng respectively. This 
combination provides highly efficient and sensitive reverse transcription over a 
wide of range of RNA template amounts. In addition, a modified form of Taq 
DNA polymerase (HotStar Taq DNA polymerase) is provided, which is in an 
inactive state and has no enzymatic activity at room temperature but is 
activated by a 15 minutes 95ºC incubation step. This prevents the formation of 
mis-primed products and primer-dimers during reaction setup and first 
denaturation step. Most importantly, the QuantiProbes (Figure 4.2) are 
sequence-specific dual labeled probes. Besides a fluorophore at the 3’ end and 
a quencher at the 5’end, there is a minor groove binder at the 5’ end. The minor 
groove binder prevents hydrolysis of the QuantiProbe by the 5’-3’ exonuclease 
activity of Taq DNA polymerase and the QuantiProbe is simply replaced by the 
template using Superbases technology during the PCR extension step. This 
increases the annealing efficiency and enables successful detection of difficult 
templates. Together with QuantiTect Multiplex RT-PCR buffer, use of uracil-
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N-glucosylase (UNG) and ROX passive reference dye, QuantiTect®Multiplex 
RT-PCR Kit is an ideal tool for RT-PCR technology. 
 
 
 
 
 
 
A) 
 
 
 
 
B) 
 
 
 
Figure 4.1: principle of Taqman probes in quantitative real-time PCR. A) Both 
the Taqman probe and the PCR primers anneal to the target sequence during 
the PCR annealing step. The proximity of the fluorophore with the quencher 
results in efficient quenching of fluorescence from the fluorophore. B) Taq 
DNA polymerase extends the primer. 5’-3’ exonuclease activity of the enzyme 
degrades the probe, resulting in physical separation of the fluorophore from the 
quencher. Increased fluorescence from the released fluorophore is proportional 
to the amount of accumulated PCR product. 
 
 
177
  
 
 
A) 
 
 
B) 
 
 
 
C) 
 
 
Figure 4.2: principle of QuantiProbes in quantitative real-time PCR. A) The 
QuantiProbe forms a random structure in solution when it is not bound to its 
target sequence. The proximity of the fluorophore with the quencher prevents 
the fluorophore from fluorescing. B) During the PCR annealing step, the 
QuantiProbe hybridizes to its target sequence, which separates the fluorophore 
and quencher, resulting in a fluorescent signal. The amount of signal is directly 
proportional to the amount of target sequence and it is measured in a real time 
to allow quantification of the amount of target sequence. C) During the PCR 
extension step, the QuantiProbe is displaced from the target sequence, bring the 
fluorophore and quencher into closer proximity, resulting in quenching of 
fluorescence. 
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4.1.7 Aims 
The purpose of this study was to simultaneously characterize CYP1A2, 
CYP2C9, CYP3A4 and CYP2B6 induction in Fa2N-4 cells through assessment 
of mRNA, protein and activity endpoints for a range of prototypical 
compounds (previously assessed in human hepatocytes) with known positive 
and negative induction potential. 
 
The induction assessment of both mRNA and activity is favorable and the 
series of experiments performed were: 
 
x Time course of mRNA and activity CYP induction in Fa2N-4 cells 
x Assessment of CYP1A2, CYP2C9, CYP2B6 and CYP3A4 induction in 
Fa2N-4 cells at the level of activity using 22 prototypical compounds 
by LC-MS/MS 
x Assessment of CYP1A2, CYP2B6 and CYP3A4 induction in Fa2N-4 
cells at the level of mRNA using 22 prototypical compounds by RT-
PCR 
 
The methodologies represented here have assisted a thorough evaluation of 
Fa2N-4 cells as a potential tool for CYP induction screening, using both 
activity and mRNA endpoints for the major inducible CYP isoforms.   
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4.2 Material and Methods 
4.2.1 Chemicals and Reagents.   
Bupropion, carbamazepine, 6-(4-chlorophenyl) imidazo[2,1-b][1,3]thiazole-5-
carbaldehydeO-(3,4-dichlorobenzyl)oxime (CITCO), clotrimazole, 
dexamethasone, diclofenac, 4c-hydroxydiclofenac, mifepristone, E-
naphthoflavone, nifedipine, omeprazole, paracetamol, phenacetin, 
phenobarbital, phenytoin, rifampicin, rifapentine, reserpine, troglitazone 
verapamil, and E-nicotinamide adenine dinucleotide phosphate, reduced form 
(NADPH), were purchased from Sigma-Aldrich (Gillingham, UK) and were of 
the highest grade available.  Bufuralol, efavirenz, hydroxybupropion, 
hyperforin, S-mephenytoin, midazolam, 1c-hydroxymidazolam, paclitaxel, 
pioglitazone, rifabutin, ritonavir and sulfinpyrazone were purchased from 
Sequoia Research Products Ltd. (Oxford, UK).  Acetonitrile, dimethyl 
sulfoxide (DMSO), ethanol and formic acid were purchased from Fisher 
Scientific (Loughborough, UK) and were of the highest grade available.  
Collagen type I coated 24-well plates, tissue-cultured treated flasks and 
trypsin-ethylene diamine tetracetic acid (EDTA) were purchased from BD 
Biosciences (Oxford, UK).  Cryopreserved Fa2N-4 cells, Multi-Function 
Enhancing (MFE) plating media and MFE support media with supplement A 
were obtained from Xenotech Ltd (Lenexa, KA, USA).  DNase I RNase free 
kit and RNase free water were from Invitrogen (Paisley, UK). 
 
4.2.2 Cell Culture 
Fa2N-4 cells were seeded on tissue culture treated T75 flask, maintained in 
MFE support media with supplement A (1 µl/ml) and incubated at 37ûC, 5% 
 
 
180
carbon dioxide and 95% relative humidity. MFE support media was changed 
every two days and the cells were passaged until they were approximately 80% 
confluent. For passaging, the cells were trypsinized for 15 minutes, harvested 
in MFE plating medium, centrifuged at 120g for 5 minutes and resuspended in 
fresh MFE plating medium. Cells were then diluted to 0.2 x 10
6 
cells/ml and 
either re-seeded in tissue culture treated flasks (~2 x 10
6
 cells/flask) or seeded 
on type I collagen coated 24-well plates (0.1 x 10
6
 cells/well; 0.5 ml/well).  
After 24 hours, MFE plating medium was replaced with MFE support medium 
containing supplement A.  All Fa2N-4 cells used in the following experiments 
were between passages 2 and 8.   
 
4.2.3 Enzyme induction experiment 
Fa2N4 cells were supplemented with MFE support medium for a few days on 
type I collagen 24-well plates. Stock solutions (× 1000) of all test compounds 
at all concentrations were prepared in DMSO and diluted 1000-fold in MFE 
support medium containing supplement A to give a final DMSO content of 
0.1% v:v. With the exception of phenobarbital (0.01-2 ȝM) prepared in MFE 
support medium to ensure solubility and hyperforin (0.01-2 ȝM) prepared in 
methanol, each inducer was prepared to a serial of six concentrations in DMSO 
to allow full induction dose response curves to be generated for each 
compound. According to the respective Emax concentrations from literature data 
for Fa2N-4 cells and human hepatocytes (LeCluyse et al., 2000; Maden et al., 
2003; Faucette et al., 2004, 2007; Ripp et al., 2006), compounds and 
concentration ranges were as follows: Rifampicin 0.1 - 20 ȝM, Carbamazepine 
3.13 - 250 ȝM, Clotrimazole 0.13 - 10 ȝM, Dexamethasone 3.13 - 250 ȝM, 
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Nifedipine 0.5 - 100 ȝM, Paclitaxol (Taxol) 0.38 - 30 ȝM, Phenytoin 3.13 - 
250 ȝM, Pioglitazone 0.5 - 100 ȝM, Rifapentine 0.25 - 20 ȝM, Reserpine 0.63 
- 50 ȝM, Rifabutin 0.1 - 20 ȝM, Ritonavir 0.06 - 5 ȝM, Troglitazone 0.1 - 20 
ȝM, Sulfinpyrazone 3.13 - 250 ȝM, Mifepristone 0.13 - 10 ȝM, E-
napthoflavone 0.63 - 50 ȝM, 50 ȝM Omeprazole, CITCO 0.13 - 10 ȝM, 
Verapamil 0.5 - 100 ȝM and Efavirenz 0.13 - 10 ȝM. Any higher concentration 
of each compound results in cell toxicity or drug insolubility. All aliquots were 
subsequently diluted in MFE support medium at the concentration of 1ȝl/ml 
and the solutions (0.5 ml) were added to appropriate wells of each 24-well 
plate. Some wells were supplemented with DMSO diluted in MFE support 
medium (1ȝl/ml) as controls. The MFE support medium with the inducers were 
changed every 24 hours for the next three days. 
 
4.2.4 Isolation and quantification of mRNA 
Total RNA was extracted from the cells in RLT buffer using RNeasy 96 kit 
(Qiagen, West Sussex, UK). The method ‘isolation of RNA from animal cells 
by the vacuum protocol’ was applied according to instructions supplied by 
QIAGEN. Quant-iT
TM
 RiboGreen RNA reagent and assay kit (Invitrogen, 
Paisley, UK) were used to quantify total RNA with a fluorescence microplate 
reader at 485 nm emission and 530 nm excitation wavelengths according to the 
manufacturer’s instructions. The data from Ribogreen were used to normalize 
the CYP1A2, 2B6 and 3A4 mRNA results from qRT-PCR. 
 
The standard curve of qRT-PCR was prepared from human hepatocyte mRNA 
pooled from cells that were induced separately with rifampicin, phenobarbital 
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and omeprazole. A no-reverse transcriptase control (No RT) and a no template 
control (NTC) should always be included to provide confidence that gene 
amplification is specific and that there has been no contamination of reagents.   
 
The PCR primers and Taqman probes for CYP1A2, CYP2B6, and CYP3A4 
were selected for their high specificity to the human CYP isoforms, afforded 
by their exon–exon spanning domains. Appropriate primers and probes were 
selected using primer express 2.0 software (Applied Biosystems, Foster City, 
CA, USA) and oligo mapping. A BLAST database search 
(http://www.ncbi.nlm.nih.gov/BLAST) was carried out to ensure selectivity. 
Primers and probes were synthesized by Eurogentec (Basel, Switzerland). 
 
Duplex assay was used for CYP1A2 and CYP3A4, and single plex assay was 
used for CYP2B6 only. Both assays have been previously established and 
optimised in DMPK, Astrazeneca, Charnwood.  The PCR reaction mixture 
containing the 2 primer-probe pairs/ 1 primer-probe pairs and complete 
mastermix was prepared using the two tables (Table 4.1 and 4.2) below for 
duplex and single plex assays respectively. 
 
 
 
 
 
 
 
 
 
183
Table 4.1: the duplex reaction mixture for CYP1A2 and 3A4 
 Volume (µl) per reaction 
Volume (µl) for 
105 reaction 
CYP3A4 Forward primer (10 µM) 0.125 13.125 
CYP3A4 Reverse primer (10 µM) 0.75 78.75 
CYP3A4 Probe (5 µM) 2.5 262.5 
CYP1A2 Forward primer (10 µM) 0.125 13.125 
CYP1A2 Reverse primer (10 µM) 0.75 78.75 
CYP1A2 probe (5 µM) 0.25 26.25 
2 x NoRox Master mix 25 2625 
Multiplex RT Mix 0.5 52.5 
dH2O 15 1575 
Total volume 45 4725 
 
 
Table 4.2: the single reaction mixture for CYP2B6 
 Volume (µl) per reaction 
Volume (µl) for 105 
reaction 
Forward primer (10 µM) 0.125 13.1 
Reverse primer (10 µM) 0.75 78.75 
probe (5 µM) 0.25 26.25 
2 x NoRox Master mix 12.5 1312.5 
Multiplex RT Mix 0.25 26.25 
dH2O 6.125 643.1 
Total volume 20 2100 
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The mRNA samples, 2× Master mix, primer-probe sets (Table 4.3), QuantiTect 
Multiplex RT-PCR No ROX Master Mix Kit (Qiagen, West Sussex, UK) were 
thawed, kept on ice during the whole experiment period and returned to -20qC 
immediately after use. The Mx3005P real-time cycler with MxPro software 
(Stratagene, Amsterdam, Netherlands) was setup according to Table 4.4. 
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Table 4.3: primers and probes for CYP1A2, 2B6 and 3A4 
Gene CYP1A2 
Forward Primer: (5c $ 3c) CTCCTCCTTCTTGCCCTTCA 
Reverse Primer:  (5c $ 3c) GGTTTACGAAGACACAGCATTTCTT 
Probe: (5c $ 3c) AGCACAACAAGGGACACAACGCTGAAT 
Gene CYP2B6 
Forward Primer: (5c $ 3c) CAAGAGTTCCTGAAGATGCTGAAC 
Reverse Primer:  (5c $ 3c) AGGAAAGTATTTCAAGAAGCCAGAGA 
Probe: (5c $ 3c) TGTTCTACCAGACTTTTTCACTCATCAGCTCTGTATTC 
Gene CYP3A4 
Forward Primer: (5c $ 3c) GCAGGAGGAAATTGATGCAGTT 
Reverse Primer:  (5c $ 3c) GTCAAGATACTCCATCTGTAGCACAGT 
Probe: (5c $ 3c) TACCCAATAAGGCACCACCCACCTATGA 
 
 
Table 4.4: Mx3005P cycle times for one-step qRT-PCR 
Step Time Temperature (º C) 
RT 20 minutes 50 
PCR initial activation 15 minutes 95 
2-step Cycling   (40 –50 cycles) 
Denaturation 45 seconds 94 
Annealing/extension 75 seconds 60 
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Each mRNA sample (5 µl) was added to a 96-well PCR plate and followed by 
a 45 µl or 20 µl of each PCR reaction mixture. After that, an optically clear 
plate lid was carefully taken and placed over a prepared PCR plate on the plate 
sealer bed.  The plate sealer was then pushed down and held for 10 seconds.  
Finally, the plate was briefly centrifuged to remove air any bubbles before the 
qRT-PCR started.  
 
4.2.5 Statistical analysis 
All the results are expressed as mean and standard deviation of triplicate 
determinations in different cell passages unless otherwise specified. 
 
The parameters Emax and EC50 were determined from dose–response data, 
where Emax is the maximum observed induction at an optimum concentration; 
and EC50 is the effective concentration that supports half-maximal induction. 
To estimate EC50 values, dose-response data were fitted to a simple Emax model 
with a Hill function according to the following equation: 
Y= (Emax  X
y
)/(EC50
y
 + X
y
) 
using Origin 6.0 (MicroCal, Northampton, MA, USA). Similar to the approach 
taken by Ripp et al. (2006), data points from wells with some evident toxicity, 
based on visual inspection of cell morphology, were excluded from the fits and 
the Emax was set at the observed Emax to prevent extrapolation of the curve fit 
beyond measured data.  
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4.3 Results 
4.3.1Time course of mRNA and activity CYP induction in Fa2N-4 cells 
The Fa2N-4 cells were treated with rifampicin and E-naphthoflavone for 24, 48 
or 72 hours. The CYP3A4 enzyme activity and mRNA levels were measured at 
these three time points. For CYP3A4 activity (after rifampicin treatment), the 
fold increased gradually from 24 hours to 72 hours and reached maximal fold 
at 72 hours (Figure 4.3A). For the rifampicin mRNA data, the fold-induction at 
48 hours was much higher than at 24 hours, but the fold-induction at 72 hours 
was similar with that at 48 hours (Figure 4.3B). For the E-naphthoflavone 
mRNA data, maximal CYP1A2 induction occurred at 24 hours and was 
maintained up to 72 hours (Figure 4.4B), whilst E-naphthoflavone induced 
CYP1A2 activity increased to 72 hours at the top two concentrations (6 and 25 
µM) (Figure 4.4A). Therefore, 72 hours was chosen as the optimal incubation 
time for measuring mRNA as well as activity of CYP1A2 and CYP3A4. 
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A) 
B) 
 
Figure 4.3: rifampicin CYP3A4 activity (A) and mRNA (B) at 24, 48 and 72 
hours.  Data are mean n=2 experiments ± S.D. 
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A) 
 
B) 
 
Figure 4.4: E-naphthoflavone CYP1A2 activity (A) and mRNA (B) at 24, 48 
and 72 hours. Data are n=1 experiment 
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4.3.2 Induction profiles of prototypical CYP1A2, CYP2C9, CYP2B6 and 
CYP3A4 inducers in Fa2N-4 cells 
The impact of 22 prototypical compounds on CYP1A2, CYP2C9, CYP3A4 
and CYP2B6 activity and mRNA levels has been investigated using the Fa2N-
4 cell line. Compounds were selected to represent a range of positive and 
negative inducers of CYP3A4 (Ripp et al., 2006), CYP1A2 and CYP2B6 
through activation of pregnane X receptor (PXR), Aryl hydrocarbon receptor 
(AhR) and constitutive androstene receptor (CAR) respectively.  
 
Fa2N-4 cells were treated for three days with varying concentrations of test 
compounds. Both CYP activities and mRNA levels were normalised to the 
vehicle control, and expressed as fold induction. Treatment with rifampicin 
resulted in an Emax of 6-fold and 3.5–fold induction of CYP3A4 and CYP2C9 
activity respectively, whilst an Emax of 36-fold induction of CYP3A4 at the 
mRNA level was observed (Figure 4.5). Both CYP3A4 activity and mRNA 
were increased in a dose-dependent manner. Also, CYP2B6 was induced at the 
level of mRNA and activity by rifampicin (Emax 4-fold and 3-fold respectively).   
The Emax values for induction of CYP3A4 and CYP2C9 activity following for 
treatment with phenobabital were 4.5-fold and 3-fold respectively. (Figure 
4.6A) The Emax value of CYP3A4 mRNA induction was 12-fold (Figure 4.6B). 
The effects of ß-napthoflavone on CYP1A2 activity and mRNA showed an 
Emax of 11-fold and 217-fold to the vehicle controls respectively (Figure 4.7). 
No induction of other isoforms mRNA and activity was noted.  
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A)  
B) 
Figure 4.5: effects of rifampicin on CYP1A2, 2C9, 3A4 and 2B6 activity levels 
(A) as well as on CYP1A2, 3A4 and 2B6 mRNA levels (B). A serial of six 
concentrations of rifampicin was added to Fa2N-4 cells in the MFE support 
medium for continuous 72 hours. Medium containing the rifampicin was 
changed every 24 hours. CYP activities and CYP mRNA levels were measured 
by LC/MS-MS and qRT-PCR, respectively. Data are mean n=2 experiments ± 
S.D. 
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A) 
B) 
igure 4.6: effects of phenobarbital on CYP1A2, 2C9, 3A4 and 2B6 activity 
experiments ± S.D. 
 
F
levels (A) as well as on CYP1A2, 3A4 and 2B6 mRNA levels (B). A serial of 
six concentrations of phenobarbital was added to Fa2N-4 cells in the MFE 
support medium for continuous 72 hours. Medium containing the phenobarbital 
was changed every 24 hours. CYP activities and CYP mRNA levels were 
measured by LC/MS-MS and qRT-PCR, respectively. Data are mean n=2 
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A) 
B) 
 
Figure 4.7: effects of E-naphthoflavone on CYP1A2, 2C9, 3A4 and 2B6 
activity levels (A) as well as on CYP1A2, 3A4 and 2B6 mRNA levels (B). A 
serial of six concentrations of E-naphthoflavone was added to Fa2N-4 cells in 
the MFE support medium for continuous 72 hours. Medium containing the E-
naphthoflavone was changed every 24 hours. CYP activities and CYP mRNA 
levels were measured by LC/MS-MS and qRT-PCR, respectively. Data are 
mean n=2 experiments ± S.D. 
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4.3.3 Emax and EC50 parameters for CYP1A2 and CYP3A4 inducers in 
Fa2N-4 cells 
The Emax and EC50 values for CYP1A2 mRNA induction by all test compounds 
were estimated and are listed in Table 4.5.  More than 2-fold induction of 
CYP1A2 mRNA was observed in a total of 6 compounds.  E-naphthoflavone 
demonstrated both CYP1A2 mRNA and activity induction with an E  of 
217-fold and 11-fold observed, respectively.  The EC50 for E-naphthoflavone 
CYP1A2 mRNA was 8 µM.  CYP1A2 mRNA and activity induced by 
omeprazole gave Emax values of 425-fold and 16-fold respectively.  CYP1A2 
mRNA and activity showed does-dependent induction with Emax value of 35-
fold and 3-fold respectively.  No CYP1A2 induction was observed following 
treatment of Fa2N-4 cells with carbamazepine, clotrimazole, dexamethasone, 
efavirenz, paclitaxel, phenobarbital, phenytoin, rifabutin, rifampicin, 
rifapentine, ritonavir, pioglitazone, sulfinpyrazone, mifepristone, troglitazone, 
hyperforin or verapamil. 
 
 
 
 
 
 
 
 
 
 
max
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Table 4.5: Emax and EC50 values of CYP1A2 mRNA induction 
 induction in 
 
EC50 (µM) Emax (fold CYP1A2
induction) human hepatocytes 
Omeprazole ND 425* ¥ 
ȕ-Naphthoflavone 8 
e 
 
N  
217 ¥ 
CITCO 2 35 × 
Clotrimazol 1 16 × 
 Nifedipine 2 16 × 
Reserpine A 3 × 
 
A= not appropriate to define EC50 from data fit; ND = not determined; 
 in human hepatocytes (not) shown in the literature 
N
*incubated at 50 µM only 
¥ (×) = CYP1A2 induction
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The Emax and EC50 parameters of CYP3A4 mRNA induction by all test 
compounds were calculated and are listed in Table 4.6.  Mostly compounds (17 
of the 22) exhibited greater than 2-fold induction of CYP3A4 mRNA, which 
were characterized to 6% of rifampicin Emax.  Among these compounds, 
phenytoin, nifedipine, rifapentine, phenobarbital, rifabutin, and ritonavir 
induced CYP3A4 mRNA more than 20% of rifampicin mRNA Emax.  Other 
compounds including phenytoin, dexamethasone, pioglitazone, phenobarbital 
and rifapentine achieved CYP3A4 activity greater than 2-fold, which was 
relvant to more than 40% of rifampicin CYP3A4 activity Emax. However, 
mifepristone, E-naphthoflavone, troglitazone and omeprazole demonstrated no 
CYP3A4 induction following exposure to Fa2N-4 cells.   
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Table 4.6: Emax and EC50 values of CYP3A4 mRNA induction 
EC50 (µM) Emax (fold Emax (% maximal 
rifamp ) 
CYP3A4 
n 
tes
 
 
induction) icin induction induction i
human 
hepatocy
Rifampicin 4 36 100 ¥ 
Rifapentine 3 27 75 ¥ 
Nifedipine 8 13 36 ¥ 
Phenobarbital 2  
one 8 
0
ine 
hasone 5 
0
 
one 
05 12 33 ¥ 
Phenytoin 74 10 28 ¥ 
Rifabutin 0.3 8 22 ¥ 
Ritonavir 0.2 8 22 ¥ 
Reserpine 3 7 19 ¥ 
Sulfinpyraz 7 19 ¥ 
Paclitaxel 2 6 17 ¥ 
Efavirenz .7 5 14 ¥ 
Verapamil 1.3 5 14 ¥ 
Carbamazep 11 4 11 ¥ 
Clotrimazole 0.4 4 11 ¥ 
CITCO 0.1 3 8 ¥ 
Dexamet 3 8 ¥ 
Hyperforin .1 3 8 ¥ 
Pioglitazone 1.2 2 6 ¥ 
E-Naphthoflav NA 1 3 × 
 
NA= not appropriate to define EC50 from data fit 
not) shown in the literature ¥ (×) = CYP3A4 induction in human hepatocytes (
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Atypical or bell-shaped dose response curves for CYP3A4 mRNA were 
observed for rifampicin, rifapentine clotrimazole, paclitaxel, pioglitazone, 
reserpine and ritonavir. Among these compounds, rifampicin and rifapentine 
are two clearly CYP 3A4 inducers in Fa2N- 4 cells with Emax of 36 fold and 27 
fold as well as EC50 of 4.2 µM and 3 µM respectively (Figure 4.8 and 4.9).  
The Emax of rifapentine is corresponded to 75 % of rifampicin maximal 
induction. However, in order to fit the dose response curve the final data point 
was omitted as induction decreased as concentration increased (Figure 4.10 and 
4.11).  In terms of clotrimazole, paclitaxel and pioglitazone, they were 
cytotoxic at their top concentrations tested under microscope through their 
morphology, but no other quantitative assessment of cytotoxicicty was carried 
out.   
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Figure 4.8: the effect of rifapentine on CYP3A4 mRNA level. Data are mean 
n=2 experiments ± S.D. 
 
Figure 4.9: the effect of rifampicin on CYP3A4 mRNA level. Data are mean 
n=2 experiments ± S.D. 
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 Figure 4.10: the does repose curve of rifampicin on CYP3A4 mRNA level 
 
 
Figure 4.11: the does repose curve of rifapentine on CYP3A4 mRNA level 
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4.3.4 CYP2B6 Response in Fa2N-4 cells 
Rifampicin is the only compound among all those tested compounds that 
showed a marked effect on CYP2B6 mRNA and activity. (Figure 4.5) No other 
tested compound demonstrated greater than 2-fold in CYP2B6 induction either 
at the mRNA or activity level. All CAR ligands like CITCO (Figure 4.12), 
phenobarbital (Figure 4.6) and E-naphthoflavone (Figure 4.7) did not induce a 
CYP2B6 response in Fa2N-4 cells. 
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A) 
 
 
 
m
 
B) 
Figure 4.12: the effects of CITCO on CYP1A2, 2C9, 3A4 and 2B6 activity 
levels (A) as well as on CYP1A2, 3A4 and 2B6 mRNA levels (B). Data are 
ean n=2 experiments ± S.D. 
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4.4 Discussion 
Evaluating CYP induction is an ultimate functional assessment for prolonged 
hepatocyte culture system as well as being a routine in the pharmaceutical 
industry. Due to phenotypic instability, genotypic variability and limited 
accessibility to primary human hepatocytes, a novel immortalised hepatic cell 
line has been developed and an evaluation is described in the chapter. In order 
to facilitate the evaluation of Fa2N-4 cells for CYP induction screening, qRT-
PCR and cassetted CYP probe substrate methodologies, which have been 
previously established in DMPK, Astrazeneca, Charnwood, were used in the 
study. 
 
4.4.1 Time course of mRNA and activity CYP induction in Fa2N-4 cells 
Assessment of CYP induction in primary human hepatocytes on average takes 
48 – 96 hours incubation with a test inducer (LeCluyse, 2001; Hewitt et al., 
2007b), whilst using mRNA as an endpoint may require a shorter induction 
period (Drocourt et al., 2001; Meneses-Lorente et al., 2007).  A time course 
study with Fa2N-4 cells showed that the cells were similar to primary human 
hepatocytes in terms of the period of incubation time required for maximal 
induction.  CYP3A4 mRNA and activity were induced by rifampicin reaching 
maximal induction at 72 hours. CYP1A2 activity, induced by E-
naphthoflavone, showed a similar time course of induction, whilst CYP1A2 
mRNA reached maximal induction by 24 hours and was maintained until 72 
hours. Consequently, 72 hours was established as the optimal incubation time 
mRNA and activity end-points for CYP1A2 and CYP3A4. 
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4.4.2 CYP1A2 and 3A4 induction in Fa2N- 4 cells 
Induction of CYP3A4 and CYP2C9 has been previously demonstrated in 
Fa2N-4 cells in response to rifampicin, phenobarbital and dexamethasone 
(Mills et al., 2004). Recently a larger set of inducers was investigated at 
mRNA levels using these immortalized hepatocytes (Ripp et al., 2006). The 
current work indicates Fa2N-4 cells can appropriately identify CYP1A2, 3A4 
and 2B6 inducers at the enzyme activity or mRNA level. Generally, it is 
considered that a compound is a CYP inducer if it produces a maximal fold-
induction of greater than or equal to 2. Omeprazole (Emax of 425) and E-
naphthoflavone (Emax of 217) were recognized as prototypical CYP1A2 
inducers in vitro, while other inducers include CITCO (mRNA Emax of 35), 
clotrimazole (mRNA Emax of 16), nifedipine (mRNA Emax of 16) and reserpine 
(mRNA Emax of 3).  No other published literature shows the data of CYP1A2 
induction in Fa2N-4 cells.  
 
The prototypical in vitro inducers of CYP3A4 including carbamazepine, 
clotrimazole, dexamethasone, efavirenz, hyperforin, nifedipine, paclitaxel 
phenobarbital, phenytoin, pioglitazone, reserpine, rifabutin, rifapentine, 
rifampicin, ritonavir, sulfinpyrazone, verapamil were also correctly identified 
using Fa2N-4 cells (Figure 4.14). Although mifepristone, omeprazole and 
troglitazone have been previously identified as CYP3A4 inducers in primary 
human hepatocytes, no CYP3A4 induction was observed in Fa2N-4 cells 
(Ramachandran et al., 1999; Raucy, 2003; Nishimura et al., 2007).  The 
absence of CYP3A4 induction with these compounds was possibly as a result 
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of cytotoxicity, previously reported for Fa2N-4 cells (Ripp et al., 2006) and for 
troglitazone with primary human hepatocytes (Masubuchi, 2006).  
 
Taken as a whole, the CYP1A2 and CYP3A4 induction data described in this 
study with Fa2N- 4 cells matches well to that previously demonstrated with 
human hepatocytes (LeCluyse et al., 2000; Meunier et al., 2000; Roymans et 
al., 2004). In particular the Emax values for CYP1A2 mRNA and activity 
induced by E-naphthoflavone were 217 and 11- fold in Fa2N-4 cells 
respectively, similar to that in human hepatocytes (Royman et al., 2004; 
Meneses-Lorente et al., 2007). Also, the Emax values for CYP3A4 mRNA and 
activity induction by rifampicin of 36 and 6-fold respectively corresponded 
well to those previously reported using human hepatocytes (Hariparsad et al., 
2004; Roymans et al., 2004). Also, the maximum fold induction of CYP3A4 
mRNA from Ripp et al. (2006) and in this study is listed in Figure 4.13. Both 
data show similar trend and are in a good agreement overall, but CYP3A4 
mRNA maximum induction of certain compounds is higher in this study. For 
example, both phenobarbital and rifampicin mRNA maximum inductions in 
this study show twice fold to those from Ripp et al. (2006). The differences 
between two groups are probably due to the application of different 
concentration of the compound and induction time. 
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Figure 4.13: maximum fold induction of CYP3A4 mRNA comparison between 
AstraZeneca (this study) and Pfizer (Ripp et al., 2006). X axis shows that 17 
compounds were used in different maximum concentration in two studies. 72 
hours and 96 hours were applied for maximum CYP mRNA induction in this 
study and Pfizer’s, respectively. 
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igure 4.14: a summary of maximum fold induction of CYP3A4 activity and 
 
 
F
mRNA in Fa2N-4 cells at 72 hours induction time. 19 compounds at their 
maximum concentrations are shown in X axis. Majority of the compounds at 
mRNA level show greater than 2 fold (dash line). 
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4.4.3 CYP2B6 induction in Fa2N-4 cells 
portant role in the regulation of 
.4.4 Conclusion and future work 
1A2, CYP2C9, CYP2B6 and CYP3A4 
Nuclear hormone receptors play an im
transcriptional activation of CYP genes. Aryl hydrocarbon receptor (AhR) is 
capable of binding to the response elements in the promoter regions of the 
CYP1A2 gene. Constitutive androstene receptor (CAR) and pregnane X 
receptor (PXR) are regulators of CYP3A4 and CYP2B6 expression (Tirona and 
Kim, 2004) with PXR predominately relating to CYP3A4 and CAR 
predominately relating to CYP2B6 (Facuette et al., 2007). In Fa2N-4 
immortalized cells, CAR exhibits high constitutive activity and spontaneous 
nuclear localization in contrast to its predominant cytosolic localization in 
primary hepatocytes (Faucette et al., 2007) therefore the expression level of 
CAR is considerably lower than in human hepatocytes (Hariparsad et al., 2008). 
Since CITCO, phenytoin and carbamazepine are selective activators of CAR 
(Faucette et al., 2006), phenobarbital activates both CAR and PXR and 
rifampicin activates CYP2B6 via PXR predominantly over CAR, there was no 
CYP2B6 induction by CITCO (Figure 4.12), weak induction by phenobarbital 
(Figure 4.6) but clear induction by rifampicin (Figure 4.5). Consequently, 
Fa2N-4 cell line may be used as a potential mechanistic tool for investigating 
CYP3A4 and CYP2B6 inducers via CAR/PXR. 
 
4
In conclusion, qRT-pCR and CYP
substrate cassette methods described here have offered capacity to competently 
evaluate CYP induction in Fa2N-4 cells. It is considered that Fa2N-4 cells 
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offer a substitute for primary human hepatocytes for CYP1A2 and CYP3A4 
induction but not for CYP2B6 due to lack of cytosolic CAR expression.  
 
The next stage of this project will be to apply these CYP induction protocols to 
primary human hepatocyte culture models (e.g. co-culture of hepatocytes and 
hepatic stellate cells). Any reasons for differences in CYP3A4 expression and 
inducibility will be investigated at a molecular level, including liver-specific 
transcription factors (TFs), nuclear hormone receptors (NRs), binding of TFs 
and NRs to the regulatory element and promoter region of the CYP3A4 gene 
and the nature of chromatin in the region of CYP3A4, PXR regulatory and 
promoter region. 
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Chapter Five: 
Co-culture of Primary Human 
Hepatocytes and Hepatic 
Stellate Cells (HSCs) 
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5.1 Introduction 
5.1.1 Isolation of primary human hepatocytes 
5.1.1.1 Sources of human liver tissues 
The major sources of human liver tissues include whole organs from 
multiorgan donors (MODs) discarded for transplantation, tissue from split-liver 
transplantation, liver specimens obtained during partial therapeutic 
hepatectomy  or small size surgical biopsies. 
 
Donor livers and tissue from reduced-sized donor livers provide lower cell 
yield and viability than other sources. Also, the metabolic competence of cells 
shows a 30-35% reduction compared to other liver sources. (Serralta et al., 
2003) The reasons why liver from organ donors are less competent are 
probably due to the use of a cold preservation solution to prevent warm 
ischemia and several hours of transportation under this condition before 
hepatocye isolation.  Cold ischemia is not the only risk factor for the efficiency 
of isolation and the metabolic competence of cultured cells. The quality of 
University of Wisconsin (UW) solution, the most commonly used solution to 
preserve the livers (Quintana et al., 2003), is also a key factor (Spinelli et al., 
2002).  A new solution, Celsior, could be an effective alternative to UW 
preservation solution for donor liver samples (Straatsburg et al., 2002; 
Cavallari et al., 2003). Further, both the viability and the percentage of 
successful culture are higher for cells obtained from livers perfused with 
Celsior solution than with UW solution. However, no difference is observed in 
CYP activities in hepatocytes cultured in each preservation solution. These 
above results indicate that livers perfused and stored in Celsior solution offer 
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higher viability and better adaption to culture, but with similar metabolic 
activity. 
  
In contrast to donor liver samples, liver specimens obtained from hepatectomy 
represent the most reliable source of healthy liver tissue, due to easier 
accessibility, more frequent availability and higher quality of isolated 
hepatocyes. (Brandenburg et al., 2005; Li, 2007) Although the surgery requires 
hepatic pedicle clamping (Pringle manoeuvre), which results in warm ischemia 
of the hepatic tissue, hepatocyte yield, viability and metabolic function are not 
greatly affected if the period of warm ischemia is no longer than 30 minutes 
(Lloyd et al., 2004; Richert et al., 2004).  Reoxygenation after a hypoxic period, 
not the duration of the ischemia, seems to be the key to preventing decrease of 
hepatocye functionality (Alexandre et al., 2002).  
 
5.1.1.2 Influence of donor characteristics on outcome of human hepatocyte 
functions  
In order to maximize the availability of high quality hepatocytes from surgical 
specimens, donor factors with the potential to affect yield, viability and 
function of isolated hepatocytes need to be considered. The following 
parameters have been evaluated: age and gender; patients' health; steatosis and 
cholestasis. 
 
For age of donor, no significant differences are observed in the viability and 
survival of cultured cells, but a significant reduction in cell yield is observed 
for donor aged >50 (Vondran et al., 2008). The total CYP-dependent oxidative 
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capability of hepatocytes is not greatly affected by the age. However, for 
certain specific CYP activity, such as CYP3A4, cultured hepatocytes from the 
older than 50 show lower activity than those under 50. This result is in good 
agreement with the observation that CYP variation exists in the adult and 
sometimes it can be greater than 50 fold for a particular CYP (Rodriguez-
Antona et al., 2003), which is probably due to genetic predisposition and the 
individual induction status.  No significant correlation between viability and 
survival of cultured cells and donor gender has been found (Serralta et al., 
2003; Vondran et al., 2008). However, the total CYP-dependent oxidative 
capability of hepatocytes is lower, and the CYP3A4 activity higher, in female 
donors (Gómez-Lechón et al., 2004).  
 
The state of the patients' liver also affects the yield, viability and functionality 
of hepatocytes (Chapman et al., 1993). Specimens with benign diseases (e.g. 
haemangioma) show the highest cell yield and viability, those with secondary 
tumours (e.g. chronic inflammation or cirrhosis) are lower in the cell yield and 
viability, but the lowest results are from those with primary tumours (Vondran 
et al., 2008). For the functionality of hepatocytes, the majority of CYP 
expressions are down-regulated and their related biotransformation pathways 
are changed during inflammation or infection (Gant et al., 2003). In particular, 
some CYPs are more susceptible by cirrhosis, including CYP1A, CYP2C and 
CYP3A (Bastien et al., 2000). 
 
In addition, steatosis and cholestasis need to be considered. Both severe 
steatosis and cholestasis lead to a significant reduction in cell yield and 
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viability (Alexandre et al., 2002; Konera and Dikdan, 2002). In these studies 
steatosis appeared to have a particularly important effect on the total CYP-
dependent oxidative capability of hepatocytes and CYP3A4 activity was lower 
in the livers with steatosis than normal tissue, which is in good agreement with 
previous studies (Weltman et al., 1998). However, the results from other 
published data are conflicting, showing either no influence of histopathological 
alteration (Richert et al., 2004) or even an increase in cell viability from tissue 
with steatosis (Lloyd et al., 2004).  
 
Other factors, including previous chemotherapy, alcohol or tobacco 
consumption have not been shown to affect the yield, viability, attachment rate 
and function of isolated hepatocytes (Alexander et al., 2002).  
 
5.1.1.3 Influence of isolation procedures and operative parameters on 
outcome of human hepatocytes 
Several factors in the isolation procedures and operative parameters have been 
identified to affect the outcome of human hepatocytes. Warm ischaemic time 
longer than 30 minutes reduces the percentage of digested liver and cell yield 
(Alexander et al., 2002), while cold ischaemic time less than 5 hours does not 
affect the cell yield and viability (Richert et al., 2004). Also, an initial high-
pressure washout is recommended to improve the efficiency, to shorten the 
warm ischaemic time and to reduce ischemia reperfusion-related injury (Hart et 
al., 2004). A liver biopsy weight of over 150 g affects the percentage of 
digested liver and a size of between 50 and 100 g is optimal for cell yield 
(Alexander et al., 2002; Richert et al., 2004). Reformation of Glisons' capsule 
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with glue or suture greatly enhances the cell yield and viability (Richert et al., 
2004; Lloyd et al., 2004).  
 
5.1.1.4 Isolation of primary human hepatic stellate cells 
One of the most common methods of isolation of primary human HSCs is 
mince/enzymatic digestion. Briefly, finely minced liver tissue is digested with 
a combination of collagenase and pronase and then HSCs are separated from 
other NPCs by centrifugation over a gradient of Stractan (Bataller et al., 1998), 
Nycodenz (Siegmund et al., 2006), Larex (Muhanna et al., 2008) or Larcoll 
(Boers et al., 2006). The purity of HSCs in these isolates is usually more than 
90% assessed by autofluorescence (Holt et al., 2009), transmission microscopy 
(Marra et al., 1993) or immunofluorescence (Boers et al., 2006).  Cells reach 
80% of confluence in approximately 15 days and generally exhibit typical 
myofibroblast-like phenotype after two serial passages. Overall, this is an 
effective, sensitive and reproducible method for isolation of HSCs. Another 
method is explant outgrowths (Levy et al., 2000). In brief, liver fragments in 
the size of approximately 1 cm
3
 are plated on collagen coated flask and left to 
dry for 30 minutes to assist adherence. A confluence monolayer is usually 
achieved in 21 days, but it always represents a heterogeneous mixture of HSCs 
with other hepatic cell types and has limited number of passages (Schnabl et al., 
2002).  
 
A simple method using normally discarded washings of a two-step collagenase 
perfusion for isolation of primary human HSCs has been established in Tissue 
Engineering group, School of Pharmacy, University of Nottingham. It 
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outweighs other methods because this technique allows simultaneous isolation 
of HSCs and hepatocytes with less contamination of other NPCs. Also, 
comparing to mince/enzymatic digestion and explant outgrowths, it does not 
require matrix coated flask or density gradient centrifugation. Human HSCs by 
this method have been identified by positive staining of monoclonal anti alpha 
smooth muscle actin, anti glial fibrillary acidic protein and anti vimentin and 
negative staining of Kupffer cells and endothelial cells markers, namely 
monoclonal anti human CD68 and endothelial cell antibody (PAL-E). Overall, 
it is a rapid, effective and reliable method of isolation of human HSCs 
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5.1.2 Aims 
The principal aims of the work presented in this chapter are: 
x to study seeding density of human hepatocytes in monoculture on 12-
well and 6-well collagen type I coated plates 
x to test the effects of medium supplements on morphology of human 
hepatocytes on 6-well collagen type I coated plates 
x to test the effects of Matrigel overlay on morphology of hepatocytes 
monoculture  
x to establish 3D spheroids by co-culturing human hepatocytes and 
human hepatic stellate cells on PDLLA coated surface 
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5.2 Material and methods 
5.2.1 Chemicals  
Soltran kidney perfusion was purchased from Baxter Healthcare Ltd, UK. 
Gibco
TM
 Liver Perfusion Solution and Gibco
TM
 Liver Digest Media were 
bought from Invitrogen, UK. Penicillin/ streptomycin solution and 
dexamethasone were purchased from Sigma, UK. Human serum was bought 
from PAA Ltd., UK.  
 
5.2.2 Human liver samples 
Human liver tissues were obtained from therapeutic hepatectomy in Queen's 
Medical Centre, University Hospital in Nottingham. Patient consent and local 
Ethics Committee approval had been given to use the segments not required for 
transplantation (those remaining after cut-down) for research purposes. Patients 
with chronically deranged liver function or cirrhosis were excluded from the 
study. 
 
5.2.3 Primary human hepatocytes isolation 
Primary human hepatocytes were isolated by a method established by the 
Tissue Engineering group, School of Pharmacy, University of Nottingham and 
then improved by Astrazeneca, Sheffield. Segments (25-150 g), distal to the 
site of tumour or other pathology necessitating liver resection, cut from intact 
liver was immediately perfused with ice-cold Soltran kidney perfusion solution 
and immersed in ice-cold Soltran in order to reduce cellular deterioration 
during transportation to the laboratory, which was usually less than 30 minutes. 
On arrival at the laboratory the liver was transferred to the perfusion apparatus 
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and the cannulae connected to the perfusion lines within a Class II biosafety 
cabinet. Veins for cannulation were chosen to give maximum perfusion 
efficiency as tested by flushing with Soltran. The number of plastic cannulae 
used depended on the size of the segment and the distribution of veins, but was 
up to 4 in maximum. Once the perfusion system was connected to the liver 
tissue through cannulae, pre-warmed (37ûC) 1L Gibco
TM
 Liver Perfusion 
Solution was circulated through the system at a rate of 17-20 ml/min for 30 
minutes. On completion, the initial perfusion medium was discarded and 1 L 
Gibco
TM
 Liver Digest Media was re-circulated at a rate of 17-20 ml/min for 40-
60 minutes. After the digestion step, the liver tissue was disrupted gently with 
scissors and the resulting cells were re-suspended in pre-cooled (4ûC) human 
hepatocyte isolation medium (Appendix 1.8.6). The tissue suspension was then 
filtered through 100 ȝm sterile cotton gauze placed over a funnel into a 
cylinder. The filtrate was centrifuged at 50 g for 3 minutes in the pre-cooled 
(4ûC) centrifuge. The cell pellet was washed twice (50 g, 5 minutes) and finally 
re-suspended in pre-cooled human hepatocyte isolation medium with 90% 
Percoll in the 25% (
v
/v) gradient and centrifuged at 100 g for 10 minutes. The 
cell pellet was re-suspended in pre-cooled human hepatocyte plating medium 
(Appendix 1.8.4) and the supernatant was kept for hepatic stellate cell isolation. 
Cell yield and viability were estimated by Trypan Blue and 0.0025 mm
2
 
haemacytometer as described in Chapter 2, Section 2.2.4. A viability of at least 
80% was considered necessary for experimental work. 
 
Collaboration with FRAME Alternative Laboratory from School of Biomedical 
Science, University of Nottingham in September 2007, led to further 
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modification of the method of isolation of primary human hepatocytes. First 
perfusion of 1L Gibco
TM
 Liver Perfusion Solution for 30 minutes was replaced 
by 1 L perfusion buffer with EGTA for 15-20 minutes and the second 
perfusion of 1 L Gibco
TM
 Liver Digest Media was substituted with 1L 
perfusion buffer with collagenase for 20-30 minutes. Also, the centrifuge speed 
for filtrate and cell pellet at 527 rpm (50 g) for 5 minutes was changed to at 
1000 rpm for 2 minutes. In addition, 90% Percoll in the 25% (
v
/v) gradient 
centrifuged at 745 rpm (100 g) was set with 90% Percoll in the 50% (
v
/v) 
gradient at 600 rpm. The remaining procedures were unchanged.  
 
5.2.4 Primary human stellate cells isolation 
The method of isolaton of primary human stellate cells was established and 
modified by the Tissue Engineering group, School of Pharmacy, University of 
Nottingham. All the supernatants from primary hepatocyte isolation were 
centrifuged at 50 g for 5 minutes at room temperature. The resulting pellets 
were discarded and then the supernatants were spinned twice at 50 g for 5 
minutes to remove any contaminated hepatocytes. After that, the supernatant 
from the final spin was centrifuged at   4024 g (5000 rpm) for 20 minutes and 
the pellets, containing hepatic stellate cells, were collected and re-suspended in 
the proper amount of stellate cell medium containing 15% human serum 
(Appendix 1.8.7).  
 
5.2.5 Cell culture 
Primary human hepatocytes were seeded at the density of 0.1429 and 0.1875 
million/m
2
 and a total of 0.5 and 1.6875 million/well were cultured on 12-well 
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and 6-well collagen type I coated plate respectively. Two different sets of 
human plating media and human culture media were used. The first one 
included human plating medium (DMEM containing 4500 mg/L L-glucose and 
25 mM HEPES, supplemented with 2 mM L-glutamine, 0.2 U/ml penicillin, 
0.2 µg/ml streptomycin, 0.5 ng/ml amphotericin B and 10% fetal calf serum) 
and human culture medium (DMEM containing 4500 mg/L L-glucose and 25 
mM HEPES, supplemented with 2 mM L-glutamine, 0.2 U/ml penicillin, 0.2 
µg/ml streptomycin, 0.5 ng/ml amphotericin B, 10 µg/ml bovine pancreas 
insulin and 1 µM dexamethasone). The second set included human plating 
medium (DMEM containing 4500 mg/L L-glucose and 25 mM HEPES, 
supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 0.1µM 
insulin from bovine pancreas, 1 µM dexamethasone and 5% FCS) and human 
culture medium (William's Medium E supplemented with 2mM L-glutamine, 
100 U/ml penicillin, 100 µg/ml streptomycin, 0.1 µM dexamethasone and  
0.1 µM (5.73 µg/ml) insulin from bovine pancreas).  
 
5.2.6 Experimental design 
The effect of seeding density on morphology of primary human hepatocytes 
was investigated. The effect of Matrigel overlay on morphology of primary 
human hepatocytes was also considered. Co-culture of primary human 
hepatocytes and human HSCs was then applied on PDLLA coated plates. All 
the cell cultures have been carried out three times except co-culture on PDLLA 
coated plate for twice. 
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5.3 Results 
5.3.1 The effects of seeding density on morphology of human hepatocytes 
on 12-well and 6-well collagen type I coated plates  
The primary human hepatocytes (viability above 80%) were cultured on 12-
well and 6-well collagen type I coated plates at a density of 0.5 million 
cells/well (0.1429 million/m
2
) and 1.6875 million/well (0.1875 million/m
2
) 
respectively. The first human plating medium was used for the initial four 
hours for cell attachment and then the first human culture medium was used to 
wash off cell debris and replaced for further culture. For cells cultured on 12-
well collagen type I coated plates, attachment to the collagen gel began after 4 
hours with some cell debris and clumping. After 24 hours, cells exhibited 
uniform typical hepatocyte morphology with well-defined polyhedral shape 
and cell membrane, nuclei and a finely granular cytoplasm (Figure 5.1A). In 48 
hours, hepatocyte monolayer became more than 80% confluent but with more 
cell debris and clumping (Figure 5.1B) and the monolayer deteriorated 
gradually within 72 hours (Figure 5.1C). Cells cultured on 6-well collagen type 
I coated plates showed better-defined cell shape and membrane, clearer nuclei 
and finer granular cytoplasm than those cultured on 12-well plates after 24 
hours (Figure 5.2A). After 48 hours, they maintained most of these phenotypic 
characteristics (Figure 5.2B), but deterioration at 72 hours still occurred 
(Figure 5.2C). 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Primary human hepatocytes (0.5 million/well) cultured on 12-well 
collagen type I coated plates in first set media after 24 hours, showing cell 
border (black arrow), nuclei (red arrow) and granular cytoplasm (green arrow) 
(A), 48 hours, showing big amount of cell debris and floating cells (black 
arrows) (B) and 72 hours, showing cell deterioration without typical cuboidal 
shape (black circle) (C). 
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Figure 5.2: Primary human hepatocytes (1.68 million/well) cultured on 6-well 
collagen type I coated plates in first set media after 24 hours, showing clear 
cell border (black arrow), distinct nuclei (red arrow), and fine granular 
cytoplasm (green arrow) (A), 48 hours, showing small amount of cell debris 
and floating cells (B) and 72 hours, showing  cell deterioration without typical 
cuboidal shape (C). 
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5.3.2 The effects of medium supplements on morphology of human 
hepatocytes on 6-well collagen type I coated plates  
Different human plating media and culture media were used to demonstrate the 
effects of supplements on morphology of primary human hepatocytes. For the 
second human plating medium, the addition of 0.1 µM insulin from bovine 
pancreas and 1 µM dexamethasone was included and the amount of fetal calf 
serum was decreased to 5% rather than 10%. For the second human culture 
medium, the concentration of bovine pancreas insulin was decreased from 10 
µg/ml to 5.73 µg/ml and that of dexamethasone was down to 0.1 µM instead of 
1µM. For both second media, the combination of 100 U/ml penicillin and 100 
µg/ml streptomycin were used as antibiotics with no addition of amphotericin 
B. 
 
Human hepatocytes were seeded on 6-well collagen type I coated plates as 
previously described in Section 5.2.5.  Cells cultured with second set media 
showed better attachment and higher survival percentage after 24 hours than 
those cultured with first set media (Figure 5.3A and B). They were more 
confluent and maintained better cell-cell interactions after 48 hours. Clearer 
nuclei and cell membranes were also observed. (Figure 5.4A and B) After 72 
hours, cells cultured with first set media started to spread out and form 
fibroblast-like protrusions. The nuclear volume increased and the cytoplasm 
appeared granulated. (Figure 5.5A), which was a good agreement with 
previous result in Section 5.3.1. However, cells cultured with second set media 
maintained the typical hepatocyte shape and cell membranes and nuclei until 
day 5 (Figure 5.5B and Figure 5.6B). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Primary human hepatocytes (1.68 million/well) cultured with first 
set media, showing about 90% confluence (A), second set media, showing 
about 95% confluence (B) and second set media with Matrigel overlay, 
showing about 100% confluence, best cell borders and the most distinct nuclei 
(C) on 6-well collagen type I coated plates after 24 hours  
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Figure 5.4: Primary human hepatocytes (1.68 million/well) cultured with first 
half cell borders (B) and second set media with Matrigel overlay, maintaining 
 
 
 
 
 
set media, losing almost all cell borders (A), second set media, losing about 
most of cell borders (C) on 6-well collagen type I coated plates after 48 hours  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: Primary human hepatocytes (1.68 million/well) cultured with first 
set media, showing cell deterioration and losing cuboidal shape (A), second set 
media, losing almost all the cell borders, but still maintaining the cuboidal 
shape (B) and second set media with Matrigel overlay, maintaining half of the 
cell borders and cuboidal shape (C) on 6-well collagen type I coated plates 
after 72 hours  
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Figure 5.6: Primary human hepatocytes (1.68 million/well) cultured with first 
set media, showing cell deterioration and losing cuboidal shape (A), second set 
media, losing almost all the cell borders, but still maintaining the cuboidal 
shape (B) and second set media with Matrigel overlay, maintaining half of the 
cell borders and cuboidal shape (C) on 6-well collagen type I coated plates 
after 5 days  
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5.3.3 The effects of Matrigel overlay on morphology of primary human 
hepatocytes  
The method of Matrigel overlay on human hepatocyte after 4 hours initial 
attachment was as described in Chapter 2 Section 2.2.6. Due to better 
maintenance shown by cells cultured with second set media, Matrigel overlay 
was only applied to those cells to investigate any further improvements on 
hepatocyte morphology. Compared to cells cultured with second set media but 
without Matrigel, cells cultured in collagen-Matrigel sandwich showed almost 
100% confluence after 24 hours (Figure 5.3C). They demonstrated tighter cell-
cell interactions, clearer nuclei, bile-canaliculi-like structures, better-delineated 
plasma membrane borders after 48 hours (Figure 5.4C) and maintained the 
better morphology until day 5 (Figure 5.5C and Figure 5.6C).  
 
5.3.4 Co-culture of human hepatocytes with human hepatic stellate cells 
The isolation of primary human hepatocytes and human HSCs were described 
previously in Section 5.2.3 and 5.2.4 respectively. The isolated human HSCs 
were not activated and ready to use until they were cultured in primary human 
stellate cell medium in T75 flask for approximately two weeks. The freshly 
isolated primary human hepatocytes (viability above 80%) and activated 
human HSCs (passage number 3) were co-cultured on 12-well PDLLA coated 
plates with second human culture medium at the density of 125,000 and 62,500 
per well respectively. The ratio of these two cell types was 2:1, which was the 
same as co-culture of rat hepatocytes and rat HSCs in Chapter 2. Small 
aggregates were formed in 72 hours after isolation (Figure 5.7A) and then big 
spheroids with better-defined cell borders were developed on day 5 (Figure 
5.7B). 
 
 
 
Figure 5.7: Co-culture of primary human hepatocytes (0.44 million/well) and 
human passage number 3 HSCs (0.22 million/well) on 12-well PDLLA coated 
plates after day 3, forming spheroids (A) and day 5, maintaining the spheroids 
(B). Second set media were used and the medium was not changed until 72 
hours.  
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5.4 Discussion 
5.4.1 The effects of cell density, media formulation and ECM application 
on morphology of human hepatocytes 
The density of 0.1875 million/m
2
 for primary human hepatocytes proved to 
maintain better cell morphology in the first 48 hours compared to the density of 
0.1429 million/m
2
. However, there was a strong perturbation of cell 
morphology after 72 hours even at a higher seeding density. This agreed with 
other reports in the conventional cultures (Hamilton et al., 2001). If cells were 
seeded at a very high density (almost 100% confluence), cells maintained 
hepatocyte-like morphology for only 1-2 days and then started to detach from 
the surface. Interestingly, the same high density did not result in the same 
confluence of cells in a three-dimensional ECM environment. Therefore, 
human hepatocytes in collagen-Matrigel sandwich with higher density showed 
better hepatocyte morphology in a longer period in this study.  
 
In addition, media formulation had some influence on the morphology of 
hepatocytes in culture. For fetal calf serum, it can enhance the surface 
attachment ability of hepatocytes (William et al., 1977), but it may inhibit the 
re-establishment of bile canaliculi in hepatocytes culture (Terry and Gallin, 
1994) and does not make a positive contribution to maintain cell differentiated 
phenotypes. Therefore, serum-containing medium was only applied to 
hepatocytes culture for the first 4 hours and serum-free medium was used for 
3D spheroids formation over the whole culture period in this study. For 
dexamethasone, it is valuable for long-term preservation of hepatocyte-specific 
functions and polygonal hepatocyte morphology at the concentration of 1µM 
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(Yamada et al., 1980). However, the addition of dexamethasone at 
concentrations from 50 nM to 10 µM altered spheroid formation in a 
concentration-dependent fashion (Abu-Absi et al, 2005). Further, the 
supplement of 10 µM dexamethasone to the medium greatly enhanced LDH 
release and reduced the amount of urea secretion (Dong et al., 2008). Therefore, 
a low concentration of dexamethasone (0.1 µM) was applied to the medium in 
this study. For insulin, its administration to an endotoxemic rodent model 
decreased pro-inflammatory and increased anti-inflammatory mediators with 
enhanced hepatic functions and structure (Jeschke et al., 2005, 2007). Also, the 
addition of insulin at a dose of 10 IU/ml (approximately 10 µg/ml) to primary 
human hepatocytes cultures reduced the expression of pro-inflammatory 
cytokine proteins, including IL-6, TNF and IL-1ȕ, IL-10 and IFN-Į. Therefore, 
the supplement of insulin in the medium might help hepatocytes recover from 
the stress in the process of isolation. 
 
Consequently, the combination of proper seeding density, media formulation 
and Matrigel overlay, which not only provides a 3D ECM environment but also 
offers a number of soluble factors, contributes to the maintenance of 
hepatocyte morphology over a long period. 
 
However, the limitation of this section is lack of hepatocyte ultrastructure data 
to further confirm the formation and maintenance of hepatocyte architecture. 
Transmission electron microscopy (TEM) should be applied to show bile 
canaliculi, tight junctions, desmosomes, and fat and glycogen storage. Myosin 
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fibre-containing HSC and multiple junctions with the adjacent hepatocyte can 
be identified in a spheroid as well by TEM. (Thomas et al., 2005) 
 
5.4.2 Co-culture of primary human primary hepatocyte and human HSCs 
Spheroids formation of primary human hepatocytes and rat HSCs on 12-well 
PDLLA coated plates has been previously achieved by Tissue Engineering 
group, School of Pharmacy, University of Nottingham. However, due to the 
difficulties of isolation and culture of primary human HSCs, spheroid 
formation from co-culture of human hepatocytes and human HSCs was not 
demonstrated. Recently, because of great improvements made on perfusion 
method of isolation HSCs and maintenance of human HSCs in vitro within the 
group, the co-culture of human hepatocytes and human HSCs was finally 
established successfully in this study. 
 
As was described in Chapter 1, hepatocyte homo-spheroids and hetero-
spheroids showed higher viability and higher level of liver-specific functions 
than hepatocyte monolayer. In particular, hetero-spheroids were of great 
interest due to the combination of the benefits of a 3D microenvironment and 
improved hetero-cell-cell interaction. However, in the literature, most of the 
hetero-spheroids were formed by co-culture of rat hepatocytes (Lee et al., 2004; 
Otsuka et al., 2004) or human hepatic cell lines (Fukuda et al. 2006), which 
could not represent the hepatocyte environment in vivo. Therefore, spheroids 
formed by primary human hepatocytes and human HSCs in this study could 
provide a highly stable long-term hepatocyte culture and offer the capacity to 
mimic a more physiologic environment. It will be extremely interesting to 
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interrogate the maintenance of hepatocyte specific functions under these 
culture conditions.  
  
237 
 
 
Chapter Six: 
General Conclusions 
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6.1 Project overview 
In vitro long-term culture of hepatocytes that exhibit high levels of metabolic 
functions is essential to the success of liver tissue engineering, drug 
metabolism studies, disease modelling and many other applications. In this 
thesis, we have demonstrated that the function of hepatocytes in 3D spheroids, 
formed by co-culture of rat hepatocytes and hepatic stellate cells (HSCs) on 
PDLLA surfaces, is enhanced by the addition of extracellular matrix, including 
collagen and Matrigel. The functional capacity of this 3D spheroid model in 
collagen-Matrigel sandwich, as assessed by albumin secretion, urea secretion 
and a number of important CYP activities, is superior to spheroids on PDLLA 
surface and hepatocytes in 2D monoculture. We also report for the first time 
the formation of 3D spheroids by co-culture of human hepatocytes and human 
HSCs on PDLLA surface. The utility of this system remains to be established 
and it may be that, due to limited availability and accessibility of primary 
human hepatocytes, hepatic cell line will remain an alternative option for 
hepatocyes in vitro studies. However, the potential of homologous human 
spheroids to contribute to liver tissue engineering and to provide an ideal 
substrate for drug metabolism studies is an exciting area for further work. 
 
In the absence of a primary cell culture model, a novel immortalized human 
cell line, Fa2N-4, was tested in this thesis. The characterization of CYP1A2, 
CYP2C9, CYP3A4 and CYP2B6 induction in Fa2N-4 cells by a range of 
prototypical compounds at both activity level and mRNA level is reported. 
Fa2N-4 expresses a wider range of CYP functions than other available liver 
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cell lines and may be an effective alternative to primary human hepatocytes for 
the study of CYP1A2 and CYP3A4 induction. 
 
6.2 The mechanism of improved hepatocyte specific functions in co-culture 
of hepatocyte and hepatic stellate cells (HSCs) 
The mechanism for the enhancement of hepatocyte specific functions in co-
cultures has not been elucidated yet. It has been reported to be caused by 
secretion of soluble factors, ECM production, cell-ECM interaction, cell-cell 
interaction or 3D spheroids (3D structure). Studies that have focused on 
separating these effects in co-culture are in disagreement. Ijima et al. shows the 
function of hetero-spheroids formed by co-culture of hepatocytes and bone 
marrow cells (BMCs) is caused by soluble factors derived from BMCs rather 
than a synergistic effect of spheroids formation and these factors (Ijima et al., 
2008). Also, an initial hetero-cell-cell contact between hepatocytes and stroma 
followed by sustained soluble factors from stroma is essential to maintain 
hepatocyte viability and liver-specific functions (Hui and Bhatia, 2007). In 
addition, a combination of hetero-cell-cell interaction between hepatocytes and 
NPCs and sandwich configuration has a strong positive influence on 
hepatocyte phenotype and metabolic capability (Schmelzer et al., 2006). The 
improved liver-specific function of hepatocyte-hepatic stellate cell co-culture 
in collagen-Matrigel sandwich found in this thesis is consistent with a 
combination of hetero-cell-cell interaction, 3D spheroids and cell-ECM 
interaction. Our work does not distinguish between these possibilities and does 
not exclude a contribution from soluble factors derived from HSCs. The exact 
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factor or combination of factors playing a crucial role in maintaining 
hepatocyte function in this co-culture will be investigated in future. 
 
6.3 Potential improvements and applications of the hepatocyte-stellate cell 
co-culture model 
Cell functional benefits of hepatocyte-hepatic stellate cell co-culture are 
identified only after the formation of spheroids in culture on day 3, which 
implies the speed and manner of formation of spheroids is crucial. Supplement 
with growth factors (Selmer et al., 2000), addition of soluble factors such as 
plasmin and plasminogen activator (Hasebe et al., 2003), modification of 
isolation methods (Okubo et al., 2002) or pre-culture of a specific passage 
number of HSCs might provide an alternative faster method of establishment 
of spheroids. Also, the sizes of spheroids appear to be variable between 100 
and 300 µm in diameter from different isolations or even on different plates 
from the same isolation. Hepatocytes in the central portion of the spheroids 
become necrotic if spheroids are bigger than 200 µm in diameter (Takabatake 
et al., 1991). This is consistent with the observation that oxygen maintains its 
ability to pass through only 100 µm depth in liver tissue (Takabatake et al., 
1991). Limiting spheroid size to less than 200 µm in diameter may therefore 
improve function. A method using fluorocarbon as a gel or fluorocarbon-based 
carrier embedded in an ECM gel can effectively increase the oxygen supply in 
vitro (Nahmias et al., 2006) and may be applicable to our spheroid system. 
Application of patterned co-culture techniques, such as microfabrication and 
microcontact printing (Fukuda et al., 2006; Nakazawa et al., 2006) are also 
useful to control spheroids sizes. Moreover, hepatic stellate cells (HSCs), 
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Kupffer cells (KCs) and sinusoidal endothelial cells (SECs) are the three major 
non-parenchymal cell types line the walls of the hepatic sinusoid in vivo. 
Hepatocytes co-cultured with more than one type of NPCs will more accurately 
replicate an in vivo-like environment, and may further enhance hepatocyte 
specific functions. 
 
The model of co-culture of hepatocyte-hepatic stellate cell in collagen-Matrigel 
sandwich in this thesis may be valuable in the development of a bio-artificial 
liver system, toxicology model, or healthy/diseased model. However, 
hepatocytes functionality should be improved in a longer period for bio-
artificial liver model; the sensitivity of spheroids responding to test compounds 
need to be tested for toxicology model; and the accessibility and permeability 
of plasmid or virus to the spheroids need to be investigated. 
 
6.4 Application of the co-culture model for the study of disease 
pathogenesis  
The development of the co-culture in this thesis is intended mainly to provide a 
model for the study disease pathogenesis, particularly that of hepatitis C. An 
estimated 200 million people carry hepatitis C virus (HCV) worldwide, which 
is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular 
carcinoma (HCC) (Seeff and Hoofnagle, 2003; Chisari, 2005).  Currently, the 
only available treatment for chronic HCV infections is the combination of 
pegylated interferon and ribavirin. However, this standard therapy is effective 
in only approximately half of the patients with chronic HCV hepatitis (Feld and 
Hoofnagle, 2005). As there are in addition no effective vaccines against the 
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infection, it is urgent to clearly understand the molecular virology of HCV 
infection.  
 
Recently, a number of small animal models for HCV infection and hepatitis C 
have been developed to evaluate the efficacy of antiviral drugs and neutralizing 
monoclonal antibodies, including immunotolerated fetal rat (Wu et al., 2005), 
immunodeficient mice (Eren et al., 2006) and uPA mice (Kneteman et al., 
2006). However, these models still have some limitations, such as over-
expressed proteins of interest compared with natural HCV infection, and a 
possible influence of the integration site of the transgene on the outcome of the 
study. Also, the chimpanzee model, which can be experimentally infected with 
HCV, is threatened by the ethical and financial issues. USA, one of the 
countries to employ chimpanzees for biomedical research, has decided not to 
continue to breed them for research (Cohen, 2007). 
 
The lack of robust and easily reproducible in vivo models leads to the study of 
in vitro models, but only limited areas have been investigated using in vitro 
models. Primary human or Tupaia hepatocytes have been mainly used for the 
study of HCV infection and of the mechanism of viral entry. For example, 
serum-derived virion is applied to primary Tupais hepatocytes for the study of 
scavenger receptor class B type I (Barth et al., 2005), and HCV-like particle 
(HCV-LP) infected in primary human hepatocytes is for the study of envelop 
glycoprotein E2 (Barth et al., 2003). For the study of viral replication processes, 
the establishment of the replicon systems and the production of recombinant 
infectious virions for HCV is a milestone in HCV research, but occur in a 
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limited cellular environment in which host cell lines have been selected for the 
capacity to sustain replication of the virus and may not be representative of 
primary cells in vivo. Consequently, an efficient cell culture system is required 
to investigate all steps of the viral life cycle and bring new insights in to the 
biology and molecular virology of HCV. A particular advantage of the co-
culture model in this chapter is the capacity to study the signalling between 
hepatocytes and HSC and this system would therefore be an ideal model for the 
study of HCV replication. Work to establish HCV infection in our system is 
currently in progress.  
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Appendix 1 Cell culture solutions 
1.1 Preparation of HanksHEPES buffer (10×) 
NaCl (Sigma, UK)                                1.37 M   (80g/L) 
KCl (Sigma, UK)                                 54 mM   (4g/L) 
KH2PO4 (BDH, Dorset, UK)                4.4 mM  (0.6g/L) 
Na2HPO4.12H2O (Sigma, UK)             3.6 mM  (1.2g/L) 
HEPES (Sigma, UK)                            200 mM   (47.6g/L) 
NaOH (Sigma, UK)                              100 mM  (4g/L) 
Sterile distilled water 1000 ml 
 
x Filter sterilized and stored at 4ûC 
x To make up 1 × buffer, diluted with sterile distilled water and stored at 
4ûC 
 
1.2 Preparation of bicarbonate/glucose solution 
NaHCO3 (Sigma, UK)                        0.74 M   (3.1g/50ml) 
Glucose (Sigma, UK)                          0.28 M   (2.5g/50ml) 
Methionine (Sigma, UK)                     0.1 M     (0.75g/50ml) 
Sterile distilled water              50 ml 
 
x Filter sterilized and stored in aliquots (12 ml) at -20ûC 
x To make up working HanksHEPES buffer, 2 ml bicarbonate/glucose 
solution added to per 100 ml 1× HanksHEPES buffer 
x Stored at 4ûC overnight 
 
1.3 Preparation of 25 mM EGTA solution  
EGTA (Sigma, UK)                              0.48 g 
Sterile 1x HanksHEPES  (no 
bicarbonate/glucose) 
25 ml 
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NaOH 1M (Sigma, UK)                       2.5 ml 
x Made up to 50 ml with 1× HanksHEPES buffer, filter sterilized and 
stored at 4ûC 
 
1.4 Preparation of 250 mM CaCl2 solution 
CaCl2 (FISONS Scientific 
Equipment, UK)                          
          1.84 g 
Sterile distilled water           50 ml 
 
x Filter sterilized and stored at 4ûC 
 
1.5 Preparation of perfusate buffer (EGTA chelating buffer) 
HanksHEPES buffer (10×) 40 ml 
Bicarbonate/glucose solution 8 ml 
25 mM EGTA solution  8 ml 
Sterile distilled water 360 ml 
 
x stored at 4ûC overnight 
 
1.6 Preparation of collagenase perfusate buffer 
HanksHEPES buffer (10×) 20 ml 
Bicarbonate/glucose solution 4 ml 
250 mM CaCl2 solution 4 ml 
Sterile distilled water 180 ml 
 
x stored at 4ûC overnight 
 
  
247
1.7 Preparation of percoll solution 
Percoll (Amersham, UK)                      90 ml 
HBSS (10×) (Sigma, UK)                    10 ml 
 
x Stored at 4ûC 
 
1.8 Preparation of culture medium 
1.8.1 Primary rat hepatocyte complete medium 
Ingredient Volume Final concentration 
Williams medium E (GibcoBRL, UK)        500 ml N/A 
L-glutamine (200 mM) (GibcoBRL, UK)   5 ml 2 mM  
Antibiotic/antimycotic (100× solution) 
(GibcoBRL, UK)                                         
5 ml 100 U penicillin 
100 Pg streptomycin 
250 ng amphotericin B 
Foetal calf serum (Sigma, UK) 50 ml 10 % 
 
1.8.2 Primary rat hepatocyte incomplete medium 
Ingredient Volume Final concentration 
Williams medium E (GibcoBRL, UK)        500 ml N/A 
L-glutamine (200 mM) (GibcoBRL, UK)   5 ml 2 mM  
Antibiotic/antimycotic (100× solution) 
(GibcoBRL, UK)                                         
5 ml 100 U penicillin 
100 Pg streptomycin 
250 ng amphotericin B 
Insulin solution (10 mg/ml) (Sigma, UK) 
Nicotinamide (500 mM solution)  
(Sigma, UK)                   
500 µl 
5 ml 
10 µg/ml 
5 mM 
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1.8.3 Primary rat hepatic stellate cell medium 
Ingredient Volume Final concentration 
Dulbecco’s modified Eagles Medium 
(DMEM) (GibcoBRL, UK)                         
500 ml N/A 
L-glutamine (200 mM) (GibcoBRL, UK)   5 ml 2 mM  
Antibiotic/antimycotic (100× solution) 
(GibcoBRL, UK)                                         
5 ml 100 U penicillin 
100 Pg streptomycin 
250 ng amphotericin B 
Foetal calf serum GOLD (Sigma, UK) 50 ml 10 % 
 
1.8.4 Primary human hepatocyte plating medium 
Ingredient Volume Final concentration 
Williams medium E (GibcoBRL, UK)        500 ml N/A 
Antibiotic (100× solution) (GibcoBRL, 
UK)                                                              
5 ml 100 U penicillin 
100 Pg streptomycin 
Insulin solution (10 mg/ml) (Sigma, UK) 
Dexamethasone (Sigma, UK)    
 L-glutamine (200 mM) (GibcoBRL, UK)
2 µl 
50 µl 
5 ml 
0.1 µM 
0.1 µM 
2 mM 
 
1.8.5 Primary human hepatocyte culture medium 
Ingredient Volume Final concentration 
Dulbecco’s modified Eagles Medium 
(DMEM) (GibcoBRL, UK)                         
500 ml N/A 
Antibiotic (100× solution) (GibcoBRL, 
UK)                                                              
5 ml 100 U penicillin 
100 Pg streptomycin 
Insulin solution (10 mg/ml) (Sigma, UK) 
Dexamethasone (Sigma, UK)    
 Foetal calf serum (Sigma, UK)                   
2 µl 
500 µl 
25 ml 
0.1 µM 
1 µM 
5 % 
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1.8.6 Primary human hepatocyte isolation medium 
Ingredient Volume Final concentration 
Dulbecco’s modified Eagles Medium 
(DMEM) (GibcoBRL, UK)                         
500 ml N/A 
L-glutamine (200 mM) (GibcoBRL, UK)   5 ml 2 mM  
Antibiotic/antimycotic (100× solution) 
(GibcoBRL, UK)                                         
5 ml 100 U penicillin 
100 Pg streptomycin 
Foetal calf serum (Sigma, UK) 50 ml 10 % 
 
1.8.7 Primary human hepatic stellate cell medium 
Ingredient Volume Final concentration 
Dulbecco’s modified Eagles Medium 
(DMEM) (GibcoBRL, UK)                         
500 ml N/A 
L-glutamine (200 mM) (GibcoBRL, UK)   5 ml 2 mM  
Antibiotic/antimycotic (100× solution) 
(GibcoBRL, UK)                                         
5 ml 100 U penicillin 
100 Pg streptomycin 
Human serum (Sigma, UK) 75 ml 15 % 
 
x Stored at 4ûC and expired in two weeks 
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Appendix 2 Assay buffers 
2.1 Fluorescence assay for ethoxy resorufin-O-dealkylase (EROD) activity 
2.1.1 Krebs buffer 
NaCl  (Sigma, UK) 120 mM (7.013 g) 
KCl (Sigma, UK) 4.8 mM (0.358 g) 
KH2PO4 (BDH, Dorset, UK)                              1.2 mM (0.163 g) 
NaHCO3 (Sigma, UK) 24 mM (2.106 g) 
MgCl2 (Sigma, UK) 1.2 mM (0.244 g) 
CaCl2 (FISONS Scientific Equipment, UK) 1.8 mM (0.265 g) 
HEPES (Sigma, UK) 10 mM (2.383 g) 
Sterile distilled water             1000 ml 
 
x Filter sterilized and stored at 4ûC 
 
2.1.2 7-Ethoxyresorufin 1mM stock solution (200 ×) 
7-Ethoxyresorufin (Sigma, UK)                       2.63 mg 
Dimethyl sulphoxide (DMSO) (Sigma, UK) 10 ml 
 
x Stored at 4ûC in 200 µl aliquots and protected from light with foil 
x Diluted to 5 µM with Krebs buffer 
 
2.1.3 Dicoumarol 2 mM stock solution 
Dicoumarol                             1.0089 g 
Dimethyl sulphoxide (DMSO) (Sigma, UK) 15 ml 
 
x Diluted to 10 µM with Krebs buffer 
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2.1.4 Sodium acetate buffer (0.1 M) pH 4.5 
NaCH3COO
.
3H2O (Fisher Scientific, UK) 4.101 g 
Sterile distilled water 500 ml 
 
x Ajusted to pH 4.5 and stored at 4ûC 
 
2.1.5 ȕ-glucuribudase enzyme stock solution (1600 units/ml) 
ȕ-glucuribudase enzyme (374000 units/g)       1.35 g 
Krebs buffer 15.75 ml 
 
x Stored at -20ûC in 500 µl aliquots 
x Diluted to 32000 units/ml  with sodium acetate buffer 
2.1.6 7-hydroxyresorufin standards 
Step Concentration Stock Krebs buffer (ml) 
1 0.1 mM 2.35 mg 10 
2 0.1 µM 10 µl from step 1 1 
3 100 pmol/ml 100 µl from step 2 10 
4 50 pmol/ml 5 ml from step 3 5 
5 25 pmol/ml 5 ml from step 4 5 
6 12.5 pmol/ml 5 ml from step 5 5 
7 6.25 pmol/ml 5 ml from step 6 5 
8 3.125 pmol/ml 5 ml from step 7 5 
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2.2 Rat albumin enzyme-linked immunosorbent (ELISA) assay 
2.2.1 ELISA coating buffer 
Carbonate-bicarbonate capsule (Sigma, UK)   1 capsule 
Sterile distilled water  100 ml 
 
x stored at 4ûC 
 
2.2.2 ELISA washing solution 
Tris buffered saline pH 8 (TBS) (Sigma, UK)   
Polyoxyethylene sorbitan monolaurate                   
(Tween 20) (Sigma, UK)                                                      
1 sachet 
0.5 ml        
(0.05% v/v) 
Sterile distilled water  1000 ml 
 
2.2.3 ELISA blocking solution 
Tris buffered saline pH 8 (TBS) (Sigma, UK)   
Bovine serum albumin (BSA) (Sigma, UK)                         
1 sachet 
10 g (1% w/v) 
Sterile distilled water  1000 ml 
 
2.2.4 ELISA dilution solution 
Tris buffered saline pH 8 (TBS) (Sigma, UK)   
Bovine serum albumin (BSA) (Sigma, UK)    
Tween 20 (Sigma, UK)                                                     
1 sachet 
10 g (1% w/v) 
0.5 ml        
(0.05% v/v) 
Sterile distilled water  1000 ml 
 
 
  
253
2.2.5 ELISA stop solution 2M H2SO4
x Made up to sterile distilled water and stored at room temperature 
 
2.2.6 Dilutions of calibrator albumin 
Step Concentration 
(ng/ml) 
Volume of stock Sample diluents 
(ml) 
1 500 5 µl 30 
2 250 1 ml from step 1 1 
3 125 1 ml from step 2 1 
4 62.5 1 ml from step 3 1 
5 31.25 1 ml from step 4 1 
6 15.625 1 ml from step 5 1 
7 7.8 1 ml from step 6 1 
8 3.9 1 ml from step 7 1 
9 1.95 1 ml from step 8 1 
10 0.975 1 ml from step 9 1 
11 0.49 1 ml from step 10 1 
 
2.2.7 Dilutions of HRP conjugated anti-albumin 
Step Concentration 
(ng/ml) 
Volume of stock Sample diluents 
(ml) 
1 1:1000 5 µl 5 
2 1:10000 1 ml from step 1 9 
3 1:20000 1 ml from step 2 1 
4 1:40000 1 ml from step 3 1 
5 1:80000 1 ml from step 4 1 
 
2.3 High performance liquid chromatography (HPLC)  
2.3.1 Mobile phase solution A 
HPLC grade acetonitrile Far UV          50 ml 
Formic acid                                           250 µl 
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Sterile distilled water 450 ml 
2.3.2 Mobile phase solution B 
HPLC grade acetonitrile Far UV          450 ml 
Formic acid                                           75 µl 
Sterile distilled water 50 ml 
 
2.3.3 Testosterone working buffer 
Testosterone (Sigma, UK)                                11.6 mg  
100 % methanol 1 ml 
 
x 5ȝl of solution mixed with 2 ml EBSS (Fisher, UK) and stored at 4ûC  
 
2.4 Estimation of DNA content using HOECHST 33258 
2.4.1 Hoechst 33258 dilution buffer 
Trizma base(Sigma, UK)                                                       
Ethylenediamine tetra-acetic acid (EDTA) (Sigma, UK)     
Sodium chloride (Sigma, UK)                                              
0.01 M 
0.01 M 
0.1 M    
Sterile distilled water  Made up to 1 L 
 
x Adjusted to pH 7 with 1 M HCl and stored at 4ûC  
2.4.2 Hoechst 33258 stock solution 
Bisbenzinide (Sigma, UK)                               20 mg  
Saline sodium citrate buffer (SSC) 20 ml 
 
x Stored at -20ûC in 200 µl aliquots 
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2.4.3 Hoechst 33258 working solution (2 µg/ml) 
Hoechst 33258 stock solution 200 µl  
Hoechst 33258 dilution buffer 49.8 ml 
 
2.4.4 DNA stock solution 
DNA (sodium salt from salmon tests) 
(Sigma, UK)     
20 mg 
Saline sodium citrate buffer (SSC) 20 ml 
 
x Stored at -20ûC in 200 µl aliquots 
 
2.4.5 DNA working solution (100 µg/ml) 
DNA stock solution 200 µl 
Papain solution 1.8 ml 
 
2.4.6 Papain buffer 
Dibasic sodium phosphate (Sigma, UK)                             
L-Cysteine hydrochloride (Sigma, UK)                              
EDTA (Sigma, UK)                                                            
0.1 M 
0.005 M 
0.005 M    
Sterile distilled water  Made up to 100 ml 
 
x Adjusted to pH 6.5 with 1 M HCl and stored at 4ûC  
2.4.7 Papain solution 
Papain (Sigma, UK) 0.0264 g 
Papain buffer 25 ml 
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x Made fresh on the day required 
2.5 Oil red O stain for hepatic stellate cells 
2.5.1 Oil read O stock solution 
Oil red O (Sigma, UK)                                    0.5 g 
Isopropanol (Fisher, UK) 100 ml 
 
x stored at 4ûC 
 
2.5.2 Oil red O staining solution 
Oil red O stock solution (Sigma, UK)              60 ml 
Sterile distilled water (Fisher, UK) 40 ml 
 
x Allowed to stand for 10 minutes and filtered before use 
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Appendix 3 Optimization of technique of primary rat hepatocytes isolation  
Rat hepatocytes functionalities were firstly assessed by albumin secretion, urea 
secretion and testosterone metabolism assay on 12-well plates (Chapter 3, 
Figure 3.2 and 3.3). However, hepatocytes spheroids were not successfully 
formed on 12-well PDLLA coated plates as expected (Chapter 3, Figure 3.1). 
After the studies of the effects of different passage number HSCs and seeding 
density on spheroids formation (Chapter 3), 6-well plates were used for 
cultured hepatocytes instead. Also, because of inaccuracy and insensitivity of 
testosterone metabolism assay, and absence of DNA normalization of data by 
12-well plates, LC-MS/MS and DNA content assay by QIAamp
®
 DNA Mini 
Kit were introduced to hepatocytes cultured on 6-well plates. As a result, the 
spheroids were successfully developed in all culture systems except 
monoculture in collagen-Matrigel sandwich. In addition, the data of albumin 
secretion, urea secretion and CYP activities by LC-MS/MS were normalized to 
DNA level. However, after the first successful experiment on 6-well plates 
(Chapter 3, Figure 3.5 and 3.6), the viability of rat hepatocytes dropped 
dramatically and the CYP activities of spheroids disappeared after only a few 
days. The viability decreased from approximately 80% to 30% before percoll. 
The CYP activities of spheroids maintained for only three days instead of over 
a week. More surprisingly, cells in monoculture showed better functionalities 
than those in culture configuration, but cells co-cultured with HSCs in 
collagen-Matrigel sandwich showed the best functionalities from previous 
experiment. Therefore, the influence of chemicals (HEPES, EGTA, CaCl2 and 
collagenase), water, medium, perfusion time and deceleration speed on the 
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quality of hepatocytes were assessed in order to get better viable and functional 
rat hepatocytes. Indices of quality were: the viability of hepatocytes following 
isolation, as assessed by dye exclusion; the morphology of hepatocytes in 
monoculture and co-culture; subsequently, the results of CYP function assays. 
The following experiments were conducted: 
 
 Solutions Collagenase Total cell 
number 
(million) 
Viability 
before 
percoll 
Spheroids 
formation 
Functional 
analysis 
Other 
Exp 1 HanksHEPES 
prepared in 
Boots 
building 
C5138 LOT 
037K7691  
715 units/ mg 
(Sigma) 
100 heps + 
good yield of 
HSCs 
 
80% Yes, except 
monoculture 
in collagen-
Matrigel 
sandwich 
Chapter 3 
Figure 3.6 
 
Exp 2 HanksHEPES 
prepared in 
CBS building 
(no de-
ionized 
water) 
C5138 LOT 
037K7691  
715 units/ mg 
(Sigma) 
5 heps + no 
yield of HSCs
10% NA NA Hard liver 
lobes 
during 
perfusion 
Exp 3 
 
HanksHEPES 
prepared in 
CBS building 
(no de-
ionized 
water) 
C5138 LOT 
037K7691  
715 units/ mg 
(Sigma) 
No heps + no 
yield of HSCs
NA NA NA Hard liver 
lobes 
during 
perfusion 
Exp 4 New 
HanksHEPES 
prepared by 
new 
chemicals 
C5138 LOT 
037K7691  
715 units/ mg 
(Sigma) 
No heps + no 
yield of HSCs
NA NA NA Hard liver 
lobes 
during 
perfusion 
Exp 5  New 
HanksHEPES 
prepared by 
new 
chemicals in 
de-ionized 
water 
C5138 LOT 
037K7691  
715 units/ mg 
(Sigma) 
10 heps + no 
yield of HSCs
20%  NA NA Less harder 
liver lobes 
during 
perfusion 
Exp 6 New 
HanksHEPES 
prepared by 
new 
chemicals in 
de-ionized 
water 
C5138 LOT 
037K7691  
715 units/ mg 
(Sigma) 
8 heps + no 
yield of HSCs
23%  NA NA Less harder 
liver lobes 
during 
perfusion 
Exp 7 New 
HanksHEPES
, same as Exp 
6 but with 
new HEPES 
Catalogue 
No. H4043, 
Sigma 
 
 
 
 
C5138 LOT 
037K7691  
715 units/ mg 
(Sigma) 
20 heps + no 
yield of HSCs
35% NA NA Soft liver 
lobes 
during 
perfusion 
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Exp 8 
 
 
 
 
 
 
Same as Exp 
7 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
20 heps + no 
yield of HSCs
 
35% NA NA Soft liver 
lobes 
during 
perfusion 
Exp 9  New 
HanksHEPES 
prepared as 
Exp 7 but 
with different 
Cat No. 
E3889 EGTA 
and Cat No. 
C8106 CaCl2
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
98 heps + 
good yield of 
HSCs 
50% NA NA Soft liver 
lobes 
during 
perfusion + 
big liver 
lobes (rat in 
450 g) 
 
Exp 10 Same as Exp 
9 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
30 heps + 
good yield of 
HSCs 
50% NA NA Small liver 
lobes (rat in 
200 g) 
Exp 11 
 
 
 
 
Same as Exp 
9 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
50 heps + 
good yield of 
HSCs 
45%  NA NA Normal 
liver lobes 
(rat in 300 
g) 
Exp 12 Same as Exp 
9 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
8.2 heps + no 
yield of HSCs
35% NA NA Normal 
liver lobes 
(rat in 300 
g) 
Exp 13 Same as Exp 
9, but 10% 
serum in 
collagenase 
buffer 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
28 heps + no 
yield of HSCs
45% NA NA Normal 
liver lobes 
(rat in 300 
g) 
Exp 14  Same as Exp 
9 
C1889 LOT 
077K8613 
(Sigma) 
 
20 heps + 
very low 
yield of HSCs
40% NA NA Normal 
liver lobes 
(rat in 300 
g) 
Exp 15 Same as Exp 
9 
C5138 with 
lower 
collagenase 
activity  
455 units/mg 
(Sigma) 
40 heps + 
very low 
yield of HSCs
 
45%, 
90% after 
percoll 
Yes, except 
monoculture 
in collagen-
Matrigel 
sandwich and 
coculture on 
collagen gel 
Appendix 3 
Figure 3.1 
Normal 
liver lobes 
(rat in 300 
g) 
Exp 16  Same as Exp 
9, but 160 
mg 
collagenase in 
200 ml buffer 
Cat No. 
11 088793 001 
(Roche) 
72 heps + no 
yield of HSCs
60% Yes, except 
monoculture 
in collagen-
Matrigel 
sandwich 
Appendix 3 
Figure 3.2 
15 mins 
collagenase 
buffer 
perfusion 
time  
Exp 17 Same as Exp 
9, but 80 mg 
collagenase in 
200 ml buffer 
Cat No. 
11 088793 001 
(Roche) 
28 heps + no 
yield of HSCs
40% NA NA 15 mins 
collagenase 
buffer 
perfusion 
time  
Exp 18 Same as Exp 
9, but 100mg 
collagenase in 
200 ml buffer 
Cat No. 
11 088793 001 
(Roche) 
70 heps + 
good yield of 
HSCs 
60.5% NA NA 20 mins 
collagenase 
buffer 
perfusion 
time  
Exp 19 Same as Exp 
18 
Cat No. 
11 088793 001 
(Roche) 
40 heps + 
good yield of 
HSCs 
65.3% NA NA 20 mins 
collagenase 
buffer 
perfusion 
time  
Exp 20 Same as Exp 
18 
Cat No. 
11 088793 001 
(Roche) 
 
 
 
 
 
82 heps + 
good yield of 
HSCs 
63.3% NA NA 20 mins 
collagenase 
buffer 
perfusion 
time  
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Exp 21 Same as Exp 
18 
Cat No. 
11 088793 001 
(Roche) 
15 heps + no 
yield of HSCs
 
20% 
NA NA 20 mins 
collagenase 
buffer 
perfusion 
time 
Exp 22 Prepared in 
Astrazeneca 
Cat No. 
11 088793 001 
(Roche) 
40 heps 80%  Yes, except 
monoculture 
in collagen-
Matrigel 
sandwich 
Appendix 3 
Figure 3.3 
Viability 
dropped to 
60% due to 
transport 
but back to 
84% after 
percoll 
Exp 23 Same as Exp 
9 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
60 heps + 
good yield of 
HSCs 
60% NA NA Fresh 
william E 
medium 
Exp 24 Same as Exp 
9 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
80 heps + 
good yield of 
HSCs 
72% NA NA Fresh 
william E 
medium 
Exp 25 
 
 
 
 
Same as Exp 
9 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
50 heps + 
good yield of 
HSCs 
65% NA NA Fresh 
william E 
medium 
Exp 26 Same as Exp 
9 
C5138 LOT 
116K7681 
715 units/ mg 
(Sigma) 
60 heps + 
good yield of 
HSCs 
63% Yes, except 
monoculture 
in collagen-
Matrigel 
sandwich 
Appendix 3 
Figure 3.4 
(no 20 mins 
activities in 
raw data) 
Fresh 
william E 
medium 
Exp 27 Same as Exp 
18 
Cat No. 
11 088793 001 
(Roche) 
50 heps + 
good yield of 
HSCs 
70% NA NA Fresh  
william E 
medium 
Exp 28 Same as Exp 
18 
Cat No. 
11 088793 001 
(Roche) 
40 heps + 
good yield of 
HSCs 
65% Yes, except 
monoculture 
in collagen-
Matrigel 
sandwich 
Appendix 3 
Figure 3.5 
Fresh  
william E 
medium 
Exp 29 
 
 
 
 
Same as Exp 
9 
Cat No.17465 
(AMS 
Biotechnology 
Ltd.) 
40 heps + 
good yield of 
HSCs 
64% NA NA Low 
deceleration 
speed 
Exp 30 Same as Exp 
9 
Cat No.17465 
(AMS 
Biotechnology 
Ltd.) 
43 heps + 
good yield of 
HSCs 
63% NA NA Low 
deceleration 
speed 
Exp 31 
 
 
 
 
Same as Exp 
9 
Cat No.17465 
(AMS 
Biotechnology 
Ltd.) 
38 heps + 
good yield of 
HSCs 
61%  Yes, except 
monoculture 
in collagen-
Matrigel 
sandwich 
Appendix 
Figure 3.6 
Low 
deceleration 
speed 
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Although cell viability was back to approximately 70% before percoll after 
changing chemicals, medium, etc, it failed to reach 80% as previous isolations. 
In addition, Figure 3.1, 3.2, 3.3, 3.4, 3.5 and 3.6 show the CYP activities of rat 
hepatocytes in different culture configurations. From all the data, cells 
monocultured in collagen-Matrigel sandwiches show better activities than cells 
in any other culture systems, which are conflict from previous experiments. In 
conclusion, despite this very extensive set of experiments assessing the 
contribution of key variables, we were unable to replicating the high 
hepatocyte viability and consistent results of earlier isolations. 
 
 
 
 
 
 
 
 
 
 
 
A) 
 
B) 
 
C) 
 
Figure 3.1 Paracetamol production (CYP1A2 activity) (A), 1’-hydroxymidazolam 
production (CYP3A1 activity) (B), and 1’-hydroxybuproprion (CYP2B6 activity) 
production (C) by rat hepatocytes on 6 well plates after 24 hours. (n=1) 
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A) 
 
B) 
 
C) 
 
 
Figure 3.2 Paracetamol production (CYP1A2 activity) (A), 1’-hydroxymidazolam 
production (CYP3A1 activity) (B), and 1’-hydroxybuproprion (CYP2B6 activity) 
production (C) by rat hepatocytes on 6 well plates after 24 hours. (n=1) 
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A) 
 
B) 
 
C) 
 
Figure 3.3 Paracetamol production (CYP1A2 activity) (A), 1’-hydroxymidazolam 
production (CYP3A1 activity) (B), and 1’-hydroxybuproprion (CYP2B6 activity) 
production (C) by rat hepatocytes on 6 well plates after 24 hours. (n=1) 
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A) 
 
B)  
 
C) 
 
 
Figure 3.4 Paracetamol production (CYP1A2 activity) (A), 1’-hydroxymidazolam 
production (CYP3A1 activity) (B), and 1’-hydroxybuproprion (CYP2B6 activity) 
production (C) by rat hepatocytes on 6 well plates after 24 hours. (n=1) 
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A) 
 
B) 
 
C) 
 
Figure 3.5 Paracetamol production (CYP1A2 activity) (A), 1’-hydroxymidazolam 
production (CYP3A1 activity) (B), and 1’-hydroxybuproprion (CYP2B6 activity) 
production (C) by rat hepatocytes on 6 well plates after 24 hours. (n=1) 
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A) 
 
B) 
 
C) 
 
Figure 3.6 Paracetamol production (CYP1A2 activity) (A), 1’-hydroxymidazolam 
production (CYP3A1 activity) (B), and 1’-hydroxybuproprion (CYP2B6 activity) 
production (C) by rat hepatocytes on 6 well plates after 24 hours. (n=1) 
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